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ABSTRACT
CHARACTERIZATION OF DE NOVO PROTEIN AGGREGATE
FORMATION IN S. CEREVISIAE
Douglas R. Lyke, B.S.
Marquette University, 2020
Misfolded proteins are commonly refolded to a functional conformation or
degraded by quality control mechanisms. When misfolded proteins evade quality
control, they often form aggregates that are sequestered to specific sites in the
cell. The proper sequestration of aggregates is thought to prevent potential
dysfunction, toxicity and disease that is often associated with the presence of
aggregates. However, the cellular mechanisms that underlie the management of
newly formed protein aggregates are unclear. To understand the cellular
response to protein aggregate formation, I used the aggregation prone prion
domain of the Sup35 protein (Sup35NM) in yeast. Previous work observing GFPtagged Sup35NM (Sup35NM-GFP) through 3D time-lapse microscopy observed
consistent two-step behavior of newly formed aggregates. The first step involves
the formation of small foci that are highly mobile. These foci can coalesce to form
larger mature aggregates. The second step is the sequestration of matured
aggregates near the periphery of the cell. In this study I developed novel
quantitative techniques to measure aggregate behavior during both steps of
formation. Using these techniques, I determined that the mobility and
coalescence of protein aggregates, step 1, is dependent on both the actin
cytoskeleton and the Myo2p motor protein. However, step 2 is dependent upon
actin networks, but not Myo2p. It was unclear whether this behavior was specific
to Sup35NM-GFP or part of a general response to protein aggregation; therefore
I also quantified the formation of other types of aggregates. Chemically induced
stress granules and a human aggregating protein associated with amyotrophic
lateral sclerosis, TDP-43, both undergo a two-step formation process that is
dependent upon actin. These data suggest that there is a general cellular
process in responding to different types of newly formed aggregates. Together,
this study provides new insights into the mechanisms used to respond to the
formation of protein aggregates, changing the current dogma of the field, and
suggests for future consideration.
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Chapter 1: Introduction
1.1: Overview
Cell biology is the study of the structure, function, and components of the
simplest unit of life, the cell. In the cell, proteins serve multi-functional tasks in all
organisms from single celled up to humans. The tasks that proteins provide can
be very diverse including structure, transport, enzymatic activity, chaperones,
messengers, antibodies, etc. To provide these various functions, polypeptides
fold into 3D conformations based on amino acids and cellular interactions. Some
conformations are more thermodynamically favorable than others, and are
typically associated with function. However, not all folds are favorable or
functional, and the cell must manage these misfolded proteins by either refolding,
sequestering, or degrading the protein. If misfolded proteins are not managed
quickly by the cell, they are capable of forming large protein aggregates that are
often associated with cellular dysfunction, toxicity, and disease (Labaddia and
Morimoto, 2015). Protein aggregation is not always detrimental to the cell,
however the cellular mechanisms that recognize and manage protein aggregates
to prevent cellular dysfunction are not well understood. This dissertation aims to
identify factors involved in the cellular mechanisms that manage the initial
formation of protein aggregates in hopes of understanding associated diseases
better.
1.2: Protein Misfolding and Aggregation
Misfolding of proteins is a much more common phenomenon than one
might expect. Misfolding occurs in a number of ways such as during translation
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through misincorporation of amino acids or mutation, by mislocalization or
molecular crowding on the nascent polypeptide, post-translational modifications,
or later through spontaneous misfolding. The initial synthesis of proteins happens
through translation at the ribosome, which is not perfect and has been described
as the most error prone step in protein synthesis (Ogle and Ramakrishnan,
2005). Scientists conservatively estimate that at least 15% of average length
proteins contain one or more misincorporated amino acids (Drummond and
Wilke, 2009). Errors to the amino acid sequence or mutations can occur
spontaneously as a result of transcriptional or translational misincorporation,
splicing errors, ribosome stalling, and premature termination (Drummond and
Wilke, 2009). Mutations can also be inherited, referred to as familial mutations.
For example, mutations in the human protein Transthyretin (TTR) can be
inherited, and lead to the development of familial amyloidotic polyneuropathies
(Hund, 2012).
Misfolding can occur even after the polypeptide is properly translated.
Post-translational modification errors can result in misfolding (Drummond and
Wilke, 2009). If the polypeptide is not localized properly in the cell it may not fold
properly. For example it is thought that proteins destined for secretory pathways
that remain in the cytosol will not fold properly (Levine et al., 2005). Molecular
crowding can also be a cause of protein misfolding (Ellis, 2001).
Even after proteins have been folded subsequent misfolding can occur
spontaneously. Protein folds are not static, but rather dynamic influenced by their
surroundings and chemical properties. “Folding Funnels” predict that
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polypeptides are directed towards, stable, low energy state folds. There could be
multiple possible conformations of different stabilities (Leopold et al., 1992). The
dynamic properties of proteins allows them to take on less stable conformations
periodically, which can be considered misfolded forms (Shakhnovich et al.,
2006). Changes to the cellular environment through things such as aging or
stress have the potential to cause alternate or misfolded conformations to be
favored in the cell (Hipkiss, 2006; Gidalevitz et al., 2011).
The cell has protein quality control (PQC) machinery to refold or degrade
proteins using chaperones, autophagy, or the proteasome. Often the first
response is an attempt of molecular chaperones to refold the protein to a correct
conformation using an ATP dependent process (Saibil, 2013). Chaperones,
acting in complex with co-chaperones, often associate directly with the ribosome
to facilitate folding as polypeptides are being synthesized, either in the ER to aid
in folding of secreted or membrane bound proteins, or in the cytosol to assist in
the refolding of proteins (Gautschi et al., 2002; Nishikawa et al., 2001; Young et
al., 2004). If misfolded proteins cannot be refolded, they can be degraded
through either autophagy or the proteasome-mediate proteolysis (Labaddia and
Morimoto, 2015). There are two types of autophagy in the cell: macroautophagy
and microautophagy which break down bulk cytoplasmic material or distinct
organelles or molecules through selective respectively (Reggiori and Klionsky,
2013). Degradation by the proteasome is much more targeted, with proteins
destined to be degraded being tagged with ubiquitins that are recognized by the
proteasome complex (Nandi et al., 2006; Wang et al., 2013). However, when
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misfolded proteins escape either refolding or degradation, they will commonly
form aggregates with other misfolded proteins (Moreno-Gonzalez and Soto,
2011).
Misfolded proteins are prone to associate together based on their
biochemical properties and form aggregates (Hipp et al., 2014). There are two
types of protein aggregates in yeast: amorphous and amyloid. Amorphous
aggregates are normally unorganized, typically made of multiple types of protein,
and not commonly associated with disease (Weids et al., 2016). This type of
aggregate usually forms as the cell responds to a transient stress in which
proteins associated with processes such as translation that need to be down
regulated are sequestered into aggregates or inclusions until the stress is
removed leading to reversal of the aggregate (Buchnan and Parker, 2009).
Conversely, amyloid aggregates are highly structured and insoluble formations,
comprised of many copies of the same protein (Greenwald and Riek, 2010).
Amyloids are also resistant to heat, detergent, and proteases, making these
aggregates difficult to resolve (Rambaran and Serpall, 2008, Greenwald and
Riek, 2010). Amyloids may have biological benefits (Bleem and Daggett, 2017),
however they are commonly associated with disease such as Alzheimer’s and
Type-II Diabetes (Rambaran and Serpall, 2008). While not all amyloids are
infectious such as TDP-43 aggregates that are associated with ALS, a subset of
amyloids called prions are infectious. Prions are self-propagating amyloids that
cause monomeric versions of the protein to misfold to the prion conformation and
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Figure 1.1: Prion Protein Aggregate Formation. In this model the circles
represent functionally folded proteins, while the squares are misfolded, prion
version of the protein. In the first panel proteins are normally folded, however
over time it is possible for a protein to take on a misfolded conformation (square,
panel 2). Prion protein aggregates are capable of influencing other normally
folded versions of the same protein to become misfolded to the prion
conformation, as shown by the arrows in panel 2 and 3. As more protein
becomes misfolded, the aggregate is able to grow larger (panel 4).

associate with the aggregate (Figure 1.1; Prusiner, 2006), and are associated
with diseases such as Creutzfeldt-Jakob’s (Imran and Mahmood, 2011).
Proteins that form either amorphous or amyloid aggregates often contain
intrinsically disordered regions (IDR) are susceptible to aggregation as this
region is prone to associating with many binding partners, including other
proteins. Exposure of the IDR in a misfolded protein increases the ability of the
protein to bind and interact with others, leading to aggregation (Uemura et al.,
2018). Another biochemical property that leads to protein aggregation is the
exposure of hydrophobic residues. Typically, at least for cytosolic proteins,
hydrophobic residues are buried within the protein and not exposed to avoid
interaction with cytosol. However, when a protein is misfolded, it is possible for
these residues to become exposed. This exposure leads to protein aggregation
as proteins clump together in an effort to hide their hydrophobic residues (Chiti
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and Dobson, 2006; Song, 2013). Once protein aggregates form, they can be
dealt with by similar mechanisms to misfolded proteins, degradation or refolding,
or incorporated into protein inclusions that sequester aggregates from the cellular
environment for later management (Hipp et al., 2014).

1.3: Mammalian Protein Aggregation
Protein aggregation is associated with a variety of diseases, many of
which are age related (Gregersen et al., 2006). While it is unclear, the
infrequency of protein aggregate diseases in younger individuals suggests that
management of misfolded proteins is more efficient but becomes less robust over
time. Similar to mutations that cause protein misfolding, diseases can be
characterized as spontaneous or familial. Spontaneous disease is typically
associated with later onset with disease progression commonly associated with
declining protein quality control with age, whereas familial diseases have earlier
onset due to inherited mutations affecting the associated protein causing
thermodynamics to favor the formation of misfiled, aggregated proteins. For
example aggregation of Wildtype TTR causing senile systemic amyloidosis is
associated with an onset after 60 years of age, however TTR-V30M is an
inherited mutation that leads to onset of familial amyloid cardiomyopathy around
45-50 years of age (Ruberg and Burk, 2012).
While much focus has been placed on curing or treating protein
aggregation diseases, the initial formation of aggregates is not well understood
and why older individuals are more susceptible to disease. It is possible that in
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younger cells PQC mechanisms are more robust to handle protein aggregation,
and as cells age misfolded proteins are allowed to accumulate with the addition
of other aging factors such as reactive oxygen species and DNA damage,
overloading the remaining PQC to efficiently recognize and manage aggregates.
Regardless of age, it is still unknown how the cell recognizes and manages
newly formed protein aggregates. The study of de novo protein aggregate
formation in particular is rather difficult in mammalian models. The spontaneous
formation of protein aggregates is very rare, with mouse models taking 1-2 years
to observe aggregate formation (Scholtzova et al., 2014). With such rare
appearance of aggregates, in a multicellular system it is difficult to capture the
formation of protein aggregates. Understanding the cellular biology in these
systems is also quite difficult as making genetic manipulations to alter a single
process is hard.

1.4: Yeast Protein Aggregation and Inclusions
To study the de novo formation of protein aggregates more efficiently, the
single celled model system of budding yeast, Saccharomyces cerevisiae, can be
used. The generation time of yeast is only 2 hours allowing high throughput
screens to be performed easily, and has 23% genome identity to humans (Liu et
al., 2017). The genome of yeast is also relatively small compared to mammalian
systems and can easily be genetically manipulated, allowing for more directed
investigation of cellular processes. This system allows for the formation of protein
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aggregates to be observed on a reliable scale to pursue directed approaches in
higher order organisms.
Yeast protein aggregation is commonly studied and induced using three
different methods: protein overexpression, stress, or heterologous expression. To
induce protein aggregation through overexpression, an endogenous protein that
is prone to aggregation is transiently overexpressed. This additional expression
increases the likelihood that a misfolded conformation of the protein will ensue
and spontaneous aggregation can take place. A protein called Sup35p in yeast is
commonly used for aggregation by overexpression as it contains an IDR (TerAvanesyan et al., 1994). The advantage to using transient overexpression to
induce protein aggregation is that a reduced cellular stress response is elicited,
however as this method requires spontaneous formation aggregation can still be
a relatively rare event.
Stress induced aggregation is one of the more studied methods of
induction due to rapid aggregation and the biological relevance of understanding
stress response. Stress granules, or stress foci, form in response to a variety of
cellular stresses such as heat, pH, and nutrient deprivation (Leeuwen and
Rabouille, 2019). Stress granules are composed of protein and RNA, which upon
the addition of stress are quickly sequestered into aggregates (Buchan and
Parker, 2009). Upon the removal of stress, stress granules are also quickly
dissolved returning proteins and RNA to their normal function (Wallace et al.,
2015). This rapid reversibility is likely fostered through phase separation. During
phase separation, proteins are locally organized into membraneless
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compartments so that are quickly accessible back under normal conditions
(Franzmann and Alberti, 2018; Franzmann et al., 2018; Kato et al., 2012;
Kroschwald et al., 2018; Molliex et al., 2015; Riback et al., 2017). Proteins that
are rich in IDR’s are thought to undergo phase separation more rapidly than
other proteins due to an inherent stress sensing ability (Alberti, 2017). To
observe stress granules in yeast, the heat shock protein Hsp104p has commonly
been used. Hsp104p is a heat shock protein functioning in disaggregation and is
needed for the characteristic reversibility (Cherkasov et al., 2013). However,
there are a large number of proteins and RNA that localize to stress granules,
including at least over 100 proteins identified to go through phase separation
alone (Wallace et al., 2015). The incorporation of this magnitude of proteins is
reflective of the global response that occurs in yeast from stress. This global,
reversible response can make it difficult to draw conclusions of specific protein
aggregate behavior in yeast that can be related to disease related aggregation
that would occur in the absence of a significant stress.
Finally, heterologous expression can be used to induce aggregation in
yeast. As described above, protein aggregation in mammalian models can be
difficult as a result of timing and tracking aggregation in a multicellular system,
however researchers still wanted to study the proteins directly associated with
human disease. These particular proteins can be expressed in “humanized
yeast”, where the proteins quickly aggregate (Laurent et al., 2016). The use of
heterologous proteins in yeast has greatly facilitated our understanding of how
aggregates impact cellular behavior and has provided some indications to how
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aggregates are associated with disease. While this method allows for rapid
aggregation of a single protein in yeast, constant overexpression is needed and
cellular response may not be as efficient. Given that the protein is not
endogenous to yeast, it may be difficult for protein quality control to recognize the
formation of the aggregate and respond accordingly. Therefore, humanized yeast
models are often associated with a high level of toxicity. Expression the
Huntingtin Protein with expanded glutamine repeats (Htt-Q103) is very toxic as
the glutamine repeats can interact with endogenous proteins that contain similar
repeats resulting in a loss of function (Meriin et al., 2002). Similarly, TDP-43,
which is aggregated in ALS patients, also forms toxic aggregates when
expressed in yeast (Johnson et al., 2009).
With each of the three models to induce protein aggregation, aggregates
are associated with different protein inclusions. These inclusions are distinct sites
in the cell where damaged, misfolded, and aggregating proteins are sequestered
for proper PQC. Amyloid aggregates formed through overexpression or
heterologous expression are usually found at one of two inclusions, IPOD or
JUNQ/INQ. The Insoluble Protein Deposit (IPOD) is a perivacuolar site that
houses insoluble, amyloid protein aggregates. The yeast prions [PSI+], [PIN+],
and [URE3] localize here along with expression of the Huntintin Protein
(HttQ103) or TDP-43 in humanized yeast (Kaganovich et al, 2008; Tyedmers et
al., 2010; Saibil et al., 2012; Farrawell et al., 2015). The Juxtanuclear quality
control compartment (JUNQ) or Intranuclear quality control compartment (INQ)
are nucleus based inclusions that house aggregates that are marked for
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degradation by the proteasome (Kaganovich et al., 2008; Gallina et al., 2015;
Miller et al., 2015). Aggregates, such as VHLp and Ubc9p, are ubiquitinated and
are sequestered to this inclusion for degradation (Kaganovich et al., 2008). An
Age Associated Protein Deposit, APOD, has recently been proposed to house
amyloid aggregates as well that appears only in old cells, however only Sup35p
aggregates have been found at this cytosolic inclusion so far (Saarikangas et al.,
2015).
Stress induced aggregates however, which are amorphous, are thought to
localize to inclusions known as Q-Bodies (Escusa-Toret et al., 2013). While QBodies are described to be cytoplasmic, localization of the stress induced
aggregates through the associated chaperone Hsp104p suggests they may also
be localized to the surface of organelles such as the mitochondria and ER (Zhou
et al., 2014). As expected, there are over 100 proteins reported to localize to QBodies in yeast (Buchan et al., 2013). Degradation of aggregates localized to QBodies can be through both the proteasome and autophagy (Escusa-Toret et al.,
2013; Buchan et al., 2013)

1.5: Sup35 Protein Aggregation and [PSI+] Propagation
Yeast has multiple proteins capable of forming prions or amyloid
aggregates. The protein Sup35p has become a standard in the field to observe
protein aggregate formation as part of the protein induced method. Sup35p is a
translation termination protein in yeast, and is essential in yeast. The protein is
modular in nature, with the C-terminal domain having translational termination
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function (Salas-Marco and Bedwell, 2004; Stansfield et al., 1993), and the Nterminal and Middle domain of the protein, while indispensible for translation
termination function, contains an IDR that makes the protein prone to
aggregation and is thought to provide stress sensing ability to enter phase
separation condensates in times of stress (Franzmann et al., 2018). The N and M
domains also allow Sup35p to form a prion called [PSI+], while the C domain is
not required (Ter-Avanesyan et al., 1994).
The [PSI+] prion is found in two different variants depending upon the size
and conformation of the aggregate. Strong [PSI+] aggregates are smaller in size
and are thought to be more infectious as a result as they can be transferred more
easily to daughter cells. Meanwhile, weak [PSI+] aggregates are large, with less
efficient propagation to daughters and are more easily cured by chaperone
manipulation (Derkatch et al., 1996; Bradley and Liebman, 2004). The size of the
aggregate allows for differentiation between the two variants, as on SDD-AGE
gels protein complexes are separated based on size (Kryndushkin et al., 2013).
Variants of prions are not unique to [PSI+] as another yeast prion, [PIN+] can be
found in multiple variations dependent on its ability to induce the formation of
[PSI+] rather than size (Bradley et al., 2002).
The propagation of [PSI+] for generations requires the chaperone
Hsp104p (Chernoff et al., 1995). Hsp104p is a AAA+ ATPase with dissaggregase
activity originally identified in stress tolerance (Sanchez and Lindquist, 1990).
The chaperone requires co-chaperones Sis1p and Ssa1p for dissaggregase
function (Glover and Lindquist, 1998). To perform this function, the chaperone
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complex binds to the protein aggregate, and pulls part of the aggregate through a
central pore via ATP hydrolysis, breaking the aggregate into two pieces
(Halsberger et al., 2008). The generation of two smaller aggregates can
propagate prions in two different ways. First it can provide two ends that
monomeric misfolded proteins can be added to (Kryndushkin et al., 2003).
Second, it can generate small aggregate fragments that can be transmitted to
daughter cells (Paushkin et al., 1996). This constant fragmenting and growing of
aggregates allows for the population to maintain the prion as cell division occurs.
Without Hsp104p, this shearing action does not take place, and the propagation
of [PSI+] does not happen, while too much Hsp104p activity also fragments
aggregates to a point where seeding cannot occur, also preventing propagation
(Ness et al., 2002; Shorter and Lindquist, 2004).

1.6: de novo [PSI+] Formation
The spontaneous de novo formation of [PSI+] happens at an extremely low
rate of 5.8 x 10-7 (Lancaster et al., 2010). Formation is enhanced through
overexpression of Sup35p to increase the chances of protein misfolding (Wickner
et al., 1994). The formation rate with overexpression can be dramatically
increased further up to 10-2 by the presence of a second prion such as [PIN+], the
prion version of Rnq1p (Derkatch et al., 1998). The presence of a second prion is
thought to seed [PSI+] formation through two possible mechanisms. The first
cross-seeding, where [PIN+] is used as a template by which overexpressed
Sup35p is misfolded and allowed to aggregate (Derkatch et al., 2001; Osherovich
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and Weissman, 2001). The second mechanism is by a titration model where
[PIN+] interacts with another protein or chaperone that is preventing the formation
of [PSI+]. The interaction with [PIN+] prevents the unknown factor from stopping
[PSI+] formation (Derkatch et al., 2001; Osherovich and Weissman, 2001).
In the de novo formation of Sup35p aggregates a seed is still required for
aggregate formation. The most common cross-seed for Sup35p is a second prion
called [PIN+], the prion version of Rnq1p. While this protein does not have a
known function, [PIN+] was identified for its ability to induce [PSI+] formation
(Sondheimer and Lindquist, 2000; Derkatch et al., 2001; Osherovich and
Weissman, 2001). Cells lacking [PIN+] have trouble forming Sup35p aggregates
unless another amyloid character protein aggregate is introduced into the cell to
provide seeding quality (Derkatch et al., 2000).
Overexpression of the prion domain of Sup35p, Sup35NM, is enough to
induce [PSI+] formation in [PIN+] cells (Figure 1.2). Using a conditional promoter,
Sup35NM fused to a fluorescent reporter such as GFP (Sup35NM-GFP) allows
for visualization of aggregate formation, leading to leading to fluorescent rings,
lines, and dots in cells (Figure 1.2; Zhou et al., 2001). During division, ring
aggregates are retained in the mother cell, however the daughter is thought to
inherit the prion through non-visible aggregates formed by Hsp104p function
(Ganusova et al., 2006; Mathur et al., 2009; Sharma and Liebman, 2012). These
ring and line aggregates are hallmarks of [PSI+] cells (Ganusova et al., 2006;
Vishveshwara et al., 2009; Manogaran et al., 2011).
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Figure 1.2: Transient overexpression of Sup35p fusion protein allows
aggregate formation to be observed. Top: Transient overexpression of Sup35p
fused to a fluorescent protein such as GFP increases the likelihood of protein
aggregation and subsequent formation of [PSI+] cells. Bottom: After transient
expression of Sup35NM-GFP, small early foci become visible in cells that are
highly mobile. Over time early foci become statically localized to a single site in
the cell, where the foci continues to grow into a large aggregate that can take on
either a dot-like or ring appearance.

The role of different cellular factors on the formation of Sup35NM-GFP
aggregates has been previously investigated. Proteins associated with cortical
endocytic patches, such as End3p, Sla2p, and Sla1p, all reduced the number of
cells that contained aggregates (Ganusova et al., 2006). A large scale genetic
screen using the yeast deletion library found several other factors that were
classified into two categories that influenced aggregate formation. Early class
genes, including some proteins associated with cortical actin patches such as
Las17p and Sac6p, reduced the formation of Sup35NM-GFP aggregates and
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propagation of [PSI+]. Late class genes had normal aggregate formation,
however still displayed a reduction in [PSI+] propagation. Interestingly, authors
found that each of the genetic deletions that altered [PSI+] formation contained
fragmented vacuoles, and as amyloid aggregates are thought to localize to the
perivacuolar IPOD, together it was suggested that there is a link between the
vacuole and protein aggregate formation (Manogaran et al., 2011; Tyedmers et
al., 2010). A later study found that the disruption of genes in the autophagy
pathway and vacuole function caused Sup35NM-GFP aggregate formation at a
faster rate and increased [PSI+] induction frequencies (Speldewinde et al., 2015).
Together, this work suggests that both actin and autophagy may be important
factors that influence the ability of Sup35NM-GFP to form aggregates and
propagate to future generations.

1.7: Initial Cellular Response to Protein Aggregation in Yeast
To study the formation of Sup35NM-GFP aggregates, most studies take a
snap shot approach. In this approach, aggregate formation is induced, and at
varying time points microscopic images are acquired in an attempt to extrapolate
dynamics and interaction. Our lab however, uses 3D-timelapse microscopy to
observe Sup35NM-GFP aggregate formation. This approach removes the
speculation aspect to the dynamics of formation as these details are visualized
throughout the process. Using this approach, Sharma et al (2017) found that the
induction of Sup35NM-GFP begins with diffuse cells, meaning GFP fluorescence
is cytoplasmic with no distinct foci. Between 12-16 hours of induction small foci
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appear in the cell that are highly mobile, which are termed early foci. These early
foci move around in the cell for about 30 minutes before becoming static at a
single location in the cell. This formation is characterized into a two step process:
step 1 is high mobility of early foci and step 2 is the static sequestration of the
larger protein aggregate. The dynamic details of this formation could not be
extrapolated from snapshot microscopy providing support that 3D-timelapse
microscopy is necessary to fully appreciate the behavior of newly formed protein
aggregates.
Given the association of Sup35NM-GFP aggregate formation with
components of the actin cytoskeleton (Ganusova et al., 2006; Manogaran et al.,
2011), studies have been performed to investigate the influence of the yeast
actin trafficking system on Sup35NM-GFP. Recent work depleting the Myo2p
motor protein, which moves cargo along the actin cytoskeleton, found that the
number of Sup35NM-GFP aggregates in [PSI+] cells increased through snap shot
microscopy (Kumar et al., 2016). While Myo2p had an effect on the number of
aggregates, the use of snap shot microscopy and pre-existing Sup35NM-GFP
aggregates is not informative towards understanding the dynamic relationship
that may exist. Meanwhile, work done with stress induced aggregates rather than
Sup35NM-GFP and time-lapse microscopy have found that disruption of the actin
cytoskeleton through pharmacological agents can alter aggregate movement,
abundance, and localization within the cell (Liu et al., 2010; Zhou et al., 2011;
Song et al., 2014). It is possible that the effect of disruptions on an actin
mediated trafficking mechanism has similar effects on Sup35NM-GFP relating to
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both the mobile behavior of newly formed aggregates and localization in the cell,
however this relationship unclear given the lack of time-lapse microscopy studies
using newly formed Sup35NM-GFP.

1.8: Summary and Significance
While recent work has revealed the formation of Sup35NM-GFP
aggregates is dynamic, it is not well understood what cellular mechanisms
manage aggregates. Expanding our knowledge of cellular response mechanisms
in yeast may enhance our ability to understand protein aggregate related
diseases in mammalian systems and provide directed approaches for further
studies in higher organisms that are difficult to study. In this dissertation I explore
the dynamics of de novo Sup35NM-GFP formation, establishing innovative
methods to quantify both step 1 and 2 of formation. The methods are then
applied to understand how both the actin cytoskeleton and Myo2p motor protein
may be involved in the formation of aggregates, as well as whether similar
mechanisms are observed for the formation of different types of protein
aggregates. Together, this work adds to our limited understanding of the
formation of protein aggregates and will help influence further studies to
eventually understand the role of the cellular response in managing protein
aggregation and preventing disease.
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Chapter 2: Materials and Methods
2.1 Yeast Strains and Growth Conditions
All strains were grown at 30oC using standard media and cultivation
procedures (Sherman, Fink, and Hicks, 1986). Yeast strains and plasmids used
in this study can be found in Table 2.1 and 2.2. Unless otherwise specified,
cultures were grown in rich media (YPD, 2% dextrose) or synthetic media
containing 2% dextrose (SD) or galactose (SGal) as indicated and the
appropriate amino acids. Yeast transformations were performed with the lithium
acetate protocol (Geitz and Woods, 2002).

2.2 Genetic Disruptions
Strains with genetic disruptions created in this study were made by
homologous recombination similar to Manogaran et al., 2011. Briefly, the HIS3
gene was amplified with primers (Table 2.3) adjacent to sequences
(approximately 39 nucleotides) flaking the 5’ or 3’ ends of the candidate gene.
PCR product was purified and transformed into the 74D-694 strain, and
disruption strains were confirmed by PCR.

20

Lab Number

Strain Name

D158

74-D694 sac6

D228

BY4741 Hsp104-GFP

MatA, ura3, leu2, his3, met15, Hsp104-GFP High [PIN+]

D229

BY4741 Hsp42-GFP

MatA, ura3, leu2, his3, met15, Hsp42-GFP High [PIN+]

D233
D267

74-D694 [psi-] High [PIN+]
Wildtype Myo2 Strain

D268

myo2-2

D269

myo2Δ

JD067

BY4741 act1-122 High [PIN+]

M102

BY4741 [psi-] High [PIN+]

M208

74D-694 High [PIN+] bug1::HIS3

M212

74D-694 High [PIN+] bem1::HIS3

M216

74D-694 High [PIN+] vps5::HIS3

MatA ade1-14, ura3-52, leu2-3,112, trp1-289, his3-200, high [PIN+]
Mat A, ura3-52, leu2-3,112, his3-200, trp1-901, lys2-801, suc2-9
Mat A, ura3-52, leu2-3,112, his3-200, trp1-901, lys2-801, suc2-9,
pep4-137, myo2-2(G1248D)
Mat Alpha, ura3-52, leu2-3,112, his3-200, trp1-901, lys2-801, suc2-9,
pep4-137, myo2::TRP1, pRS416-Myo2-Pep4
Mat A, his3-delta1, leu2, ura3, met15, lys2 act1-122::NATr High
[PIN+]
Mat A, leu2, his3, ura3, met15, [psi-], High [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 bug1::HIS3,
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 bem1::HIS3,
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 vps5::HIS3,
high [PIN+]

M254

BY4741 microdot [PIN+]act1-122::NATr

M256

BY4741 High [PIN+] act1-101::NATr

M261

BY4741 High [PIN+] with Sis1-GFP

M262

BY4741 High [PIN+] with Ssa1-GFP

M310

BY4741 High [PIN+] act1-120::NATr

M327

74-D694 High [PIN+] atg40::HIS3

M353

74-D694 High [PIN+] fis1::HIS3

M356

74-D694 High [PIN+] num1::HIS3

M359

74-D694 High [PIN+] mdm36::HIS3

M373

74-D694 High [PIN+] mmm1::HIS3

M375

74-D694 High [PIN+] mdm12::HIS3

M380

74-D694 High [PIN+] cho2::HIS3

M383

74-D694 High [PIN+] hsp42::HIS3

M384

74-D694 High [PIN+] ice2::HIS3

M386

74-D694 High [PIN+] atg32::HIS3

M438

Wildtype High [PIN+] Myo2p Strain

M440

myo2-2 High [PIN+]

M442

myo2-AfIll High [PIN+]

M443

myo2-D1297G High [PIN+]

M444

myo2-D1297N High [PIN+]

M515

74D-694 hsp104::HIS3

Table 2.1: Yeast Strains

Genotype
MatA ade1-14, ura3-52, leu2-3,112, trp1-289, his3-200, sac6::HIS3
high [PIN+]

MatA his3, leu2, ura3, act1-122::NATr, MET15, LYS2, microdot [PIN+]

Reference
Manogaran et al. 2011
Invitrogen (YLL026w), BY4741 GFP
Tagged Library
Invitrogen (YDR171w), BY4741
GFP Tagged Library
Derkatch et al. 1997
Catlett et al. 1998
Catlett et al. 1998
Catlett et al. 1998
Dorweiler et al., in revision
Dorweiler et al., in revision
Manogaran et al. 2011
Manogaran et al. 2011
Manogaran et al. 2011
Dorweiler et al., in revision

MatA his3, leu2, ura3, act1-101::NATr, met15, LYS2, High [PIN+]
Dorweiler et al., in revision
Mat A ade1-14 his3-200 trp1-289 ura3-52 leu2-3112
Invitrogen (YLL026w), BY4741 GFP
SIS1GFP::KANMX6 [psi-] High [PIN+]
Tagged Library
Mat A ade1-14 his3-200 trp1-289 ura3-52 leu2-3112
Invitrogen (YLL026w), BY4741 GFP
SSA1GFP::KANMX6 [psi-] High [PIN+]
Tagged Library
MatA his3, leu2, ura3, act1-120::NATr, met15, LYS2, High [PIN+]
Dorweiler et al., in revision
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 atg40::HIS3,
This Study
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 fis1::HIS3,
This Study
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 num1::HIS3,
This Study
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200
This Study
mdm36::HIS3, high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200
This Study
mmm1::HIS3, high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200
This Study
mdm12::HIS3, high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 cho2::HIS3,
This Study
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 hsp42::HIS3,
This Study
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 ice2::HIS3,
This Study
high [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200 atg32::HIS3,
This Study
high [PIN+]
Mat A Wild Type ura3-52, leu2-3,112, his3-200, trp1-901, lys2-801,
This Study
suc2-9 High [PIN+]
Mat A myo2-2 mutant: ura3-52, leu2-3,112, his3-200, trp1-901, lys2This Study
801, suc2-9, pep4-137, myo2-2(G1248D) High [PIN+]
mat alpha, myo2 deletion: ura3-52, leu2-3,112, his3-200, trp1-901,
lys2-801, suc2-9, pep4-137, myo2::TRP1, pRS416-Myo2-Pep4 (lost by
This Study
5-FOA), pRS413-myo2-Af1II [PIN+]
mat alpha, myo2 deletion: ura3-52, leu2-3,112, his3-200, trp1-901,
lys2-801, suc2-9, pep4-137, myo2::TRP1, pRS416-Myo2-Pep4 (lost by
This Study
5-FOA), pRS413-myo2-D1297G [PIN+]
mat alpha, myo2 deletion: ura3-52, leu2-3,112, his3-200, trp1-901,
lys2-801, suc2-9, pep4-137, myo2::TRP1, pRS416-Myo2-Pep4 (lost by
This Study
5-FOA), pRS413-myo2-D1297N [PIN+]
Mat A, ade1-14, leu2-3,115, ura3-52, trp1-289, his3-200
Manogaran Lab
hsp104::HIS3
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Lab Number
p3032
p3053
p3068
p3069
p3071
p3085
p3089
p3121
p3162
p3165
p3167
p3172
p3203
p3204
p3205

Plasmid Name
pCU1P-SUP35NM-GFP
pRS413-pCUP1-SUP35NM-CFP
pRS416 pCUP1-GFP-ATG8
pBJ1808 pRS416-COF1RFP
pRS416 GAL1-TDP43WT-YFP
pRS416-GAL1-SUP35NM-RFP
pABP140-ABP140-3XYFP
pRS316-pCUP1-SUP35NM-RFP
pYX142 MITO-dsRED
pRS416-pSEC63-SEC63-mCherry-Tcyc1
pRS416-pGPD-mCherry-SKL-Tcyc1
pAG415GPD-Hsp104-mCherry
pRS413-MYO2-AFlII
pRS413-MYO2-D1297G
pRS413-MYO2-D1297N

Table 2.2: Plasmids Used

Marker
Original Reference
LEU2, CEN
Zhou et al. 2001
HIS3, CEN
Zu et al. 2014
URA3, CEN
Addgene # 49423
URA3, CEN
Lin et al. 2010, Addgene # 37103
URA3, CEN
Addgene # 27447
URA3, CEN
Arslan et al. 2015
URA3, Digest with Hpa1 for Integration
Buttery et al. 2007
URA3, CEN
Arslan et al. 2015
LEU2, CEN
Naylor et al. 2005
URA3, CEN
Wang et al. 2014
URA3, CEN
Wang et al. 2014
Leu, Cen
Malinovska et al., 2012
HIS3, CEN
Catlett et al. 2000
HIS3, CEN
Catlett et al. 2000
HIS3, CEN
Catlett et al. 2000
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Lab Number
AM200

Name and Number
AM200 His Primer

Sequence
CTTATGGCAACCGCAAGAGC
GTGAGTAGGAACGTGTATGTTTGTGTATATTGGAAAAAGGCCTACA
TAAGAACACCTTTGGTGG
GCGGAACATAGCACCAAAGAGG
TATTGAAGTCCTAATCACAAAAGCAAAAAAAATCTGCCAGGAACAG
TAAACATATGACAGAGCAGAAAGCCCTAGTAAAGC
CTACCATTATGGTAAAATGGAAAAACTATTCTAATCCAATCCTACAT
AAGAACACCTTTGGTGG
TCCCAGAGAACGCTTCCTTTG
ACGTTCTTTCTGCTGTGCTTCACTCCACCATAGAAAACTA
ATGACAGAGCAGAAAGCCCTAGTAAAGC
ATAGAAGCACAGATCAGAGCACAGCCATACAACATAAGTATGACA
GAGCAGAAAGCCCTAGTAAAGC
ATGTATGTACGTATGTGCTGATTTTTTATGTGCTTGCTACATAAGAA
CACCTTTGGTGG

AM250
AM251

AM250 Atg32 Antisense
AM251 Atg32 promoter

AM288

AM288 Atg32 Corrected Sense

AM256
AM257

AM256 Atg40 Antisense
AM257 Atg40 Promoter

AM290

AM290 Atg40 Corrected Sense

AM311

AM311_Fis1::His3 Sense

AM312

AM312_Fis1::His3 Antisense

AM313

AM320

AM313_Fis1::His3 Diagnostic Sense CTGCCGTGCCCTGCATCTG
AAGACGCAACGGTCAAGGCTTTCCACGAGACGTTCGAATATGA
AM316_Num1 Sense
CAGAGCAGAAAGCCCTAGTAAAGC
TATTGTTCTTAATTTACTTAGAGTTATTTAGTTTTTTTAACTA
AM317_Num1 AntiSense
CATAAGAACACCTTTGGTGG
AM318_Num1 Diagnostic
ATCGGTTCTAATAGGACCAC
AGTTAAAAACCCTCCAGAGAGAACACTTACTACTATAGCATGA
AM319_Mdm36 Sense
CAGAGCAGAAAGCCCTAGTAAAGC
CATTTAGTTTGTTTACATAGCAATGATATCCTTATTCTTACTA
AM320_Mdm36 AntiSense
CATAAGAACACCTTTGGTGG

AM321

AM321_Mdm36 Diagnostic

AM335

AM335_Mmm1 Sense

AM336

AM336_Mmm1 AntiSense

AM337

AM337_Mmm1 Diagnostic

AM339

AM339_Mdm12 Sense

AM340

AM340_Mdm12 AntiSense

AM341

AM341_Mdm12 Diagnostic

AM346

AM346_Ice2 Sense

AM355
AM348

AM355_Ice2 New AntiSense
AM348_Ice2 Diagnostic

AM349

AM349_Cho2 Sense

AM350
AM351

AM350_Cho2 AntiSense
AM351_Cho2 Diagnostic

AM352

AM352_Hsp42 Sense

AM353
AM354

AM353_Hsp42 AntiSense
AM354_Hsp42 Diagnostic

AM316
AM317
AM318
AM319

Description
HIS3 complementary primer ("470")
ATG32 AntiSense Primer for Disruption
ATG32 Promoter Region for Disruption Confirmation
ATG32 Sense Primer for Disruption
ATG40 AntiSense Primer for Disruption
ATG40 Promoter Region for Disruption Confirmation
ATG40 Sense Primer for Disruption
FIS1 Sense Primer for Disruption
FIS1 AntiSense Primer for Disruption
FIS1 Promoter Region for Disruption Confirmation
NUM1 Sense Primer for Disruption
NUM1 AntiSense Primer for Disruption
NUM1 Promoter Region for Disruption Confirmation
MDM36 Sense Primer for Disruption
MDM36 AntiSense Primer for Disruption
MDM36 Promoter Region for Disruption
Confirmation

CATTACTGTCATGGGATCCG
TTGAGAGAGTCAATATAATACCTGTAGCCTTTTTCTGAAAATG
ACAGAGCAGAAAGCCCTAGTAAAGC
MMM1 Sense Primer for Disruption
ATAGGAAAAAGATAGAACAAAAAATTTGTACATAAATATCTA
CATAAGAACACCTTTGGTGG
MMM1 AntiSense Primer for Disruption

CTCGTAAGTGACTTGACTGGC
MMM1 Promoter Region for Disruption Confirmation
CGGTTGAAACAGATCATAAGCTGGCTTCAACTAATCCAAATGA
CAGAGCAGAAAGCCCTAGTAAAGC
MDM12 Sense Primer for Disruption
TTATGTAGACACTATTTTCAAACTATCTTTGTTAAACTACATA
AGAACACCTTTGGTGG
MDM12 AntiSense Primer for Disruption
MDM12 Promoter Region for Disruption
AGAAGTTCTACCATGGCCG
Confirmation
GGTGCTGTTTGTGGCCGATCACGCTAAAGATTAGGCAACGATG
ACAGAGCAGAAAGCCCTAGTAAAGC
ICE2 Sense Primer for Disruption
CAATCCCTTCATGATCCTGCGACTCTTGCGCAACTGCTACATA
AGAACACCTTTGGTGG
ICE2 AntiSense Primer for Disruption
AGCGGTTACTGGTTTCGGAG
ICE2 Promoter Region for Disruption Confirmation
AGTGATTTTCTTAGTGACAAAGCTTTTTCTTCATCTGTAGATG
ACAGAGCAGAAAGCCCTAGTAAAGC
CHO2 Primer for Disruption
CCTAGTACTTTTTAAATATATATACTCAAAAAAAAAAAACCTA
CATAAGAACACCTTTGGTGG
CHO2 AntiSense Primer for Disruption
GAACGGCGATGCCAGAAACGGC
CHO2 Promoter Region for Disruption Confirmation
CATATCCCACACAAATTAAGATCATACCAAGCCGAAGCAATGA
CAGAGCAAAAAGCCCTAGTAAAGC
HSP42 Sense Primer for Disruption
AATATAAATGTATGTATGTGTGTATAAACAGATACGATATCT
ACATAAGAACACCTTTGGTGG
HSP42 AntiSense Primer for Disruption
GCAACGCCTGGAACACGCGC
HSP42 Promoter Region for Disruption Confirmation

Table 2.3: Primers Used in This Study
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2.3: Induction of Sup35NM Fusion Protein Expression
Plasmids containing copper inducible promoters (Sup35NM-GFP, p3032;
Sup35NM-RFP, p3121) were transformed into indicated strains and grown in
5mL of synthetic media with 50µM copper sulfate overnight (16-18 hours). Our
previous work showed that most cell still retained diffuse fluorescence at these
time points (Sharma et al., 2017). Plasmids containing galactose inducible
promoters (Sup35NM-RFP, p3085) were transformed into indicated strains and
grown for (18-22 hours) in 5mL of synthetic media containing 2% galactose. Note
for time-lapse microscopy, induction was performed for the indicated times and
then removed during image capture.

2.4: Snapshot Fluorescent Microscopy
Snapshot microscopy was used to take single 3D images of cells. Cell
imaging was performed using Leica DMI 6000 deconvolution microscope (63X oil
immersion with N.A. 1.4 magnifier) with DFC365FX camera. DIC, brightfield,
GFP, texas red, CFP, DAPI, and YFP filters were used where appropriate with
fluorescent protein expression or chemical stains. Cells expressing Sup35NMGFP were selected based on the appearance of low levels of diffuse background
fluorescence in the cell; ensuring aggregates were at their sequestration state.
Leica LASX software was used to capture images with approximately 21 z-stack
steps (step size around .5-.75µm) The Z-stack was set by setting the top and
bottom points at which the cells lost focus and the DIC/brightfield channel would
become small for that individual cell signaling either the top or bottom of the cell.
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Images were subjected to 3D deconvolution using Autoquant deconvolution
algorithms (Media Cybernetics) with intensity boost and background reduction
unless otherwise indicated.

2.5: Time-lapse Fluorescent Microscopy
3D-Time-lapse Microscopy was performed in two different ways: short
term and long term. Short-term microscopy was used to capture early formation
events as they were occurring. Induced cells were placed on a glass slide with
coverslip similar to snapshot microscopy. Diffuse cells or cells that contained an
extremely early foci (barely visible aggregates with a brightly diffuse background)
were subject to 3D-time-lapse microscopy. Upon finding a cell for timelapse, the
z-stack was set to the same parameters as in snapshot microscopy, and image
acquisition was set for every 30 seconds to 1 minute. Recordings were taken for
1-2 hours to capture the full visualization of aggregate formation.
Long-term microscopy was used to capture the initial formation of foci and
was followed through sequestration. Long-term microscopy was often chosen for
cells that were difficult to image (such as those containing Sup35NM-RFP), or
those that we were particularly interested in observing how early foci were
forming. 20µL of overnight induced cell cultures was added to 230µL of fresh
media lacking copper or galactose in a single well of an Ibidi 8-Well Slide that
was previously treated with ConcavalinA (ConA). Cells were allowed to settle for
10-15 minutes before imaging was performed. Images were recorded every 4
minutes in 3D for 6-8 hours with 10 or 21 step z-stacks.
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2.6: Cell Staining
Budscar staining and quantification: 1mL of cell culture from 5mL of
overnight growth was removed into a 1.5mL Eppendorf Microcentrifuge Tube.
The sample was spun at 3000rpm for 2 minutes to pellet the cells. The
supernatant was dumped off, and the pellet was resuspended in 1mL of 1X PBS.
1µL of 25µM Calcafluor White Stain (Sigma) was added to the sample. Cells
were incubated for 20 minutes at 30°C. After incubation, cells were again
pelleted and the supernatant was removed. The pellet was resuspended with
1mL of 1X PBS. Cells were pelleted once more, and resuspended in 250µL 1X
PBS. An additional wash was performed at the discretion of the user. 2.2µL of
stained cells were placed on a slide and a coverslip was put over the top of the
sample. Cells were observed at 630X for discernable bud scars and protein
aggregates identified in the DAPI and GFP filter sets respectively. Images were
recorded in 3D as described in Snapshot Microscopy. Images were double
blinded and analyzed by an independent investigator for aggregate profile and
bud scar number.
Vacuole Staining: Cell cultures were grown overnight under standard
conditions. 1mL of culture was removed from overnight growth, and pelleted at
3000 rpm for 2 minutes in a 1.5mL Eppendorf Microcentrifuge Tube. The
supernatant was dumped off, and the pelleted cells were resuspended in 1mL of
water. Resuspened cells were treated with 6.6µM FM4-64 stain (Molecular
Probes). Cells were incubated for 20 minutes at 30°C. After incubation cells were
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pelleted, supernatant was removed, and the pellet was resuspended in water.
The wash was repeated. After the second wash, cells were resuspended in
250µL of water for imaging. 2.2µL of the sample were placed on a slide and
covered with a coverslip. Cells were observed at 630X for vacuole appearance
and protein aggregates using the Texas Red and GFP Filter Sets respectively.
Images were acquired in 3D as described in Snapshot Microscopy and further
analyzed as described in Adjacent and Co-localization Analysis.
Phalloidin Staining: Cells were grown under standard conditions overnight.
1mL of culture was removed in a 1.5mL Eppendorf Microcentrifuge Tube. 10µL of
3.7% formaldehyde was added to the cells and incubated at room temperature
for 10 minutes. The sample was then pelleted at 3000 rpm for 2 minutes, with the
supernatant dumped off. Pelleted cells were resuspended in 1mL of 1X PBS and
10µL of 3.7% formaldehyde. The sample was allowed to sit for 1 hour at room
temperature before being pelleted again. The pellet was resuspended in 250µL
of 1X PBS and 8.8µM rhodamine-phalloidin (Invitrogen) was added. The sample
was kept in the dark using aluminum foil, and placed in the 30°C incubator for
one hour. Following incubation, cells were pelleted and resuspended in 250µL of
1X PBS for washing. The wash was repeated a second time. Cells were then
imaged using Snapshot Microscopy Methods and the Texas Red Filter to
observe staining.
DAPI Staining: Cell cultures were grown overnight under standard
conditions. 1mL of culture was removed from overnight growth, and pelleted at
3000 rpm for 2 minutes in a 1.5mL Eppendorf Microcentrifuge Tube. The
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supernatant was dumped off, and the pelleted cells were resuspended in 1mL of
1X PBS. 2.5µL of DAPI from 1mg/mL stock was added to the resuspended
sample, and incubated for 30 minutes at 30°C. After incubation cells were
pelleted, supernatant was removed, and the pellet was resuspended in 1X PBS.
The wash was repeated. After the second wash, cells were resuspended in
250µL of 1X PBS for imaging. 2.2µL of the sample were placed on a slide and
covered with a coverslip. Cells were observed at 630X for vacuole appearance
and protein aggregates using the DAPI and GFP Filter Sets respectively. Images
were acquired in 3D as described in Snapshot Microscopy and further analyzed
as described in Adjacent and Co-localization Analysis.
Quinacrine Staining: Cell cultures were grown to mid-log phase (OD = 0.71.0). Culture was cooled in ice for 5 minutes, and then 1mL of culture was
pelleted at 3000 rpm for 2 minutes. The remaining pellet was resuspended in
YPD with 100µM HEPES added for pH buffering. 200µM Quinacrine was added
to the sample (1µL of 200mM stock). Sample was incubated for 10 minutes at
30°C, and then cooled briefly on ice. Sample was washed three times at 3000
rpm for 2 minutes each was using water containing 100µM HEPES and 0.2%
glucose at pH 7.6. After washes the sample is resuspended in 200µL of the water
solution for imaging. Protocol was adapated from Brett et al., 2011.

2.7: Imaging of Fluorescent Proteins
Hsp104-mCherry Stress Granules: Cell cultures expressing Hsp104mCherry (p3172) were grown in 3mL of synthetic media for 3 hours at standard

28
conditions. Stress granule formation was induced following methods used by
Buchan, Yoon, and Parker, 2011. 1mL of culture was removed from overnight
growth in a 1.5mL Eppendorf Microcentrifuge Tube. The sample was then treated
with 0.5% NaN3 and left at room temperature for approximately 5 minutes before
2.2µL of sample were placed on a slide and covered with a coverslip for imaging.
Stress foci were observed at 630X using the Texas Red Filter. Stress foci
formation typically took place within the first 15 minutes of exposure to NaN3, and
cells on slides could be imaged in 3D for up to 90 minutes with acquisition every
minute before either bleaching the sample or the slide dried.
TDP43 Imaging: For snapshot microscopy, cells expressing TDP43-YFP
(p3071) were grown in synthetic media containing 2% galactose overnight. 2.2µL
of sample were placed on a slide and covered with a coverslip for imaging. Cells
were observed at 630X using the YFP filer and images were acquired in 3D
following Snapshot Microscopy Methods. For Time-lapse microscopy, cells
expressing TDP43-YFP were grown in synthetic media containing 2% galactose
for 3 hours. After growth, Long-term Time-lapse microscopy methods were then
used to observe aggregate formation.
Abp140 Imaging: Strains containing Abp140-YFP (p3089) were grown
overnight under standard conditions. 1mL of the overnight culture was pelleted at
3000 rpm for two minutes and the supernatant was dumped off. The pellet was
resuspended in 100µL of water. 10µL of the resuspended pellet was added to
5mL of fresh synthetic media and subsequently grown overnight for a maximum
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of 18 hours under standard conditions. After overnight growth, the culture was
imaged following Snapshot Microscopy Methods.
Cof1-RFP, Mito-dsRed, Sec63-mCherry, and SKL-mCherry Imaging: Cells
expressing Cof1-RFP (p3069), Mito-dsRed (p3162), Sec63-mCherry (p3163),
and SKL-mCherry (p3165) were grown in synthetic media containing 2%
dextrose overnight for snap shot images. Cultures were imaged following
Snapshot Microscopy Methods. The Texas Red filter was used for visualization.

2.8: Pharmacological Treatment
Cell cultures were grown under standard conditions overnight. Cultures
were equally divided into two halves. 3µL of 200 proof ethanol was added to one
half of the culture. The other half of the culture was treated with either 100µM
LatrunculinA (Santa Cruz Biochemical), 100µM CytochlasinB (Cayman Chemical
Company), or 25µM Jasplinkinolide (Cayman Chemical Company). Drug
concentrations were determined to be effective in Lyke et al., 2018 (BioRx).
Cultures were subsequently incubated for an additional 30-60 minutes at 30°C.
After incubation, cultures were imaged following Snapshot Microscopy Methods.
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Drug
Protease Inhibitor
Rhodamine Phalloidin
FM4-64
Cytochlasin B
Jasplakinolide
Latrunculin A
Calcafluor
PMSF
5-FOA
Cycloheximide
ConA
DAPI
Sodium Azide

Product Description
Protease Inhibitor Cocktail (P8215)
Rhodamine Phalloidin (R415)
FM4-64 Membrane Stain (T13320)
Cytochlasin B (11328)
Jasplakinolide (11705)
LatA (sc-202691)
Fluorescent Brightener 28 (F3543-1G)
Phenylmethanesulfonyl fluoride (P7626)
5-Fluoroorotic acid (R0811)
Cycloheximide (C-6255)
Concanavalin A (L7647)
DAPI (D9542)
Sodium Azide (S-2002)

Company
Sigma
Invitrogen
Molecular Probes
Cayman Chemical Company
Cayman Chemical Compnay
Santa Cruz Biochemcial
Sigma
Sigma
Thermo Scientific
Sigma
Sigma
Sigma
Sigma

Table 2.4: Pharmacological Agents Used

2.9 Heat Shock Treatment
Cultures subject to heat shock were grown overnight under standard
conditions. 1mL of the culture was removed for imaging to confirm cellular
phenotype prior to heat shock conditions. The remaining culture was incubated at
40°C, shaking for 30 minutes. The heat-shocked culture was removed from
incubation and imaged promptly within 30 minutes of completing the heat shock.

2.10: Pathway Distribution
3 individual transformants of Sup35NM-GFP for each strain were grown
overnight under standard conditions. After overnight growth, cells were imaged at
630X following Snapshot Microscopy Methods. Each transformant was blinded
and images from each were quantified for the type of aggregate they contained
(single dot, multiple dot, single line/ring, or multiple lines/rings). Categorization of
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aggregates is based on Sharma et al., 2017 and performed with assistance by
Abbey Kuborn.

2.11: Adjacent and Colocalization Analysis
For adjacent analysis, designated structures were scored as either
adjacent or non-adjacent based on the distance between the structures. If
structures were found in 2 or more z-steps away from each other, the structures
were determined to be non-adjacent. If the distance in either the X or Y direction
was more than 500nm apart, the structures were considered non-adjacent. Only
cells that were in question were measured; those that were clearly non-adjacent
were not measured. Images were rendered by deconvolution with intensity boost
and background reduction.
For colocalization analysis, images were exported from LASX software as
.avi files to maintain full z-stacks. Files were then imported to ImagePro software,
where the co-localization was quantified for regions of interest encompassing the
aggregate. This analysis provided Pearson’s Correlation Coefficient Scores
(PCC) that were used to determine levels of colocalization. PCC scores range
from 1 to -1, indicating perfect co-localization to the absence of any colocalization respectively. Cells used for colocalization were not edited by
deconvolution, and were the cropped version of the raw image.
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2.12: Vacuole Quantification
FM4-64: Images of vacuoles stained by FM4-64 were quantified through
visual categorization. The number of aggregates per cell was recorded and
binned into separate class categories: Wildtype Class = 1-3 vacuoles, Class B =
4-6 vacuoles, and Class C = 7+ vacuoles. To quantify vacuole class, images
were analyzed by scrolling through the z stack, and counting the number of
individual stained vacuole membranes were observed. In the case that two
vacuole membranes were not distinguishable from one another, that was
classified as a single vacuole. This was performed for each strain in triplicate,
with at least 100 cells in each trial.
Quinacrine: Images of quinacrine stained cells were assessed for
fluorescent intensity. Using the region of interest tool in Leica LASX software, an
ellipse is drawn around the stained vacuole region. The software gives an
average fluorescent intensity value for the region of interest, which was then
recorded. This was performed for each strain in triplicate, with at least 100 cells
in each trial.

2.13: GFP-Atg8 Foci Quantification
Quantification of GFP-Atg8 foci was performed by analyzing images on
the Leica LASX software. The number of distinguishable GFP-Atg8 foci per cell
was counted for each strain in triplicate. To find the average area of each foci,
the region of interest tool was used to draw an ellipse around individual foci. This
tool provided the area of the ellipse drawn, giving a rough estimate of the area of
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the foci. To quantify the average intensity of the foci, the cursor was placed over
the brightest pixel within the foci and that value was recorded. All quantification
was done in triplicate for each strain with at least 100 cells quantified in each
trial.

2.14: Distance to the Periphery Measurement
Images containing a 21-step Z stack with either DIC or Brightfield channel,
and respective fluorescent channels were used to measure the distance between
a protein aggregate to the cell periphery. The diameter of the cell was measured
in 4 separate directions (top-bottom, side-side, both diagonals) with the average
used to find the radius (r). The coordinates of the edges of the cell and the radius
were used to generate a virtual sphere that represents the mathematical
periphery of the cell. The coordinates for the protein aggregate were plotted,
within the sphere, and the distance between the origin (center) of the sphere can
be determined using equation 1, derived from the equation for a sphere.

D = ((𝑟 − 𝑋)! + (𝑟 − 𝑌)! + (𝑟 − 𝑍)! )

Equation 1

Once the distance between the origin and protein aggregate is determined
(D), this value is subtracted from the radius, leaving the distance to the periphery
of the cell from the protein aggregate.

2.15: Rate of Movement Quantification
To determine the rate of movement for a protein aggregate, the distance
to the periphery is first quantified at each timepoint for the duration of the time
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frame being quantified. Next the coordinates for the first time point are used to
generate an arbitrary sphere the same size of the cell, however using the
coordinates of protein aggregate as the center or origin of the cell. Next, the
coordinates of the protein aggregate at it’s second time point are plotted within
the newly generated sphere, and the distance between the origin (aggregate in
the first time point) and the protein aggregate (aggregate at it’s second time
point) can be determined using equation 1. This distance represents the distance
moved over the designated period of time between images in the timelapse.
Each rate was plotted on a graph, and a linear trendline was overlaid. The
average slope of the trendlines for a given genetic strain and protein aggregate
were averaged.
Mean average deviation (MAD) was determined by taking the difference
between each data point of the rate of movement, and substracted from the
corresponding value of the trendline at the given time point. The average
absolute value of deviations from the trendline represent the MAD value.

2.16: Protein Lysis, Sucrose Gradients, and Western Blotting
Protein lysates were obtained from cell cultures grown overnight under
standard conditions in 50mL volume. Cultures were transferred to Oakridge
Tubes and centrifuged at 3000rpm for 5 minutes. Supernatant was removed and
25mL of water was added to the pellet. Centrifugation was repeated after the
addition of water to wash the cells. Pelleted cells were resuspended in 300µL of
1X Lysis Buffer (Composition) and transferred to a 1.5mL Eppendorf
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Microcentrifuge Tube containing 0.5mL of chilled glass beads. Tubes containing
cell culture were kept on ice, cold for the remainder of the lysis procedure. 7.5µL
of Protease Inhibitor Cocktail (Sigma) was added to each culture. Samples were
then vortexed for 30 seconds 20 times, resting on ice for at least 30 seconds
between vortexing. Samples were then pelleted at 3000rpm for 1 minute at 4°C.
The supernatant, lysate, was collected after centrifugation.
Protein concentration of lysates was determined using optical density
readings and Bio-Rad Protein Assay Dye. 1µL of protein lysate was added to
99µL of water in a 1.5mL Eppendorf Microcentrifuge Tube. 1mL of 1X Bio-Rad
Protein Assay Dye was added to the diluted sample. All samples were prepared
in triplicate. Separate tubes were prepared to generate a standard curve. Protein
standard was diluted in water to 100µL total volume (0µL, 5µL, 10µL, 20µL,
30µL, and 40µL of standard), and the Assay Dye was also added. Samples were
allowed to site for a few minutes before reading absorbance on
spectrophotometer set at 595nm wavelength. The standards were recorded first
followed by the samples in triplicate. The standard curve was used to identify
protein concentration in the samples, providing an average protein concentration
for individual lysates.
For sucrose gradient centrifugation, 2mg of protein were loaded into a
2mL microcentrifuge tube with a continuous gradient previously prepared. The
gradient was made of sucrose cushions ranging from 20% up to 60% sucrose.
Once loaded, samples were centrifuged for at least 90 minutes at 4°C,
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13,000rpm. 7 equal fractions were collected after centrifugation, and the final
fraction included the pellet resuspended in lysis buffer.
Prepared samples were run on SDS-PAGE gels. Samples were typically
run ranging from 100-300ug of protein total. To prepare that amount of protein,
the volume of each fraction of the gradient needed to contain the desired
concentration of protein was determined and added to a 1.5mL Eppendorf
Microcentrifuge Tube. 4X Sample Buffer Containing Beta-mercapthanol was
added to the protein lysate followed by the volume of water needed to dilute the
sample buffer to 1X (Typically total volume was kept between 12 and 16µL for
ease of calculations). If needed, prepared samples were boiled by placing in a
100°C heating block for 10 minutes. Samples were centrifuged at 3000 rpm for 1
minute after boiling. With prepared samples, they are carefully loaded into a lane
on the SDS-PAGE gel (8% Acrylamide Stacking Gel and 10% Acrylamide
Resolving Gel). Gels were run until the samples reached the bottom of the
resolving gel at 125V (typically around 70 minutes total). Gels were transferred
onto PVDF membrane (Immobilon-P Transfer Membranes) at 0.25A for 20-25
minutes. Filter paper was used on either side of the gel and membrane
(Whatman by GE Gel-Blotting Paper 150 X 150mm GB005 CAT NO. 10426972).
After transfer, membranes were removed and washed in blocking buffer 3
times for 15 minutes each (I-Block). The appropriate dilution of the primary
antibody was then added and incubated for either 1 hour, or overnight at 4°C if
needed (See Table 2.5 for antibodies, concentrations, and incubation times).
After incubation with primary antibody, membranes were once again washed with
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blocking buffer at least 3 times for 15 minutes each wash. Following washes, the
secondary antibody was added for 1 hour). The membrane was one again
washed in blocking buffer at least three times.
For detection of proteins after incubation with a secondary antibody with
alkaline phosphatase conjugate, membranes were washed twice for 5 minutes
with 1X Assay Buffer. Membranes were placed on plastic wrap on the benchtop,
and covered in CDP-STAR Substrate for 5 minutes. Substrate was carefully
blotted off from the corner of the membrane holding it up to drip off excess
substrate. After adding substrates the membrane was put between a plastic
sheet and taken to the developing room. Film was put over the plastic sheet
containing the membrane and inside of a cassette closed tightly to expose the
film to the substrates that attached to the protein. Initial exposure starts at 5
minutes, then the film is developed to observe protein levels. If protein levels are
low, exposure time is increased with a new film, and the opposite if protein levels
are high.

Antibody
GFP
Sup35
Mouse
Rabbit

Host
Mouse
Mouse
Goat
Goat

Source
Titer
Incubation
Sigma
1:10000 1 Hour
CoCalico Biologicals
1:10000 Overnight
Sigma
1:5000 1 Hour
Sigma
1:5000 1 Hour

Table 2.5: Antibodies

Product Description
Monoclonal Anti-GFP (G1546)
Monoclonal Anti-Sup35c (BE4)
Anti-Mouse IgG Alkaline Phosphatase (A3562)
Anti-Rabbit IgG Peroxidase Antibody (A9169)
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2.17: 5-FOA Plasmid Swap
myo2Δ strains containing a URA3-selected plasmid expression of Myo2p
were transformed with plasmids for expression of myo2-D1297G, myo2-D1297N,
or myo2-AflII (each containing HIS as an auxotrophic marker). Transformations
were selected on media containing 5-Fluoroorotic acid (5-FOA) and lacking
Histidine (similar to procedures as performed by Catlett et al., 1998).
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Chapter 3: Characterization of Newly Formed Protein
Aggregates in Wildtype Strains
3.1 Introduction
As described in Chapter 1 and in Sharma et al (2017), using Sup35NMGFP to characterize the formation and behavior of prions has revealed a multistep process. The initial observation comes from biochemical work that shows a
molecular weight species larger than the monomer that appears after just 8 hours
of induction, indicating that protein aggregation takes place prior to the
visualization of the aggregate (16 hours). The appearance of a higher molecular
weight species early during induction reflects the requirement of a certain size of
the aggregate in order to become visible microscopically. However, this
observation of a size requirement to visualize aggregates was only made with
Sup35NM-GFP, and not the endogenous Sup35p, leaving it to speculation that
both the overexpressed and endogenous protein aggregate similarly.
Once aggregates are visible, time-lapse microscopy characterized
formation of aggregates into two steps subjectively, without quantification. While
qualitative or subjective observations are able to identify trends and
generalization of behavior, it is difficult to identify differences or changes that may
be subtle. Establishing quantifiable measures for behavior enables research that
can extrapolate biological mechanisms through the use of differences identified
based on genetic backgrounds or exposure to pharmacological agents. For
example, quantifying the mobility of early foci in genetic mutants that lack
proteins involved in cargo trafficking may provide an understanding of the
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mechanism by which early foci are mobile. Measuring characteristics, such as
distance and time, is provides more detail about the dynamics of protein
aggregate formation and explores particular traits that may be important to
explaining behavior that cannot be identified through qualitative approaches.
Therefore, the need to develop quantifiable measures to characterize protein
aggregate formation is crucial.
Here, the goal of this chapter is to monitor the biochemical aggregation of
endogenous Sup35 protein, and establish quantifiable measures to investigate
the formation of Sup35NM-GFP aggregates. The formation of Sup35NM-GFP
aggregates is monitored using 3D-time-lapse microscopy as previously done
(Sharma et al., 2017) and the formation of Sup35NM-GFP aggregates is
quantified by three different measurements of Mobility and Coalescence (Step 1),
and Sequestration (Step 2). Each quantifies a particular trait of protein aggregate
formation that can be used to understand what cellular mechanisms are
important in managing de novo aggregate formation. A better understanding of
the cellular mechanisms managing protein aggregates especially during
formation may lead to improved therapeutics to prevent or reduce the symptoms
of aggregate related diseases.

3.2 Results
3.2.1 Endogenous Sup35p is found in high molecular weight complexes
during prion formation.
As described in Chapter 1, Sharma et al. (2017) showed that Sup35NMGFP forms SDS-resistant oligomers prior to the visualization of aggregates that
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have infectious properties. However, the sedimentation of endogenous Sup35p
was not investigated during prion formation. The goal of this section is to
determine whether endogenous Sup35p also forms high molecular weight
complexes.
Here, I performed sedimentation analysis on induced cultures at specific
time points using sucrose gradient centrifugation. Protein lysates were collected
from several cultures that have undergone 8 hours, 16 hours, or 24 hours of
induction. An un-induced culture was also included as a control to ensure [psi-]
cultures containing the Sup35NM-GFP plasmid did not contain aggregation prior
to induction. I also included strains without the Sup35NM-GFP plasmid that had
no prion, [psi-], or contained the [PSI+] prion. Lysates were separately centrifuged
into a continuous sucrose gradient ranging from 20% sucrose to 60%, and 7
equal fractions were collected. A sample from each fraction was loaded and run
on an SDS-PAGE gel, and probed for endogenous Sup35p. In [psi-] strains,
Sup35p is not aggregated and should sediment to the lighter fractions (fractions
1-3), compared to [PSI+] strains where Sup35p is aggregated and sediments to
the heavy fractions (fractions 5-7).
I found as early as 8 hours of induction, Sup35p sediments to heavier
fractions compared to un-induced and [psi-] controls (Figure 3.1; Lyke and
Manogaran, 2017). By 24 hours, the relative distribution of endogenous Sup35p
shifts from lighter to heavier fractions. Since visual fluorescent aggregates do not
appear until 12-16 hours after of induction, the sedimentation of Sup35p into
heavier fractions by 8 hours corresponds with previous results, which showed
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Figure 3.1: Endogenous Sup35p settles into heavier fractions with
induction of Sup35NM-GFP. Wildtype cells containing the copper inducible
Sup35NM-GFP plasmid (p3032) were either uninduced, or induced with 50µM
copper sulfate for 8,16, and 24 hours. [psi-] and [PSI+] cultures without the
plasmid were also included. Cultures were lysed using glass beads and protein
was immediately separated by a continuous sucrose gradient centrifugation (2060% sucrose). Seven fractions were collected and run on SDS-PAGE for
immunoblotting. Anti-Sup35C monoclonal antibody (1:10,000) was used in
immunoblot analysis. Figure was published in Lyke and Manogaran, 2017.

that Sup35NM-GFP forms SDS-resistant oligomers at the same time point
(Sharma et al., 2017). These data suggest that aggregation of both endogenous
Sup35p and Sup35NM-GFP happen at approximately the same time.

3.2.2 Sup35NM-GFP Aggregate Formation undergoes two distinct steps
that can be quantified
To begin to understand the mechanisms of cellular response to visible
protein aggregate formation, I analyzed 3D time-lapse videos of newly formed
Sup35NM-GFP aggregates. Previous work revealed that the initial formation of
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visual Sup35NM-GFP aggregates involves two steps. The first step involves the
initial appearance early foci. These early foci are highly mobile for approximately
30-60 minutes (Figure 1B, Sharma et al., 2017). In cells with multiple early foci,
fusion can occur with early foci merging together into a single focus that can also
be mobile. Together, I define step 1 as consisting of early foci mobility and
coalescence, which have been observed to occur simultaneously (Figure 3.2
Left, Lyke and Manogaran, 2017; Sharma et al., 2017). The second step involves
the localization of early foci near the cell periphery (Figure 3.2 Right). Early foci
are quickly sequestered near the cell membrane, where they grow into either dot,
line, or ring like aggregates, and remain for several hours (Mathur et al., 2009;
Sharma et al., 2017).
To begin to understand the cellular mechanisms that are involved in
aggregate formation, I established several methods to quantify different parts of
this two-step process. Mobility is considered the time in which early foci move
through the cytoplasm. Using 3D time-lapse microscopy, the mobility of early
foci, or movement over time, is determined by measuring the distance individual
early foci move per minute. Briefly, the 3D coordinates of the early foci from the
one time point and the second are plotted within a sphere representative of the
cell. Next, using geometry the distance between the two time points can be
extrapolated, representing the distance traveled by the early foci in three
dimensions over that time frame.
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Distance from the
cell periphery

Figure 3.2: Model of Sup35NM-GFP Formation. Left. Step 1 of formation
consists of two parts, mobility and coalescence. Mobility happens approximately
during the first 30-60 minutes of formation, where the aggregates are observed to
move throughout the cell. The mobility of early foci can be quantified by
measuring the distance early foci have moved over time. Coalescence (right)
also happens within the first 30-60 minutes of formation. It has been observed
that multiple early foci can merge together in some cells but not in others
(Sharma et al., 2017). The ability to merge or coalesce can be measured by
counting the number of aggregates well after step 1 is completed. Right. Step 2
of formation involves the sequestration of matured early foci, or aggregates near
the cell periphery. Once positioned to the cell periphery, the aggregate remains
relatively static for several hours. The position of the aggregate can be measured
spatially in three dimensions in reference to the edge of the cell.

I used two different wildtype genetic backgrounds to determine whether
this two-step process could be observed in different backgrounds and whether
behavior was similar. The 74D-694 strain is commonly used for prion studies
because of the genetic markers available and the ease in which prionogenic
proteins aggregate (Chernoff et al., 1995). The BY4741 strain is routinely used
by the yeast community, and is the genetic background of the single gene
disruption library and GFP-tag collection (Winzler et al., 1999). An analysis of
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both wildtype genetic backgrounds showed that the average rate of movement
over the first 30 minutes was approximately 0.65µm/min (Figure 3.3). Previous
studies observing the rate of movement for heat induced aggregates show a
similar rate of 5-15nm/second (0.3-0.8µm/min; Escusa-Toret et al., 2013),
possibly suggesting that the initial mobility Sup35NM-GFP aggregates is similar
to other types of aggregates. Multiple trials of mobility for both wildtypes show
similar patterns of high initial mobility that slows over time (Figure 3.4 Top). While
BY4741 strains showed a significantly negative slope by regression analysis, the

Figure 3.3: Mobility of Sup35NM-GFP Aggregates. A. Sup35NM-GFP was
induced for 16 hours in 74D-694 and BY4741 cells. Cultures were then imaged
by long-term 3D time-lapse microscopy (see Chapter 2) for the initial appearance
of a protein aggregate. Movement of the early foci was tracked using 3D
coordinate mapping with representative images shown. The yellow outlined cell
for was used for mobility. To the right of the images are a particle trace showing
the movement of the individual foci through the recording. B. A graph
representing the distance moved per minute for the foci shown in A. On each
graph a linear trend is displayed as the dashed line.

46

BY4741 WT

74D WT

74D Wildtype

74D-694 2
74D-694 3

0.0

74D-694 4

-0.5
-1.0
-1.5

Slope (µm/min)

7

0
-3

27

1

8

4

-2

-2

24

-2

21

18

5

BY4741 2
BY4741 3

0.0

BY4741 4

-0.5
-1.0

03. 3
06.
0
6.
09.
9.
-1
12 2.
.-1
5
15 .
-1
8
18 .
-2
1
21 .
-2
4
24 .
-2
7
27 .
-3
0.

03. 3
06.
0
6.
09.
9.
-1
12 2.
.-1
5
15 .
-1
8
18 .
-2
1
21 .
-2
4
24 .
-2
7
27 .
-3
0.

-1.5

Time Elapsed (Minutes)

Time Elapsed (Minutes)

74D-694 Wildtype

BY4741 Wildtype

Distance Traveled (µm)

0.0
.6
-

.6

.8
.8
-1
11
1. .2
21
1. .4
41
1. .6
61.
8
1.
82
2+

.6

.6
-

.4
-

.2
-

0-

.4

0.0

0.1

.4
-

0.1

0.2

.4

0.2

0.3

.2
-

0.3

0.4

.2

0.4

0.5

0-

Percentage of Movements

0.5

.2

Percentage of Movements

-1

BY4741 1

0.5

.8
.8
-1
11
1. .2
21
1. .4
41
1. .6
61.
8
1.
82
2+

Slope (µm/min)

BY4741 Wildtype
1.0

74D-694 1

0.5

-1

Time Elapsed (Minutes)

Time Elapsed (Minutes)

1.0

15

9

3
0-

0

7

0.00

-3

4

1

8

0.01

27

-2

24

-2

-2

21

5

-1

18

-1

15

12

9
6-

12

6
3-

9-

3
0-

0.00

BY4741 4

12

0.01

BY4741 3
0.02

9-

74D-694 4

0.02

BY4741 2

0.03

12

74D-694 3

6

0.03

BY4741 1

6-

74D-694 2

3-

74D-694 1

0.04

Distance Moved (µm/sec)

Distance Moved (µm/sec)

0.04

Distance Traveled (µm)

Figure 3.4: Mobility Comparison of Multiple Cells. Sup35NM-GFP was
induced for 16 hours in 74D-694 and BY4741 cells, using similar methods to
Figure 3.3. Aggregates from four individual cells of each genetic background
were recorded. Top: Average distance moved of each aggregate per three
minutes of recording. Middle: Average slope of each aggregate per three minutes
of recording. Bottom: Percentage of movements by distance moved. Each minute
the distance the aggregate moved was recorded and binned into a distance
range. After the first 30 minutes of formation, the percentage of movements for
each distance range is determined and represented above. Strains were
compared using Kolmogorov-Smirnov test.
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74D-694 strain did not, suggesting that while the pattern of behavior is similar
there may be differences in cellular response (Figure 3.4 Middle). Further
comparison of mobility profiles was done by binning the number of events that a
particular distance was moved. Similar to the comparison of slopes, the 74D-694
strain was significantly different from the BY4741 strain (Figure 3.5 Bottom). We
also looked at mobility during the first 10 minutes and third 10 minutes of
formation to better understand where differences between the strains lied in the
response to aggregate formation. During the first 10 minutes of formation 74D694 early foci had an average rate of movement of 1.06µm/min and BY4741 was
1.21µm/min. As expected based on the overall average, the mobility of both
strains slowed down by the third 10 minutes to 0.81µm/min and 0.47µm/min for
74D-694 and BY4741 respectively. The variability in the mobility of aggregates
can also be assessed through calculating the mean absolute difference (MAD).
The MAD value is the absolute difference of each datapoint from the mean value.
This statistical tool can be used to investigate the similarity between two separate
data sets, such as 74D-694 and BY4741 strains. A high MAD value (0.3 – 0.5)
suggests that the mobility of aggregates does not follow a consistent rate similar
to the trendline, but rather indicates that the aggregate has times in which
movement is high and then low throughout formation that deviate from the
consistency of the trendline. Meanwhile, a low MAD value (0.1-0.2) indicates that
aggregates remain at a constant rate of movement similar to the trendline. Both
wildtype strains exhibited higher MAD values (0.33 for 74D-694 and 0.30 for
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Mean Overall
rate Rate
(μm/min)

Mean Rate in
first 10 minutes

Mean Rate in
third 10 minutes

Mean Slope

Mean MAD

74D694

0.65 +/- 0.58

1.08 +/- 0.63

0.81 +/- 0.60

-0.013 +/0.009

0.33 +/0.08

BY4741

0.66 +/- 0.55

1.21 +/- 0.52

0.47 +/- 0.38

-0.028 +/0.007

0.30 +/0.06

Table 3.1: Mobility Quantification of Sup35NM-GFP in wildtype strains.
The mean rate of movement was determined by taking the distance moved
per minute over approximately thirty minutes, for at least four individual early
foci. The slope was determined by plotting a trendline of the movement over
time (Fig. 3.3 and 3.4), calculating the slope, and averaging values from at
least three early foci. The Mean Absolute Difference (MAD) was determined
by taking the deviation of the distance moved per minute from the trendline at
that particular time point. Individual deviations are averaged for each data set,
and the average deviations from the multiple datasets provide the Mean
Absolute Difference (Lyke et al., unpublished).

BY4741; Table 3.1), suggesting that aggregates experience variable rates of
movement until their movement eventually slows.
Coalescence reflects the number of aggregates per cell, and the ability of
early foci to merge together as a single focus indirectly. If coalescence occurs,
there would be one aggregate per cell after 60 minutes. If coalescence does not
occur, it would be expected that more aggregates would be observed after 60
minutes. While the majority of 74D-694 cells had one dot, line, or ring aggregate
per cell, there was a large range in the number of aggregates in wildtype strain
cells (Figure 3.5). 74D-694 ranged from 1 to 15 aggregates while BY4741 ranged
from 1 to 6 aggregates. However, coalescence was not significantly different
between strains, with a median number of aggregates of 1 for both. I also
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investigated the distribution of aggregate phenotypes between the two genetic
backgrounds. Previous work showed that 74D-694 cells can contain a single dot,
multiple dots, a single line or ring, or multiple lines (Sharma et al., 2017). 74D694 generally contained an equal distribution in all four possible aggregate
pathways, however BY4741 favored cells that contained either single aggregates
(Figure 3.6). It has been previously suggested that the number of protein
aggregates per cell can be reflective of cellular age (Saarinkangas and Caudron.,
2017; Ruan et al., 2018), so I investigated the age of the cell in relation to the
number of protein aggregates.
During cell division the dividing cell forms a bud scar where the daughter
was attached. A mother cell that has undergone several divisions will have more
budscars than a new daughter cell, therefore the number of budscars represents
the replicative age of the cell. In 74D-694 cells, more budscars corresponded to
higher numbers of protein aggregates per cell, however BY4741 cells generally
contained a low number of aggregates regardless of replicative age (Figure 3.7).
Given that older cells had more protein aggregates in 74D-694 cells, I
investigated the role age may play on the formation of aggregates. In budding
cells, the mother cell is chronologically older than the newly formed daughter,
allowing a direct comparison of young and old cells by analyzing mother
daughter pairs. 21 time-lapse recordings of Sup35NM-GFP formation in motherdaughter pairs of 74D-694 background was analyzed.
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Figure 3.5: Coalescence of Sup35NM-GFP aggregates. Sup35NM-GFP was
induced in cultures of either 74D-694 or BY4741 genetic background for 18-22
hours. Cells were imaged and the number of protein aggregates in each cell was
quantified to assess coalescence with assistance by Abbey Kuborn. The average
number of aggregates per cell is graphed. Moods Median T-Test revealed no
significant difference between the two strains. Statistical analysis was performed
by Dr. Steve Merrill.
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Figure 3.6: Distribution of Sup35NM-GFP Aggregates in cells between two
genetic backgrounds. Sup35NM-GFP was induced for 18-22 hours in either
74D-694 or BY4741 and subsequently imaged. Cells were quantified based on
the type of aggregate present in the cell with assistance by Abbey Kuborn. Over
200 cells were quantified for both genotypes.

The mother cell always contained a higher number of aggregates compared to
the corresponding daughter (Figure 3.8A-C; Lyke and Manogaran, 2017).
Interestingly, time-lapse observations of early foci were mobile and coalesced in
daughter buds. However, early foci were mobile but generally lacked
coalescence in the corresponding mother cell (Figure 3.8A-C). Mother daughter
pairs were further analyzed in both 74D-694 and BY4741 backgrounds using
snapshot microscopy for higher sample size comparison. Similar to budscar
staining experiments, the BY4741 cells contained mostly single aggregates
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regardless whether early foci were located in the mother cell or corresponding
daughter bud, whereas 74D-694 mother cells had higher aggregate counts
compared to corresponding daughters (Figure 3.8D). Taken together, the
differences between 74D-694 and BY4741 in the number of aggregates
corresponding to age suggests that both genetic background and age may play a
role in the ability to coalesce early foci, while maintaining a single aggregate
appears to be the preferred pathway by cells.

Figure 3.7: Aggregate Distribution by Budscar Number. Sup35NM-GFP was
induced for 18-22 hours in either 74D-694 or BY4741 and subsequently stained
with Calcafluor White for budscars. Cells were quantified based on the type of
aggregate present in the cell and the number of budscars. The number of cells
analyzed are shown above each bar. Abbey Kuborn assisted with quantification
analysis.
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Figure 3.8: Mother cells contain more aggregates compared to
corresponding daughter cells. A. Sup35NM-GFP was overexpressed for
approximately 18 hours in 74D-694 cells. Diffuse cells were imaged using 3D
time-lapse microscopy for an additional 12 hours. Representative images of an
early foci appearing in both mother cell and daughter bud (01:00 minute) to their
fusion in the daughter bud (04:00 minute) are shown. Yellow and green arrows
point to the early foci in the mother cell, while red and blue arrows are in the
daughter bud, turning grey when they merge. B. Early foci trajectories (from A)
followed for 16 minutes are shown. The movement of each foci was tracked on a
2D plane, with colors corresponding to arrows in A in the mother (left cell) and
daughter bud (right cell; Lyke and Manogaran, 2017). C. 20 time-lapse videos
were analyzed for the number of aggregates in the mother cell and daughter bud
present approximately 1 hour after the initial appearance of the early foci. The
graph represents the average number of aggregates per cell, compared by T-test
(p<0.0001). D. Sup35NM-GFP was overexpressed for approximately 18 hours in
74D-694 or BY4741 cells. Cells were imaged and the number of aggregates per
cell was quantified only for cells that were currently dividing (mother cell with
daughter bud still attached). The number of mother-daughter pairs analyzed is
shown above each mother cell plot. Abbey Kuborn assisted in quantifying
aggregates per cell in mother-daughter pairs.
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The sequestration step (Step 2) can be quantified as the distance the
aggregate is positioned from the cell periphery. To quantify the distance to the
periphery, aggregate position was determined within the cell using a 3D
coordinate mapping technique (see Chapter 2). This technique extrapolates the
distance measured between Sup35NM-GFP aggregates and the edge of the cell.
For both wildtype strains, the average distance from the cell periphery was 0.82
µm and 0.88µm for 74D-694 and BY4741 respectively (Figure 3.9), suggesting
similar spatial localization of the aggregate. Taken together, these quantification
techniques indicate that Sup35NM-GFP formation is mostly similar between two
different wildtype backgrounds, albeit with the exception of aging effects.

3.3 Discussion
In this chapter I developed methods to quantify the formation of protein
aggregates utilizing data generated from 3D time-lapse recordings. These
quantifications allow comparison of the behavior of aggregates in two different
genetic backgrounds. Regardless of genotype, the behavior of newly formed
Sup35NM-GFP early foci mobility (Figure 3.3) and aggregate sequestration
(Figure 3.9) appear to be very similar. The one caveat is the number of protein
aggregates formed per cell, especially in aging cells (Figure 3.5-8). While
BY4741 cells maintained a low number of dot-like aggregates regardless of age,
74D-694 showed a wide range of aggregate number and type in older cells. It is
possible that the 74D-694 strain has weaker protein quality control mechanisms
that result in poor management of aggregates especially as cells age
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Figure 3.9: Sequestration of Sup35NM-GFP Aggregates. Sup35NM-GFP was
overexpressed for 18 hours in 74D-694 and BY4741 cells. Cultures were imaged,
and the distance between the aggregate and the periphery in each cell was
measured by 3D coordinate mapping. The number of cells assessed are shown
above each plot. Unpaired T-Test showed no significant differences between the
two strains.

The dynamics of aggregate formation have never been previously
characterized in this manner. Zhou et al. (2011) and Zhou et al. (2014) made
general claims on the mobility of heat-induced aggregates through observations
of time-laspe recordings. Liu et al. (2010) and Escusa-Toret et al. (2013) took
similar observations one step further by quantifying the rate of movement,
however the aggregates used were heat induced also. Recent work by Sharma
et al. (2017) made the first observations of de novo Sup35NM-GFP formation
using time-lapse microscopy, however the behavior of the aggregate was once
again only characterized with generalizations. The work done in this chapter

56
goes beyond any aggregate behavior characterization previously performed.
Innovative quantitative measures developed here allow combined with statistical
analysis with the help of Dr. Steve Merrill at Marquette University, allows for a
novel approach to characterize aggregate formation and behavior. These new
tools can be leveraged to understand the biology of protein aggregate formation.
I observed that in both wildtype strains Sup35NM-GFP aggregates had
similar, general formation behavior, starting with high mobility and most cells able
to coalesce aggregates together, leading to peripheral sequestration of
aggregates. However, using quantifiable methods I found that there were
differences between the two strains. Aggregates in BY4741 cells slow down in
mobility much quicker than aggregates in the 74D-694 genetic background
(Table 3.1). 74D-694 also appear to have difficulty managing aggregates as cells
age, with older cells containing multiple aggregates more often than in the
BY4741 background (Figure 3.7). It is interesting that the differences between
the two strains both occur during the first step in aggregate formation, suggesting
that 74D-694 strain cells have trouble managing early foci. The first step of
formation involved the movement and fusion of aggregates, which previous work
suggests is associated with cellular trafficking mechanisms. Cells with disrupted
cytoskeletal networks have an increased number of heat-induced aggregates
(Specht et al., 2011), and have reduced observed mobility (Zhou et al., 2011). It
is possible that older 74D-694 cells have reduced cytoskeletal networks resulting
in poor management of the formation of protein aggregates. Differences,
especially during aging, are common between different yeast genetic
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backgrounds (Lippuner et al., 2014). Further work to understand the role of the
cytoskeleton in protein aggregate formation may not only provide clues to
differences observed between wildtype strains, but also begin to explain the
mechanism of cellular response to protein aggregate formation.
Together, this chapter demonstrates that the formation of protein
aggregates can now be quantified rather than simply observed. The
quantification described is reliable, and consistent or Sup35NM-GFP formation in
two different genetic backgrounds. The ability to quantify aggregate formation
under wildtype conditions allows for a baseline to be set in quantification. This
baseline can be used to compare the behavior of protein aggregates formed
under different conditions to identify what cellular components are necessary for
a normal response to aggregate formation. Understanding what is involved in the
mechanism of cellular response could potentially lead to a better understanding
of how protein aggregates eventually lead to cellular dysfunction and potential
toxicity.
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Chapter 4: Actin Plays a Role In Newly Formed Protein
Aggregate Dynamics
4.1 Introduction
As described in Chapter 3, early foci are highly mobile upon initial
appearance, but slow down over time to statically localize near the cell periphery.
The consistency at which aggregates localize to the cell periphery suggests that
mobility is not passive or by random diffusion, but rather due to a cellular
trafficking mechanism that actively moves aggregates to a retention site. In
yeast, protein and organelle trafficking is commonly associated with the actin
cytoskeleton (Moseley and Goode, 2006). It is possible that newly formed protein
aggregates are trafficked along actin network roadways to a distinct destination
in the cell. However, if trafficking does not influence aggregate movement, then it
is possible that the slow down is due to aggregate growth over time.
Previous studies have suggested that the movement of heat induced
Hsp104p associated aggregates is associated with the actin cytoskeleton.
Spatially, Hsp104p aggregates have been shown to localize to the actin network
observed by phalloidin staining (Liu et al., 2010; Song et al., 2014). The mobility
of stress induced aggregates is impaired when the actin network is disrupted by
LatrunculinA (LatA) treatment, an pharmacological actin inhibitor (Zhou et al.,
2011). Similar treatment of cells by LatA also results in an increase in the number
of heat induced aggregates per cell (Specht et al., 2011), together supporting the
role of actin in the formation of protein aggregates. Actin has also been shown to
affect the segregation of Hsp104p aggregates between dividing cells. The folding
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of actin monomers is impaired in the genetic disruption sir2Δ, and in this strain
daughter cells have an increase in the number of aggregates they contain,
suggesting that the actin network plays a role in managing protein aggregates to
restrict inheritance in daughter cells (Liu et al., 2010; Song et al., 2014). These
changes to the behavior of aggregates based on the actin network are not unique
to stress induced aggregates however, as the human protein Optineuron displays
similar effects. Optineuron (OPTN) is a trafficking protein in humans that has
been shown to be aggregated in ALS patients. The OPTN protein also
aggregates when expressed in yeast. Treatment of cells with LatA caused an
increase in the number of OPTN aggregates (Kryndushkin et al., 2012). It is
possible that the formation of many other newly formed protein aggregates, such
as Sup35NM-GFP, are also depending upon the actin cytoskeleton.
The formation of Sup35NM-GFP aggregates has been shown to be
dependent on factors that influence actin assembly. Disruptions associated with
endocytosis and the cortical actin patch, such as sla1Δ, sla2Δ, and las17Δ
reduce the number of cells that form Sup35NM-GFP aggregates (Ganusova et
al., 2006; Manogaran et al., 2011). Similarly, pharmacological disruption and
mutations in certain actin polymerizing genes inhibit the formation of oxidative
stress induced Sup35NM-GFP aggregates (Speldewinde et al., 2017).
In this chapter, I investigate how the actin cytoskeleton influences the
behavior of aggregate formation. Mutations to the ACT1 gene, which encodes
actin in yeast, are used to understand how the actin cytoskeleton alters
aggregate behavior. This work supports previous literature and further suggests
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a potential role for actin in protein aggregate formation, beginning to add more
detail to the cellular response mechanisms.

4.2 Results
4.2.1 Aggregate localization with actin is unclear
Two previous studies indicated that Sup35NM-GFP aggregates colocalize
with the actin stain, rhodamine-phalloidin (Ganusova et al., 2006; Speldewinde et
al., 2017). However, these observations were made using snapshot microscopy
in 2D. To quickly assess the association of actin with Sup35NM-GFP aggregates
in cells by 3D microscopy, I investigated colocalization between newly formed
aggregates and the actin network. While actin can be visualized by rhodaminephalloidin stain, I found that the requirement to fix the cells altered the
appearance of protein aggregates (Figure 4.1). Altering the appearance of
protein aggregates raised questions as to the reliability of colocalization analysis
under these conditions.
Therefore, I turned to 3D-live cell imaging techniques to observe the actin
cytoskeleton. Actin patches are observed using Cof1-RFP, which is a protein that
localizes to depolarizing actin patches (Lin et al., 2010), while actin cables are
observed using Abp140-YFP, an actin binding protein (Asakura et al., 1998;
Yang and Pon., 2002). Colocalization was quantified using Pearson’s Correlation
Coefficient (PCC). PCC quantifies the degree of overlap between two different
fluorescent channels, with a score of 1 representing perfect colocalization and a
score of 0 indicating a lack of overlap. PCC values for aggregates and the actin
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Figure 4.1: Sup35NM aggregate localization with the actin network is
unclear. A. Sup35NM-GFP was induced in 74D-694 wildtype cells overnight.
Cells were fixed in formaldehyde and stained with Rhodamine Phalloidin.
Representative images are shown above. B. 74D-694 cells endogenously
expressing Co1-RFP (actin patches) or Abp140-YFP (actin cables) had
Sup35NM-GFP or Sup35NM-YFP induced respectively. Representative images
are shown. Images were analyzed for co-localization by PCC (Left) and for
adjacent localization (Right). A positive control was included in PCC for
comparison by T-test analysis ( p < 0.01).

network were compared to a positive control strain that contained Sup35NM-GFP
and Sup35NM-RFP. Adjacent localization was also quantified for aggregates and
actin. Structures are considered adjacent when localized within 500nm of each
other. No overlap or consistent adjacent localization was observed between
either actin structure with Sup35NM aggregates (Figure 4.1). Unfortunately,
quantification was difficult to rely on as Cof1-RFP was highly dynamic, and
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Abp140-YFP was commonly found throughout the cell, which made
colocalization difficult to determine. Therefore, to determine whether actin is
involved in the formation of Sup35NM-GFP aggregates, I had turned to
assessing aggregate behavior in strains with disrupted actin cytoskeletons.

4.2.2 Mutations in Actin Reduce Sup35NM-GFP Early Foci Mobility
Actin in yeast is encoded by the ACT1 gene. Deletion of ACT1 is lethal,
but there are many point mutations which are temperature sensitive. Amino acid
substitutions of the ACT1 gene were originally engineered by Wertman et al.
(1992) in the BY4741 background. act1-122 (D80A, D81A) and act1-120 (E99A,
E100A) contain substitutions in or near the Sac6p binding site, the yeast
homolog of the fimbrin actin bundling protein (Figure 4.2; Wertman et al., 1992).
These mutants show depolarized actin patches, reduced actin cables, and grow
normally at permissive temperatures (Wertman et al., 1992; Drubin et al., 1993;
Miller et al, 1996; Dorweiler et al., in revision). act1-101 (D363A, D364A) partially
disrupts actin cables, but has no effect on actin patches (Wertman et al., 1992;
Drubin et al., 1993; Miller et al, 1996; Dorweiler et al., in revision).
The formation of Sup35NM-GFP aggregates was recorded with 3D timelapse microscopy in each of the three actin mutant strains and a BY4741
wildtype strain. Each strain contained High [PIN+], except act1-122, which was
µd, which was previously shown to induced [PSI+] similar to High [PIN+] wildtype
strains (Dorweiler et al., in revision). The average rate of movement for both
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Figure 4.2: The Structure of the Actin Protein. Rendering of an actin monomer
is shown with the three point mutant sites designated. The model was created
using the Pymol Program with the help of Dr. Jane Dorweiler from the
Manogaran Lab. The structure of the actin protein (PDB ID:3ith highlighted
amino acids corresponding to those residues mutated in the act1-120 (E99A,
E100A; green), act1-122 (D80A, D81A; blue), and act1-101 (D363A, E364A;
purple) strains.
act1-122 and act1-120 (0.29µm/min and 0.27µm/min respectively) was
significantly reduced compared to the wildtype (0.66µm/min; Figure 4.3). As
expected the slopes of the aggregate mobility were also much less negative for
act1-122 and act1-120 compared to either the wildtype or act1-101 strains
(Figure 4.4). Both of these mutant strains also had the majority of aggregate
movements of extremely short distances, which once again was much different
than the wildtype and act1-101 strains (Figure 4.4). Given the difference, I
investigated whether mobility was different within the first 10 minutes of
appearance when early foci have the highest rate of movement and between 20
and 30 minutes (as done in Table 3.1).
During the first ten minutes of quantification, the average rate of
movement for wildtype was 1.2µm/min, while in act1-122 and act1-120 the rate
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was 0.37µm/min and 0.41µm/min respectively (Table 4.1). In the third ten minute
interval (starting 20 minutes after formation), the average rate of movement for
wildtype was 0.47µm/min, and in the act1-122 and act1-120 mutants 0.29µm/min
and 0.19µm/min respectively (Table 4.1). The rates for act1-122 and act1-120
suggests that although aggregates appear to slow down in movement over time,
aggregates in the act1-122 and act1-120 mutants are always slower than the

Figure 4.3: Sup35NM-GFP Mobility is reduced in actin mutant strains. A.
Sup35NM-GFP was induced in High [PIN+] versions of BY4741 wildtype, act1120, act1-101, and µd [PIN+] BY4741 act1-122 cells. Strains were imaged in 3Dtimelapse with representative images from a single timelapse shown. Aggregates
marked with the white caret in the yellow outlined cell were tracked for mobility
and a representative particle trace is shown to the right of the images. B The
distance moved per minute was graphed for the aggregate shown in A, including
the linear trend. Table 4.1 provides statistical analysis of this data.
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Figure 4.4: Mobility Comparison in Wildtype and actin mutants. Sup35NMGFP was induced in High [PIN+] BY4741 wildtype, act1-120, act1-101, and µd
[PIN+] BY4741 act1-122 cells. Cultures were then imaged by long-term 3D
timelapse microscopy (see Chapter 2) for the initial appearance of a protein
aggregate. Movement of the early foci was tracked using 3D coordinate mapping.
Aggregates from four individual cells of each genetic background were quantified
and the rate of movement for each is shown above. Top: Aggregate mobility is
shown in three minute increments from initial formation. Middle: The slope of
mobility per three minute increment is shown. Bottom: The number of events that
moved a particular distance during recordings is shown.
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Mean Rate in
first 10
minutes
1.2 +/- 0.52
0.37 +/- 0.19*
0.41 +/- 0.32*

Mean Rate in
third 10
minutes
0.47 +/- 0.38
0.29 +/- 0.21
0.19 +/- 0.10

Mean Slope

Mean MAD

Wildtype
act1-122
act1-120

Mean Overall
rate Rate
(μm/min)
0.66 +/- 0.5
0.29 +/- 0. 2*
0.27 +/- 0.3*

-0.028 +/- 0.007
-0.003 +/- 0.004*
-0.010 +/- 0.008*

0.30 +/- 0.06
0.16 +/- 0.03*
0.15 +/- 0.06*

act1-101

0.92 +/- 0.6*

1.01 +/- 0.57

0.81 +/- 0.69*

-0.015 +/- 0.015

0.39 +/- 0.16*

Table 4.1: Slope and Mean Absolute Difference (MAD) values of Aggregate
Mobility. Mann-Whitney Test was used to compare values between actin
mutants and wildtype. Analysis revealed act1-122 and act1-120 had slower
mobility overall and during the first 10 minutes of formation, as well as slopes
significantly less negative than wildtype. act1-101 differed in overall rate and
during the third 10 minute interval, and while not different in slope from widltype,
act1-101 also displayed a higher amount of variability within samples of rate of
movement compared to wildtype (* p < 0.01).

wildtype. The consistent slower mobility in actin mutants is reflected by the slope
of the trendline in act1-122 and act1-120 being closer to 0 when compared to the
negative slope observed in wildtype (Table 4.1). The variability of mobility, as
quantified by MAD values, was also much lower in act1-122 and act1-120 (Figure
4.4, Table 4.1). The reduced MAD values and negligible slope in act1-122 and
act1-120 suggest that the mobility of aggregates is consistently very low for the
duration of formation. Together, aggregates in act1-122 and act1-120 are nearly
immobile, appearing and being retained at the same site as initial formation.
In contrast, average early foci mobility was slightly higher in act1-101
strains (0.921µm/min) compared to wildtype. The increase in average rate can be
attributed to aggregates maintaining higher rates of mobility longer in act1-101
compared to the wildtype, as the rate of movement does not drop as sharply in
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the actin mutant between the first ten minutes of appearance to the third ten
minutes (1.01µm/min and 0.81µm/min respectively; Table 4.1). While the slope of
the act1-101 mobility trendline was negative, act1-101 MAD values were higher
than wildtype. The negative slope indicates that the overall aggregate mobility is
decreasing over time, however the high MAD values suggest that there is more
variability in the rate of movement compared to wildtype. These data suggest that
mobility is altered differently in the act1-101 mutant compared to the act1-122
and act1-120 mutants.

4.2.3 Actin Mutants Have a Reduced Number of Sup35NM-GFP Aggregates
The number of protein aggregates per cell was also affected by
disruptions to actin. act1-122 and act1-120 cells contained a median of 2
aggregates per cell, while both wildtype and act1-101 cells contained 1
aggregate per cell (Figure 4.5). It should be noted that while increased aggregate
number may indicate reduced coalescence, it is also possible that actin mutants
lead to the formation of more early foci per cell than wildtype strains resulting in
more aggregates regardless of coalescence activity. act1-122 and act1-120
contain substitutions within the Sac6p binding domain. It is possible that the
bundling activity of actin influences aggregate number. Therefore, we looked at a
sac6Δ generated in the 74D-694 genetic background. Similar to act1-122 and
act1-120 mutants, sac6Δ mutants also have depolarized actin patches (Karpova
et al., 1998). Compared to a wildtype 74D-694 strain, sac6Δ was not significantly
different (Figure 4.5). These data suggest that Sac6p mediated actin bundling
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does not influence coalescence or aggregate number in the 74D-694 genetic
background. The similarity between wildtype and sac6Δ strains could be due to
the intrinsically high number of aggregates found in the 74D-694 genetic
background that could buffer out any observable effects of the genetic mutant.

4.2.4 Disruption to Actin Increases Aggregate Number In Older Cells
Previously, I observed that wildtype BY4741 strain cells typically contained
a low number of protein aggregates regardless of age (Chapter 3). Wildtype cells
in the 74D-694 background however, had increased numbers of Sup35NM-GFP
aggregates in older cells (Chapter 3, Figure 3.7). Given that in actin mutant
strains (BY4741 background) I observed an increase in the number of protein
aggregates, I tested whether the increase in aggregates corresponded to the age
of the cell, similar to that of 74D-694 wildtype cells.
Wildtype and actin mutants were stained with budscars similar to figure
3.7, and the number of aggregates and budscars for each cell was quantified.
Both act1-122 and act1-120 showed a population of cells that had increased
aggregate numbers compared to any population seen in wildtype or act-101
(Figure 4.6). Interestingly, the population of cells with a high number of
aggregates corresponded to cells containing higher numbers of budscars (Figure
4.6). The number of aggregates found in actin mutants by age is reminiscent of
wildtype 74D-694 strains (Figure 3.7), suggesting that differences between the
74D-694 BY4741 strains may have to do with the actin cytoskeleton.
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Figure 4.5: Disruption of Actin Alters Coalescence of Newly Formed
Sup35NM-GFP Aggregates. A. Sup35NM-GFP was induced in BY4741
wildtype, act1-120, act1-101, and act1-122 cells. The average number of protein
aggregates was quantified per cell in each strain from still shot microscopy, and
is represented in the graph. Aggregate number was compared to the wildtype
value using T-test analysis, finding act1-122 and act1-120 significantly different.
B. Sup35NM-GFP was induced in sac6Δ 74D-694 cells. The number of
aggregates per cell was quantified, and compared to a wildtype control by T-test
analysis. (* p<0.001).

4.2.5 Peripheral localization of Sup35NM-GFP aggregates is changed in the
presence of actin mutants and actin inhibiting drugs
Next, I investigated whether peripheral localization is affected in the actin
mutants discussed above. act1-122 and act1-120 mutants showed significantly
different peripheral localization profiles compared to wildtype. While the average
distance of the aggregate from the cell periphery was 0.88µm in wildtype strains,
aggregates were 1.20µm and 1.07µm from the periphery in act1-122 and act1-
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120 mutants, respectively (Figure 4.7). The peripheral localization of aggregates
in both actin mutants is statistically different than wildtype strains. Not all actin
mutants impact peripheral localization because aggregates were located
approximately 0.89µm in act1-101 mutants, which is similar to wildtype. Next I
asked whether sac6Δ mutants, which have depolarized actin patches and are
associated with actin bundling, have altered sequestration. Aggregates are found
to be on average further from the cell periphery than its isogenic wildtype (Figure
4.7). This data suggests that actin networks influence aggregate sequestration,
and possibly it is the Sac6p mediated bundling of actin and/or actin patches that
influence aggregate localization.
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Figure 4.6: Aggregate Distribution by Budscar Age in Actin Mutant Strains.
Sup35NM-GFP was induced for 18-22 hours in wildtype BY4741, act1-122, act1120, and act1-101, and subsequently stained with Calcafluor White for budscars.
Cells were quantified based on the type of aggregate present in the cell and the
number of budscars. The overall column is the sum of all of the data. Abbey
Kuborn assisted with data analysis.
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Figure 4.7: Sequestration of Sup35NM-GFP aggregates is altered by
disruptions to the actin cytoskeleton. A. Sup35NM-GFP was induced in
BY4741 wildtype, act1-122, act1-120, and act1-101. 3D-coordinate mapping was
used to quantify distance to the periphery of aggregates in each strain. act1-122
and act1-120 were significantly different from wildtype by T-test analysis, while
act1-101 was not. B. Sup35NM-GFP was induced in 74D-694 Wildtype and
sac6Δ. The localization of protein aggregates was quantified in both strains and
analyzed as done in A. C. Sup35NM-GFP was induced in wildtype BY4741 cells
and treated with Latrunculin-A, CytochlasinB, Jasplinkinolide, or paired ethanol
controls for at least thirty minutes prior to imaging. Protein aggregate localization
was quantified after treatment using coordinate mapping. Individual treatments
were compared using T-test to their corresponding paired control (ethanol
treated). Latrunculin-A and CytochlasinB were significantly different from their
corresponding control samples. (* p<0.01).
Next, I asked whether peripheral localization of aggregates could be
disrupted by transient inhibition of actin by pharmacological agents. Sup35NMGFP aggregates were allowed to form in wildtype (untreated) cells. Cultures were
then treated briefly with actin inhibitors. LatrunculinA (LatA) and CytochlasinB
(CytoB) inhibit F-actin polymerization by capping the plus end of actin fibers
preventing monomer addition, resulting in a near abolishment of actin cables and
actin patches (Ayscough et al., 2000; Yang and Pon., 2002; Kopecka et al.,
2015; Macklean-Fletcher and Pollard.,1980). Jasplinkinolide (Jasp.) stabilizes
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actin patches and cables by preventing the removal of actin monomers for the
minus end of actin fibers (Ayscough et al., 2000). This transient inhibition of the
actin cytoskeleton allows Sup35NM-GFP aggregates to form and localize to the
periphery of the cell as usual, and then observe localization after disruption. If
introduction of an actin inhibitor changes peripheral localization, then it is
possible that the actin networks influence the ability to keep Sup35NM-GFP
tethered at a specific location. Treatment with LatA or CytoB changed the
average localization of aggregates to 0.96µm and 1.03µm respectively, a
significantly different distribution compared to their paired untreated controls
(0.72µm and 0.77µm respectively, Figure 4.7). Meanwhile, treatment with the
actin stabilizing drug Jasp. did not change distribution compared to it’s paired
control, both having an average localization at 0.89µm. Since disrupting the actin
cytoskeleton after aggregates have been sequestered to the periphery results in
a change in localization, this suggests that aggregates maintain an association to
actin even after mobility is reduced. Actin, both bundled cables and patches, may
play a role in holding protein aggregates at a specific, peripheral site in the cell.

4.3 Discussion
Here, I have shown that the formation of Sup35NM-GFP aggregates is
impacted by disruption of the actin cytoskeleton. Specifically, act1-122 and act1120 mutants, which disrupt actin patch polarization and actin cable presence,
reduced mobility, coalescence, and sequestration of newly formed aggregates.
This work provides evidence that the behavior of newly formed aggregates may
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not be completely random, but actually involve a universal mechanism of
response by the cell.
While there are likely many factors involved in the formation of newly
formed aggregates, here I show that the actin cytoskeleton is a major player in
the movement of early foci into a single, peripheral inclusion. The rate of
movement of early foci in act1-122 or act1-120 strain cells was severely
impaired, with foci seemingly remaining in the same spot as their initial formation
took place (Figure 4.3, 4.4). The lack of mobility presumably also decreased the
ability of early foci to merge together, resulting in more aggregates per cell that
were localized inconsistently in the cell (Figure 4.5, 4.7). The effect of actin on
mobility and the number of aggregates per cell is similar to the results obtained
using stress induced aggregates previously. As described above, stress induced
aggregates both localize with the actin cytoskeleton, but have mobility impaired
by LatA disruption (Liu et al., 2010; Zhou et al., 2011; Song et al., 2014). While
actin is made up of both patches and cables, it is unclear whether they serve
different functions in aggregate formation. sac6Δ is known to alter actin patch
polarization (Young et al., 2004), and while the strain exhibits normal
coalescence, sequestration is altered (Figure 4.5. 4.7). However, sequestration is
also impaired by the disruption of actin cables pharmacologically (Figure 4.7).
Therefore, it seems as thought the role of actin cables and patches in the
formation of protein aggregate is much more complex then cables being used in
step 1 and patches for step 2 of formation.
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This is the first study to investigate newly formed Sup35NM-GFP
aggregate mobility and coalescence, and the role of the actin cytoskeleton.
However, a possible interaction between the actin cytoskeleton and Sup35NMGFP aggregates has been proposed previously. Ganusova et al. (2006) found
that disruption of cortical actin patch proteins resulted in a decrease in the
formation of Sup35NM-GFP aggregates, suggesting that there is a link between
the formation of aggregates and the actin cytoskeleton. In support of actin having
a role in aggregate formation, mutations to a protein called Lsb2, which binds to
an actin patch protein, that impair the ability of Lsb2p to bind to actin patches
reduces the formation of Sup35NM-GFP aggregates (Chernova et al., 2011).
Furthermore, treatment of cells with LatA or in abp1Δ strains, an actin nucleation
protein, Sup35NM-GFP aggregate formation is also reduced (Speldewinde et al.,
2017), adding to the idea that an intact actin cytoskeleton contributes to
aggregate formation. It is possible that in these previous studies, Sup35NM-GFP
forms aggregates that are not visible microscopically, but could potentially be
biochemically as I observed in Chapter 3, Figure 3.1. Together with my work, it
could be suggested that the actin cytoskeleton is needed to promote the fusion of
early foci together by the associated trafficking mechanism to form a single, large
observable aggregate that is much easier for the cell to manage rather than
multiple aggregates.
Interestingly, not all actin mutants caused similar behavior of newly formed
aggregates. The act1-101 mutant acted mostly like wildtype, although this mutant
displayed higher mobility that slowly declined through recordings. It was
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expected that the shortened actin cables in the act1-101 mutant (Tang et al.,
2000) would result in limited mobility, but my data suggests just the opposite. It is
possible that early foci are moved along shortened cables but reach the end
quickly, resulting in a short period that resulting the aggregate must re-associate
with another actin cable. The increased association and dissociation from actin
cables may reflect the large variability in mobility that is observed in MAD values,
and may explain why aggregates are mobile for a longer period of time as it
simply takes longer for aggregates to reach their destination. However,
eventually aggregates do reach a peripheral destination, allowing for the negative
slope of movement observed.
It is unclear how actin plays a role in the sequestration of newly formed
aggregates. In actin mutants, Sup35NM-GFP aggregates have a wide
distribution of peripheral localization compared to wildtype cells. However, this
distribution in wildtype cells can be disrupted by adding pharmacological
inhibitors of actin, becoming more reflective of the sequestration in genetic
mutants. This change in localization suggests that the actin cytoskeleton possibly
had a role in tethering the aggregate to a specific location, and transient
treatment of actin drugs mildly released the aggregate to change localization. On
the other hand, drug treatment could release the aggregate, yet due to molecular
crowding, the aggregate moves drifts to any space that is available. It is possible
aggregates maintain association with the actin cables or patches, after
sequestration. This association may function to tether protein aggregates to a
single site in the cell or as part of a peripheral protein deposit. Whether
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aggregates directly interact with the actin cytoskeleton for sequestration should
be further explored to fully understand the role of actin in the cellular response to
newly formed aggregates.
The actin cytoskeleton is not only involved in the formation of protein
aggregates, but it also appears to play a role in aging. As described previously,
sir2Δ strains that are used to model premature aging in yeast with misfolded
actin have issues with asymmetric inheritance of Hsp104p associated
aggregates (Erjavec et al., 2007; Liu et al., 2010; Song et al, 2014). Disruption of
actin by LatA has also been observed to decrease the asymmetric inheritance of
stress induced aggregates (Zhou et al., 2011). In my study, in the BY4741
wildtype cells, regardless of age cells maintain about 1 aggregate per cell.
However, in the act1-122 or act1-120 cells while young cells maintain a single
aggregate, older cells have multiple (Figure 4.5). The increased number of
aggregates in the older actin mutant population is similar to 74D-694 wildtype
cells observed previously (Chapter 3). However, previous literature would
suggest the opposite effect, that both older and younger cells should have
multiple aggregates when actin is disrupted. It is possible that in actin mutants
while the ability to traffic aggregates may be lost, the mechanism for asymmetric
inheritance is still partially intact to prevent transmission of aggregates into
daughter cells. The Sir2p is most likely still functional in our actin mutants,
therefore although actin is disrupted Sir2p may still be able to provide enough
function to allow for asymmetric inheritance. However, given the weak actin
cytoskeleton, older cells continue to have decreased protein quality control
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mechanisms and are less efficient at managing the formation of protein
aggregates, resulting in the increase of aggregates observed in older, actin
mutant cells or 74D-694 wildtype cells, compared to BY4741 strains.
Overall, here I have shown that the actin cytoskeleton plays an important
role in the cellular mechanism of response to the formation of protein aggregates.
Further work will identify how actin plays this role, such as whether there is a
direct interaction between actin and the aggregate, and what other factors could
be involved. Given the movement of newly formed protein aggregates, one
possibility to explore is the role of actin in cell trafficking. Organelles, vesicles,
and other cellular components are trafficked in the cell by motor proteins along
the actin cytoskeleton, a mechanism that could similarly be used for the
movement of protein aggregates. Further study to understand the role of the
actin cytoskeleton in responding to protein aggregate formation may uncover
more details of the mechanism by which aggregates can lead to age associated
diseases with the potential to identify new therapeutic targets that would prevent
or reduce disease symptoms.
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Chapter 5: Early Foci Dynamics Require Myo2p.
5.1 Introduction
The goal of this chapter is to determine whether Myo2p has a role in the
early formation of protein aggregates. The work done in Chapter 3 established
quantifiable measures to characterize de novo formation of Sup35NM-GFP
aggregates, and this quantification was used to identify a role of the actin
cytoskeleton (Chapter 4). However, although actin may directly affect the
dynamics of aggregate formation, it is unclear how protein aggregates may be
interacting with the cytoskeleton. Recent work has lead to this investigation of the
myosin motor protein Myo2p as a potential link between the actin cytoskeleton
and protein aggregate.
Myosin motor proteins travel along the actin cytoskeleton moving cargo,
such as proteins and organelles, and this movement may provide the mobility of
protein aggregates observed. In yeast there are five different known myosin
proteins. Myo3p and Myo5p function as part of endocytosis machinery, and
Myo1p plays a role in cytokinesis during cell division (Brown., 1997). Meanwhile,
Myo2p and Myo4p are both Class V Myosin’s that play a role in the transport of
cellular components. The role of Myo4p is limited as it does not contain many of
the tail regions required to bind cargo, and is mainly responsible for transporting
mRNA during cell division through the aid of myosin binding proteins (Brown.,
1997; Mermall et al., 1998; Schott et al., 1999). Myo2p however, is responsible
for transporting a variety of cellular components such as organelles and vesicles
along the actin network (Matsui., 2003; Pruyne et al., 2004; Weisman., 2006;
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Fagarasanu et al., 2010). Myo2p is made up of three domains: a motor domain, a
coiled coil domain, and a tail domain. The motor domain uses ATP hydrolysis to
drive motility function along the actin network while the coiled coil domain allows
interaction for Myo2p monomers to bind together as a dimer. The tail domain
contains a globular head, which allows interaction with a diverse range of cargo
(Cheney et al., 1993). The diverse role of Myo2p makes it a candidate for
potentially trafficking protein aggregates in the cell.
Previous work suggests that Myo2p could be the motor protein that is
trafficking protein aggregates along the actin network. Point mutations in actin
that disrupt the ability of Myo2p to interact with the cytoskeleton causes reduced
asymmetric inheritance of heat induced aggregates (Liu et al., 2010), allowing
more aggregates to be inherited by daughter cells during division; the change in
inheritance suggests that the interaction between Myo2p and actin is necessary
for aggregate retention. Mutations to the globular head of Myo2p that disrupt
vacuole cargo binding similarly reduce asymmetric inheritance of stress induced
aggregates (Bockler et al, 2017). Although Hsp104p heat induced aggregates
have been shown to localize with Myo2p (Song et al., 2014), interaction between
the aggregate and Myo2p may not be direct. Disruption of either Vac17p or
Vac8p, which have both been shown to interact with Myo2p and facilitate vacuole
cargo binding, results in a decrease in Hsp104p aggregate asymmetric
inheritance, suggesting that an intermediate protein such as Vac17p facilitates
interaction. Meanwhile, recent work with pre-existing Sup35NM-GFP aggregates
in [PSI+] cells showed that when Myo2p is depleted from the cell, through an
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auxin-inducible degron system, the number of aggregates per cell increases
(Kumar et al., 2016). This same lab later showed that deletion of Vps1p, not
Vac17p, causes a similar increase in Sup35NM-GFP aggregates as depletion of
Myo2p (Kumar et al., 2017). Despite the support in the literature for the influence
of Myo2p trafficking along the actin cytoskeleton on protein aggregate mobility,
the role of Myo2p in Sup35NM-GFP de novo formation has not been addressed.
Therefore, I investigated whether disruption to Myo2p affects early foci dynamics.
In this chapter, I used several genetic mutants that disrupt the function of
Myo2p to investigate whether the motor protein has a role in the dynamics of
protein aggregate formation. Using the same quantification methods discussed
previously (Chapter 3 and 4), Myo2p influences step 1, but not step 2 of early foci
dynamics. This study begins to shed light onto the mechanism of cellular
response to protein aggregate formation.

5.2 Results
5.2.1 myo2-2 mutant strain reduces newly formed aggregate mobility
Myo2p is essential for viability, localizes cargo to the bud tip, and is
involved in organelle movement. A point mutation within the globular tail of
Myo2p (myo2-2, G1248D; Catlett and Weismann, 1998) leads to defective cargo
localization and mislocalization of Myo2p, while maintaining essential function
(Catlett and Weismann, 1998; Catlett et al., 2000). Early foci mobility was
significantly reduced overall in myo2-2 mutants (0.33µm/min) compared to the
isogenic wildtype strain (0.99µm/min; Figure 5.1). Similar to Chapter 4, given the
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Figure 5.1: myo2-2 mutant displays reduced de novo Sup35NM-GFP
mobility. A. Sup35NM-GFP was induced in High [PIN+] wildtype and myo2-2
strains (Catlett et al. 1998). Strains were imaged in 3D-timelapse with
representative images from a single timelapse shown. A particle trace of the
white caret marked aggregate in the yellow outlined cell is shown. B. The rate of
movement was quantified in individual timelapse recordings using 3D-coordinate
mapping, and a representative graph is shown next to each. On each graph a
linear trend is displayed as the dashed line.

difference between wildtype and the myo2-2 strain, both the slope of aggregate
mobility and the distance moved was also significantly different between strains
(Figure 5.2). I investigated the average rate of movement both during the first 10
minutes of formation and then the third ten minutes. During the first ten minutes
of formation, the wildtype strain mobility averaged 1.4µm/min while myo2-2 was
at 0.57µm/min. During the third 10 minute interval, the wildtype strain average
mobility was 0.91µm/min and the myo2-2 mutant was 0.25µm/min (Table 5.1).
The low rate of mobility in myo2-2 mutants was consistent, as the slope for a
trendline in multiple trials was nearly zero, and the MAD values were low as well
indicating that sample rates did not vary much from the trendline. This is in
contrast to isogenic wildtype cells that exhibited a negative slope with large MAD
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values indicating that the rate of movement varied throughout formation from a
linear trend (Table 5.1). Together, myo2-2 mutants exhibit a low rate of mobility
that does not change or vary throughout formation. These results are reminiscent
of observations associated with act1-120 and act1-122 (Chapter 4, Figure 4.2
and 4.3), indicating that movement behavior is similarly altered in Myo2p and
Act1p mutations compared to wildtype strains.

5.2.2 Coalescence of newly formed aggregates is decreased in myo2-2
Coalescence of newly formed aggregates also differed in the myo2-2
mutant compared to wildtype. The median number of aggregates per cell in the
myo2-2 mutant was significantly higher (2 aggregates/cell) compared to wildtype
(1 aggregates/cell; Figure 5.3). Taken together, these results suggest that either
more aggregates form in myo2-2 cells or aggregates are unable to coalesce like
wildtype strains.

83

myo2-2

Wildtype 2
Wildtype 3
Wildtype 4

-0.5

Wildtype 5

-1.0

Slope (µm/min)

Slope (µm/min)

7

0
-3

27

1

8

4

-2

-2

24

-2

21

myo2-2 1

0.5

myo2-2 2
myo2-2 3

0.0

myo2-2 4

-0.5

myo2-2 5

-1.0
-1.5

03. 3
06.
0
6.
09.
9.
-1
12 2.
.-1
5
15 .
-1
8
18 .
-2
1
21 .
-2
4
24 .
-2
7
27 .
-3
0.

03. 3
06.
0
6.
09.
9.
-1
12 2.
.-1
5
15 .
-1
8
18 .
-2
1
21 .
-2
4
24 .
-2
7
27 .
-3
0.

-1.5

Time Elapsed (Minutes)

Time Elapsed (Minutes)

Myo2 Wildtype

myo2-2

0.4
0.3
0.2
0.1

Distance Traveled (µm)

2+

0.0

0.5
0.4
0.3
0.2
0.1
0.0

0.2
.2
-.4
.4
-.6
.6
-.8
.8
-1
11
1. .2
21
1. .4
41
1. .6
61.
8
1.
82
2+

Percentage of Movements

0.5

0.2
.2
-.4
.4
-.6
.6
-.8
.8
-1
11.
1. 2
21
1. .4
41
1. .6
61.
8
1.
82

Percentage of Movements

18

1.0

Wildtype 1

0.0

-1

myo2-2

Myo2 Wildtype

0.5

-1

0-

Time Elapsed (Minutes)

Time Elapsed (Minutes)

1.0

5

0.00

3

0.00

myo2-2 5

0.01

15

0.01

myo2-2 4

0.02

9

Wildtype 5

12

0.02

myo2-2 3

0.03

9-

Wildtype 4

12

0.03

myo2-2 2

6

Wildtype 3

myo2-2 1

0.04

6-

Wildtype 2

3-

Distance Moved (µm/sec)

Wildtype 1

0.04

0.05

03
36
69
912
12
-1
5
15
-1
8
18
-2
1
21
-2
4
24
-2
7
27
-3
0

Distance Moved (µm/sec)

Myo2 Wildtype
0.05

Distance Traveled (µm)

Figure 5.2: Mobility Comparison of Wildtype and myo2-2. Sup35NM-GFP
was induced for 16 hours in Wildtype and myo2-2 cells. Cultures were then
imaged by long-term 3D timelapse microscopy (see Chapter 2) for the initial
appearance of a protein aggregate. Movement of the early foci was tracked using
3D coordinate mapping. Aggregates from five individual cells of each genetic
background were quantified. Top: The mobility of each aggregate per three
minutes of recording. Middle: Slope of aggregate movement over three minute
intervals during formation. Bottom: The number of events during formation
separated by the distance moved for each minute recorded.
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Wildtype

Mean
Overall rate
Rate
(μm/min)
0.99 +/- 0.8

myo2-2

0.33 +/- 0.3*

Mean Rate in
first 10
minutes

Mean Rate in
third 10
minutes

Mean Slope

Mean MAD

1.43 +/- 0.74

0.91 +/- 0.73

-0.052 +/- 0.08

0.49 +/- 0.21

0.57 +/- 0.45*

0.25 +/- 0.19*

-0.01 +/- 0.01*

0.20 +/- 0.05*

Table 5.1: Slope and Mean Absolute Difference (MAD) values of Aggregate
Mobility. Statistical significance performed using Mann-Whitney Test (* p <
0.01).

Figure 5.3: myo2-2 increases the number of protein aggregates per cell.
Sup35NM-GFP was induced in High [PIN+] wildtype and myo2-2 strains (Catlett
et al. 1998). The average number of protein aggregates was quantified per cell in
each strain from still shot microscopy, and is represented in the graph. Aggregate
number was significantly different between wildtype and myo2-2 by T-test
analysis. (* p<.01)
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5.2.3 Coalescence of newly formed aggregates does not depend on [PIN+]
in wildtype or myo2-2 mutants
As described previously, the formation of Sup35NM-GFP aggregates is
enhanced by the presence of [PIN+] (Chapter 1). Up to this point all of my work in
this chapter has been done using strains containing the high [PIN+] variant.
However, the myo2-2 strain and isogenic wildtype were gifts from Lois
Weisman’s lab, and were found to contain an endogenous version of [PIN+] that
has never been characterized. Both strains were cured by passing on guanidine
hydrochloride (Eaglestone et al., 2000), and subsequently cytoduced with high
[PIN+] for experiments. Given the different behaviors of the wildtype and myo2-2
strain, I investigated whether there were differences between the endogenous
[PIN+] or the cytoduced high [PIN+] variants on Sup35NM-GFP aggregate
coalescence. Coalescence results indicate that the presence of either [PIN+]
variant did not affect Sup35NM-GFP aggregate coalescence (Figure 5.4).

5.2.4 Coalescence of newly formed aggregates in Myo2p Disruptions
I also investigated three other Myo2p mutants for effects on coalescence
to determine whether the previous results were specific to the mutated site on
Myo2p or the disrupted function. The three other Myo2p mutants were: myo2aflII, myo2-D1297G, and myo2-D1297N. The myo2-aflII mutant contains a 33
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Figure 5.4: [PIN+] variant does not alter Sup35NM-GFP aggregate number
between wildtype or myo2-2 strains. Sup35NM-GFP was induced in both High
[PIN+] and endogenous [PIN+] wildtype and myo2-2 strains. The number of
protein aggregates per cell was quantified, with the average displayed in the
graph. While it appears that the number of aggregates in High [PIN+] myo2-2
strains have a broader distribution, the median for both myo2-2 strains was 2
aggregates per cell. T-test analysis showed no significant difference between
wildtype strains and myo2-2 strains respectively.
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amino acid deletion in the Myo2p globular tail, and is not able to bind essential
cargo causing growth and viability issues (Catlett et al., 2000). The myo2D1297G and myo2-D1297N strains are mutations at a site needed for
competitive binding of non-essential cargo such as the mitochondria and vacuole
(Catlett et al., 2000; Eves et al., 2012). myo2-D1297G impairs the inheritance of
vacuoles and causes clumped mitochondria (Catlett et al., 2000; Altmann et al.,
2008). The myo2-D1297N strain only prevents vacuole binding and inheritance
(Eves et al., 2012). Interestingly, both the myo2-aflII and myo2-D1297N had an
increased number of aggregates per cell (median of 2 aggregates per cell),
whereas the myo2-D1297G mutant did not (1 aggregate per cell; Figure 5.5).
Similar to previous reports (Catlett et al., 2000), we found that the myo2-aflII
strain is associated with viability issues and may account for the differences we
observed. However, while both myo2-D1297N and myo2-D1297G both effect
interaction with the vacuole, only myo2-D1297N also effects potential interaction
with protein aggregates.

5.2.5 Myo2p mutants do not alter Sup35NM-GFP aggregate sequestration
The second step of aggregate formation involves early foci localization to
the cell periphery and subsequent growth of foci into larger aggregates such as
dots, lines, and rings (Chapter 3, Sharma et al., 2017). I asked whether
localization of aggregates to the cell periphery was also dependent on Myo2p.
myo2-2 mutants (0.87µm) had similar aggregate sequestration to isogenic
wildtype strains (0.92µm, Figure 5.6), as did the myo2-D1297N (0.88µm) and
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Figure 5.5: Disruptions to Myo2p cause an decrease in Sup35NM-GFP
coalescence. Endogenous [PIN+] myo2Δ strains expressing myo2-AflII, myo2D1297G, or myo2-D1297N from a plasmid, and induced to express Sup35NMGFP were quantified for the average number of protein aggregates per cell. Ttest analysis showed significance between all three deletion strains to a wildtype
control. (* p<.01)
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Figure 5.6: Myo2p disruption does not reduce peripheral localization of
Sup35NM-GFP aggregates. A. Sup35NM-GFP was induced in High [PIN+]
wildtype and myo2-2 strains (Catlett et al. 1998). Protein aggregate localization
was quantified with coordinate mapping in both strains. T-test analysis showed
no significant difference between wildtype and myo2-2. B. Endogenous [PIN+]
myo2Δ strains expressing myo2-AflII, myo2-D1297G, or myo2-D1297N from a
plasmid, and induced to express Sup35NM-GFP were quantified for aggregate
distance to the periphery. myo2-aflII was significantly different from wildtype by
T-test analysis (* p<.01).

myo2-D1297G mutations (0.85µm, Figure 5.6). The myo2-aflII strain (0.77µm)
however, showed a significant difference in aggregate distribution compared to
the isogenic wildtype (Figure 5.6). As with coalescence however, again the effect
seen with the myo2-aflII strain is more than likely due to issues with viability
rather than an effect on aggregate formation. Once again, the presence of either
high [PIN+] or the endogenous [PIN+] did not effect Sup35NM-GFP aggregate
sequestration (Figure 5.6).
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5.3 Discussion
In this chapter the role of Myo2p was explored in relation to the dynamics
of newly formed protein aggregates. In myo2-2 strains, mobility and coalescence
of newly formed Sup35NM-GFP aggregates was reduced, however
sequestration remained at wildtype levels. In addition, two other Myo2p mutant
strains, myo2-AflII and myo2-D1297N, reduced coalescence as well. However,
myo2-D1297G did not change Sup35NM-GFP formation behavior. This work
suggests that Myo2p has a role in the management of newly formed protein
aggregates, and there are specific cargo binding sites that interact with protein
aggregates to potentially traffic aggregates along the actin cytoskeleton.
The myo2-D1297G and myo2-D1297N mutations are at a competitive
binding site on Myo2p for Vac17p and Mmr1p, two “intermediate” proteins that
link the vacuole or mitochondria to Myo2p for trafficking respectively. myo2D1297N prevents only Vac17p interaction, while myo2-D1297G prevents
interaction for both intermediate proteins (Catlett et al., 2000; Altmann et al.,
2008; Eves et al., 2012). myo2-2, although a mutation at a different site but still
within the globular head to bind cargo on Myo2p, has also been reported to
impair vacuole interaction with the motor protein (Catlett and Weismann, 1998).
Given the effects on mobility and coalescence in these mutants, this would
suggest that the interaction with Vac17p may be important for managing
aggregate formation. Recent work involving Vac17p interaction with protein
aggregates and Myo2p is still unclear. Disruption of Vac17p has been shown to
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increase asymmetric inheritance of heat stress induced Hsp104p aggregates
supporting interaction between aggregate-Vac17p-Myo2p (Hill et al., 2016).
However, work with Sup35NM-GFP aggregates in strains that have the preexisting [PSI+] prion has shown the opposite, where disruption of Vacp17p had
no effect on protein aggregates, rather deletion of a different protein that interacts
with Myo2p, Vsp1p, did cause an increase in the number of Sup35NM-GFP
aggregates per cell (Kumar et al., 2017). It is possible that different intermediate
proteins facilitate interaction between different protein aggregates and Myo2p.
The identification of which intermediate proteins, such as Vac17p or Vps1p,
facilitate interaction between different protein aggregates and Myo2p may explain
why different mutations to the same site in Myo2p result in different effects on
Sup35NM-GFP formation. It will be necessary to continue investigating how
protein aggregates interact with Myo2p, specifically the potential relationship that
intermediate proteins facilitate with Myo2p and the possibility of a similar
mechanism of formation between different protein aggregates.
In contrast to actin disruptions, Myo2p mutants did not affect the
sequestration of newly formed Sup35NM-GFP aggregates. While myo2-aflII did
slightly alter localization, again this was suspected to be a produce of viability
issues with the strain rather than changes to sequestration give this mutant
maintains the ability to bind to cargo such as the vacuole or mitochondria. The
ability to localize aggregates to the periphery normally in Myo2p mutants was
surprising as I suspected that localization would be dependent on the ability to
move aggregates towards a particular site in the cell. Localization was expected
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to be highly variable similar to that in actin mutants (Chapter 4), as aggregates
should appear randomly in the cell and due to the lack of mobility by Myo2p,
remain at their site of formation. Given that Sup35NM-GFP is still localized at the
cell periphery in Myo2p mutants, protein aggregates may form near the periphery
of the cell and maintain that localization, with Myo2p only required for mobility
and coalescence.
Taken together, this chapter suggests that Myo2p is required for the
trafficking of newly formed protein aggregates to a single location in the cell,
although it is not necessary for maintaining peripheral localization. It is unclear
how protein aggregates interact with Myo2p, and therefore the potential for other
factors in this mechanism should be explored. Understanding the role of Myo2p
in responding to protein aggregate formation may allow for application to
differentiate where older or diseased cells breakdown in management of protein
aggregates.
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Chapter 6: Sup35p Aggregate Formation Does Not Associate
with Vacuole Fragmentation or Protein Inclusions
6.1 Introduction
In Chapter 3 (Figure 3.9) Sup35NM-GFP aggregates were described to
localize near the cell periphery regardless of genetic background. The peripheral
localization of aggregates is disturbed by mutations to the actin cytoskeleton
(Chapter 4, Figure 4.7), but not the Myo2p motor protein (Chapter 5, Figure 5.6).
The objective of this chapter is to identify other factors that may dictate the
peripheral localization of newly formed protein aggregates.
A screen performed by Manogaran et al., (2011) suggested that there
might be a role of vacuole function on protein aggregate formation. The screen
identified genetic deletions that altered the formation of Sup35NM-GFP
aggregates and/or the later induction of [PSI+], here referred to as ‘prion
mutants’. The prion mutants were characterized into two different classes, early
or late. Early class deletions reduce Sup35NM-GFP aggregate formation and the
induction of [PSI+], while late class deletions form aggregates but have reduced
[PSI+] induction frequencies. Interestingly, strains containing either early or late
class deletions all had fragmented vacuoles. It is possible that changes to
vacuole morphology may alter the spatial localization of newly formed
aggregates in the cell.
Damaged or aggregating proteins are often collected and held in protein
inclusions, holding sites that function to sequester damaged proteins away from
the rest of the cellular environment and provide a potential site to either be
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refolded or enter degradation pathways. Sup35NM-GFP aggregates have been
proposed to localize to a vacuole-associated deposit called the Insoluble Protein
Deposit, IPOD (Tyedmers et al., 2010). Rnq1p, a protein of unknown function,
has previously been used as a marker for IPOD, and Sup35NM-GFP aggregates
are suggested to co-localize with the marker (Tyedmers et al., 2010). Atg8p, an
essential component of the autophagy pathway in yeast and the preautophagosomal structure, PAS, (Reggiori and Klinosky, 2013) can also be used
to identify IPOD (Kaganovich et al., 2008). Observations by snap shot
microscopy found Sup35NM-GFP to be colocalized with Atg8p, and authors
proposed that IPOD may be the site of aggregate formation (Tyedmers et al.,
2010; Arslan et al., 2015). However, these data are in contrast to findings by
Mathur et al. (2009), who suggested that aggregates are first sequestered to the
cell periphery and then localized to the vacuole much later on. The role of
autophagy has also been linked to Sup35NM-GFP aggregation. Disruptions in
autophagy related genes that code for proteins in the general autophagy pathway
cause aggregates to form in more abundance and faster (Speldewinde et al.,
2015). These data suggest that both IPOD and autophagy influence aggregate
formation and possibly localization.
In yeast many protein inclusions have been identified, each associated
with housing different subsets of the protein population (Saarikangas et al.,
2017). Not only have Sup35NM-GFP aggregates been suggested to localize at
IPOD and the PAS, but also with Q-Bodies, which are cytoplasmic protein
inclusions that are often associated with stress induced protein aggregates
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(Arslan et al., 2015). Q-bodies can be identified using Hsp42-GFP. While
Sup35NM-GFP aggregates have been shown to co-localize with various protein
inclusions, there has yet to be a link established between inclusions and the
peripheral localization characterized in the previous chapters.
Here, I explore the link between vacuole morphology, autophagy, and
protein inclusions with Sup35NM-GFP formation and localization. My results
suggest that vacuole morphology or autophagy do not impact the formation of
Sup35NM-GFP aggregates, but also reveal an unexpected finding that the
presence of centromeric plasmids in 74D-694 genetic strains result in vacuole
fragmentation. I also find that newly formed Sup35NMp aggregates do not
localize with Q-Bodies, PAS, or IPOD.

6.2 Results
6.2.1 Characterization of Prion Mutants
Manogaran et al (2011) used the BY4741 background to screen for
deletions that reduced prion formation, and confirmed their results by reengineering the deletions in the 74D-694 background. The original observations
of vacuole fragmentation associated with prion mutants were only qualitative. To
understand the percentage of cells within a population that are fragmented, I
counted the number of cells that had different vacuole phenotypes. Like most
organelles in yeast, vacuole morphology can be very dynamic, with vacuoles
fragmenting and fusing back together (Weisman., 2003; Efe et al., 2005). When
these dynamic processes are altered, persistent fragmentation occurs. The
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fragmentation of vacuoles is characterized into three separate classes: wildtype
cells consisting of 1-3 individual vacuoles, Class B cells consisting of 4-6
vacuoles, and Class C cells with 7+ vacuoles (Figure 6.1A, Seeley et al., 2002).
Two early class mutants (sac6Δ and vps5Δ) and two late class mutants (bem1Δ
and bug1Δ) were characterized along with the isogenic wildtype. The wildtype
strain contained mostly Wildtype Class vacuoles as expected, with 2.5% Class B
and 1.6% Class C (Figure 6.1). bug1Δ was similar to the wildtype strain with 98%
wildtype vacuoles. The sac6Δ mutant was also somewhat similar to the wildtype
strain, but had an increased number of Class B vacuoles to 7.2%. vps5Δ and
bem1Δ showed much more vacuole fragmentation, with 23.4% and 14.9% Class
B vacuoles. Overall there was a large proportion, if not the majority, of cells
regardless of genetic stain that contained wildtype class vacuoles. The high
number of wildtype vacuoles regardless of genetic strain was unexpected and
suggests that vacuole fragmentation itself may not cause a decrease in prion
formation.
Meanwhile, if there is a link between prion mutants and IPOD, then it is
possible that changes to in IPOD localization could be observed in prion mutant
strains. As described above, Atg8p localizes to the perivacuolar inclusion IPOD,
but it is also an integral component of autophagy. Cells that have disruptions to
autophagy possess multiple GFP-Atg8p foci as they are unable to be taken into
the vacuole (Lipatova et al., 2012). I speculated that even low levels of vacuole
fragmentation in prion mutants may impair the ability of Atg8p to localize
properly. Similar to other studies, I found that wildtype cells contained a median
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Figure 6.1: Characterization of Vacuoles and GFP-Atg8p in Prion Mutants.
A. 74D-694 Cells grown overnight were stained with FM4-64 for the vacuole
membrane. Above are images representative for each of the three different
vacuole classifications based on morphology. B. 74D-694 strains of cells were
grown overnight and stained with FM4-64. Vacuoles were quantified for each
genetic strain over three individual trials. C. GFP-Atg8p was expressed in yeast
strains overnight. The number of GFP-Atg8p foci was quantified for each strain in
three separate trials. D. GFP-ATG8 was induced in cell strains overnight. Each
culture was imaged and GFP-ATG8 foci per cell was quantified. After
quantification, each culture was subjected to a thirty minute heat shock of 40°C.
Immediately following heat stress, cells were imaged again with GFP-ATG8 foci
per cell quantified. Above are the average values recorded for each cell strain
under normal or heat stressed conditions.
of one GFP-Atg8p focus. Late class deletions, bem1Δ and bug1Δ also had one
GFP-Atg8p focus (Figure 6.1C). However, early class deletions, sac6Δ and
vps5Δ, had a noticeable increase of GFP-Atg8p foci. It should be noted that even
though sac6Δ and bug1Δ strains have wildtype vacuoles, only sac6Δ has an
increase in GFP-Atg8p foci, suggesting that there is not link between vacuole
fragmentation and the number of GFP-Atg8p foci.
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However, Atg8p has functions that are independent of autophagy. It was
recently shown that Atg8p expression is induced during heat stress as part of a
general proteostasis response, rather than autophagy alone (Ishii et al., 2019).
Given the additional roles of Atg8p outside of autophagy, I speculated that if
prion mutants have altered response to heat stress, than GFP-Atg8p foci may be
different than wildtype cells. To assess whether there were changes based on
the stress response in prion mutants, I subjected all cell strains to a thirty minute
heat shock of 40°C, and then quantified the number of GFP-Atg8p foci per cell.
The average number of foci roughly doubled in each of the genetic strains
including wildtype after heat stress (Figure 6.1D). Given that each strain
responded similarly to heat stress, these data suggest that stress response is not
impaired in any of the prion mutants.

6.2.2 Sup35NM-GFP aggregation is independent of vacuole morphology
Although vacuole fragmentation was observed in prion mutants in Figure
6.1, the figure did not investigate whether localization of Sup35NM-GFP changed
depending upon the level of vacuole fragmentation. In order to perform this
experiment, plasmids containing an inducible Sup35NM-GFP were introduced
into 74D-694 and BY4741 strains. Unexpectedly, 74D-694 wildtype strains with
Sup35NM-GFP aggregates also had fragmented vacuoles (Figure 6.2). To
understand why wildtype cells with the plasmid exhibited fragmented vacuoles, I
considered that the presence of the Sup35NM-GFP construct was causing the
fragmentation. However, the presence of an empty vector in wildtype 74D-694
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resulted in vacuole fragmentation, indicating that the Sup35NM-GFP vector did
not cause fragmentation specifically (Figure 6.2). Fragmentation was not a
product of the transformation protocol, as cells having gone through
transformation without the addition of a plasmid did not cause vacuole
fragmentation. Interestingly, BY4741 wildtype cells, with or without Sup35NMGFP, had higher levels of Class B and C vacuoles compared to the 74D-694
wildtype cells. Given the ability to induce Sup35NM-GFP aggregation in the
BY4741 strain (Chapter 3), the fragmentation of the vacuole is most likely not
related to changes in aggregate appearance. However, these data do indicate
that centromeric plasmids may contribute to vacuole fragmentation.

6.2.3 The role of autophagy in Sup35NM-GFP formation is unclear
Our experiments above indicate there is no link between vacuole
fragmentation, the number of Atg8p foci, and prion mutants. However, it is
possible that autophagy could still be involved. To explore vacuole function in
prion mutants, we used two different methods. The first method was by
quinacrine staining. Quinacrine has been commonly used in yeast to visualize
the vacuole as it is capable of diffusing across membranes and accumulates in
acidic environments (Weisman et al., 1987). As more of the stain accumulates in
acidic environments, previous groups have used the intensity of staining to
determine the level of acidification in the vacuole (Morano and Klinosky., 1994;
Hughs and Gottschling., 2012).
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Figure 6.2: Plasmid expression causes vacuole fragmentation. All cells were
grown overnight and stained with FM4-64 for vacuole morphology
characterization. 74D-694 and BY4741 wildtype cells were used. 74D-694 No
Plasmid cells had gone through the transformation procedure without the
incorporation of a plasmid.

The pH of the vacuole can vary slightly depending upon the needs of the cell,
such as acidification for autophagy function (Nakamura et al., 1997). Therefore,
quantifying the intensity of quinacrine staining will be reflective of changes in the
function of the vacuole.
Both of the early class mutants (sac6Δ and vps5Δ) and bem1Δ had higher
fluorescent intensity compared to the wildtype strain, suggesting a more acidic
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vacuole pH (Figure 6.3A). Coincidentally these three mutants also exhibited
fragmented vacuoles (Figure 6.1). However, the bug1Δ mutant had reduced
intensity compared to the wildtype despite reduced [PSI+] induction. It is possible
that bug1Δ reduces formation through a different mechanism other than a
pathway associated with enhanced vacuole acidification. It should be noted that
the intensity of quinicrine can vary greatly between sample preparations, and
therefore can display some variability in quantitative comparisons. Therefore, a
second measure of vacuole function was used to determine whether aggregate
formation is impacted by the vacuoles’ level of activity.
Using pharmacological agents, general and selective autophagy
processes can be enhanced. Each of these processes leads to degradation in
the vacuole, suggesting that if Sup35NM-GFP aggregation is decreased in
response to one of these treatments, that autophagy processes and vacuole
function influence formation of Sup35NM-GFP. Non-selective autophagy is
enhanced through spermidine treatment (Speldewinde et al., 2015). Selective
autophagy mechanisms for the mitochondria (mitophagy) and ER (reticulophagy)
were also enhanced based on reports of protein aggregates localizing to the
surface of either organelle (Zhou et al., 2014). Ethacrynic Acid (EA) enhances
mitophagy (Deffieau et al., 2009), and DTT or Tunicamycin (TM) enhance
reticulophagy (Cebollero et al., 2012). Enhancing both general autophagy and
mitophagy reduced the formation of Sup35NM-GFP aggregates (Figure 6.3B).
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Figure 6.3: Quinacrine staining is increased in prion mutants, while
autophagy reduces aggregate appearance. A. All strains were grown
overnight and stained with quinacrine to highlight vacuole pH. More acidic
vacuole pH values cause an increase in fluorescent intensity. Vacuoles of
individual cells had fluorescent intensity values quantified through ImagePro
Software. T-test analysis was used to compare mutant strains to the wildtype. B.
Wildtype 74D-694 yeast culture was inoculated in 10mL of media for overnight
growth and expression of Sup35NM-GFP. Prior to incubation, the culture was
split into two 5mL cultures. One culture was left untreated for incubation, while
the second was subject to Spermidine treatment, Ethacryinic acid treatment, DTT
treatment, or Tunicamycin treatment. After overnight growth of each culture, the
percentage of cells expressing Sup5NM-GFP aggregates was quantified in at
least 300 cells over three trials for each treatment. Treatments were compared to
the corresponding untreated control by T-test analysis (* p < 0.01).

Enhancing reticulophagy with either DTT or TM did not alter aggregate
appearance. EA enhances mitophagy by binding to glutathione and preventing
antioxidant properties, resulting in oxidative stressed mitochondria that are not
able to function properly (Schaffer and Buettner., 2001). However, the build up of
reactive oxygen species, as EA treatment would be promoting, is also a major
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driver of general autophagy (Filomeni et al., 2010). Together, this work supports
previous literature (Speldewinde et al., 2015) suggesting that the formation of
Sup35NM-GFP is influenced by autophagy mechanisms.

6.2.4 Previously Defined Inclusion Bodies Are Not All Adjacent to the
Vacuole
To assess whether aggregates are sequestered to protein inclusions, I
first wanted to understand where individual protein inclusions were located in the
cell. Of the three inclusions described in the introduction, a separate protein
marker identifies each (GFP-Atg8p for the PAS, Rnq1-GFP for IPOD, and
Hsp42-GFP for Q-bodies). FM4-64 is a vital dye that is internalized by
endocytosis and remains on the vacuolar membrane. As expected, the PAS was
localized adjacent to the vacuole in nearly all of the cells quantified (Figure 6.4).
However, both IPOD and Q-Bodies were only localized near the vacuole in
roughly half of the cells. Sup35NM-GFP was also localized near the vacuole
approximately 55% of the cells. Together the localization of Sup35NM-GFP near
the vacuole in only roughly half of cell suggests that localization is not associated
with the PAS.

6.2.5 Newly Formed Aggregates Do Not Localize with Previously Defined
Inclusion Bodies
I then investigated colocalization between Sup35NM-RFP and markers for
the PAS, Q-Bodies, and IPOD, and quantified co-localization with snapshot
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image capture and Pearson’s Correlation Coefficient (PCC). PCC quantifies the
degree of overlap between two different fluorescent channels, with a score of 1
representing perfect colocalization and a score of 0 indicating a lack of overlap.
PCC values for aggregates and inclusions were compared to a positive control
strain that contained Sup35NM-GFP and Sup35NM-RFP. As expected, the
positive control gave a PCC median value of 0.67, indicating that PCC can be
used to indicate co-localization. No significant colocalization was observed
between Sup35NM-RFP and the PAS (0.38; Figure 6.5). However, unexpectedly,
no colocalization was also observed between Sup35NM-RFP aggregates and

Figure 6.4: Localization of Protein Inclusions near the Vacuole. A. Individual
cells expressing protein markers for protein inclusions or aggregates (PAS –
GFP-ATG8; IPOD – Rnq1-GFP; Q-Bodies – Hsp42-GFP; APOD – Hsp104-GFP;
aggregate – Sup35NM-GFP) were grown overnight and stained with FM4-64 for
vacuole visualization. Representative images of each are shown. B. Cells imaged
in A were quantified for adjacent localization between the protein marker and the
stained vacuole. The percent of cells with adjacent localization is shown in the
graph.
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Figure 6.5: Newly formed Sup35NM-RFP aggregates do not localize with
previously defined inclusion bodies. A. 74D-694 cells expressing GFP-ATG8
(PAS), Hsp42-GFP (Q-Bodies), or Rnq1-GFP (IPOD) were subjected to
Sup35NM-RFP induction. Representative images of each are shown. B.
Pearson’s Correlation Coefficient (PCC) was used to identify overlap between
Sup35NM-RFP and GFP labeled inclusions. 74D-694 cells expressing
Sup35NM-GFP and Sup35NM-RFP were used as a positive control. Box plots
indicate median and interquartile ranges, with statistical analysis by T-test ( *p
<0.01).

Atg8p (IPOD; -0.07) or Hsp42p (Q-Bodies 0.16; Figure 6.5), despite the fact that
two other studies reported localization (Tyedmers et al., 2010; Arslan et al.,
2015).
It is possible that the snapshot image approach did not adequately capture
the localization of Sup35NM-GFP. Therefore, I assessed colocalization through
the formation of aggregates using time-lapse microscopy to determine whether
colocalization was transient. In 26 recordings of Sup35NM-RFP formation, no
colocalization was observed (Figure 6.6). The distribution of Sup35NM-GFP
aggregate sequestration was also not changed in hsp42Δ strains (Figure 6.7).
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These data suggest that Sup35NM-GFP localization is not Hsp42p dependent
and is not localized to a previously defined inclusion body.

6.3 Discussion
In this chapter I investigated previously identified prion mutants and the
mechanism by which these mutations reduce the formation of Sup35NM-GFP
aggregates, and whether the aggregates were localized with previously defined
inclusion sites. While it was suspected that vacuole fragmentation may influence
aggregate formation, my results indicate that changes to vacuole morphology are
a product of plasmid expression in yeast. I also found that aggregates were not
localized with any of the inclusions previously defined, suggesting that the site
initial aggregate localization remains unclear. While this data does not explain
why prion mutants alter [PSI+] formation, it does suggest that aggregate
localization is independent of the vacuole and provides characterization that can
help target future experiments into the mechanisms of aggregate formation and
management.
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Figure 6.6: Newly formed Sup35NM-RFP aggregates do not colocalize with
Hsp42-GFP at any point during formation. Sup35NM-RFP aggregates were
induced in cells expressing Hsp42-GFP overnight. The formation of Sup35NMRFP aggregates was recorded using 3D timelapse microscopy. PCC was used to
quantify colocalization between Sup35NM-RFP and Hsp42-GFP throughout the
formation process. PCC values were compared to a positive control strain of
Sup35NM-GFP and Sup35NM-RFP by T-test analysis (* p<0.01).

Figure 6.7: Sup35NM-GFP localizes to the cell periphery normally in hsp42Δ
strains. A. Sup35NM-GFP was induced in 74D-694 hsp42Δ cells. B. The
distance to the periphery of the Sup35NM-GFP aggregate from cells represented
in A was quantified. Statistical analysis by T-test did not show significant
difference to wild type.
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While Manogaran et al. (2011) proposed that vacuole morphology may
influence Sup35NM-GFP formation, my results suggest that vacuole
fragmentation does not alter aggregate appearance. As shown, vacuoles were
fragmented in wildtype cells that contained plasmids, indicating that Sup35NMGFP aggregate formation in wildtype cells would also be in the presence of
fragmented vacuoles. However, the prion mutants that had fragmented vacuoles
also had increased quinacrine intensity, indicating a more acidic vacuole possibly
from enhanced autophagy. Autophagy, as my results also suggest, has
previously been shown to influence the formation of Sup35NM-GFP
(Speldewinde et al., 2015). However, early class mutants also had an increased
number of GFP-Atg8p foci. While these mutants also responded to heat stress
similar to wildtype, it is possible the increased number of GFP-Atg8p foci is in
response to enhanced autophagy from inherent stress caused by the genetic
mutation, which in turn reduces the ability to form aggregates.
Most studies have investigated Sup35NM-GFP localization using preexisting aggregates, or long after formation has occurred. Arslan et al. (2015) did
look for colocalization at different time points of formation, however only by using
snap shot microscopy at these time points. Here, I used 3D-timelapse
microscopy to show that Sup35NM-RFP is not associated with Hsp42-GFP
throughout formation (Figure 6.6). It is possible that previous work has found
colocalization as a result of 2D microscopy, or collecting snap shots of transient
overlap of proteins. Using genetics I further showed that Hsp42p does not
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influence the sequestration of Sup35NM-GFP. Together my work provides higher
resolution colocalization studies than have been previously used.
The results of this chapter show that newly formed aggregates do not
localize to previously defined inclusions, or to the vacuole surface. It is possible
that Sup35NM-GFP is localizing to the surface of a different organelle. Work
done by Zhou et al. (2014) using heat induced protein aggregates, found that
aggregates were localized to the surface of the mitochondria and ER. Chapter 7
explores Sup35NM-GFP localization with the surface of these specific two
organelles, and a few others. Defining where newly formed aggregates are
localized will provide insight into the mechanisms by which aggregates are
managed, and possibly define whether all aggregates are managed similarly.
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Chapter 7: Newly Formed Protein Aggregates Localization is
Independent of Peripheral Organelles
7.1 Introduction
In this chapter, I investigate the spatial localization of newly formed
Sup35NM-GFP aggregates with organelles previously identified to associate with
heat-induced protein aggregates (Zhou et al., 2014). Adjacent localization shows
that Sup35NM-GFP aggregates are near the surface of both the mitochondria
and the ER. However, use of strains with genetic manipulations altering the
morphology and localization of organelles suggests that aggregates are not truly
associated with either organelle.

7.2 Results
7.2.1 Newly Formed Aggregates are localized near the Mitochondria/ER
Using markers for the vacuole (FM4-64), mitochondria (Mito-dsRED), ER
(Sec63-mCherry), Nucleus (DAPI), and Peroxisome (SKL-mCherry), I
investigated Sup35NM-GFP localization with each of these organelles.
Sup35NM-GFP did not show any significant overlap by PCC with the vacuole,
mitochondria, ER, nucleus, or peroxisome (Figure 7.1). However, I found
approximately 80% of Sup35NM-GFP aggregates to be localized within 500nm
(adjacent) to either the mitochondria or ER structures (Figure 7.1). These data
suggest that newly formed Sup35NM-GFP aggregates may be localized to the
surface of the mitochondria and ER at the periphery of the cell similar to stress
induced aggregates.
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Figure 7.1: Sup35NM-GFP aggregates localize adjacent to the mitochondria
and ER. A. 74D-694 cells had Sup35NM-GFP expression induced while either
co-expressing Mito-dsRED (mitochondria), Sec63-mCherry (ER), SKL-mCherry
(peroxisome), or were stained with FM4-64 (vacuole) or DAPI (nucleus).
Representative images of each are shown. B and C. Images were quantified for
co-localization by PCC (B) and adjacent localization (C). A positive control was
included in PCC for comparison by T-test analysis (* p < 0.01).
7.2.2 Sup35NM-GFP aggregate localization is not dependent on the
mitochondria or ER
Since I observed Sup35NM-GFP aggregates were localized near the
mitochondria and ER surfaces in the majority of cells, I then wanted to determine
whether aggregates are truly associated with these organelles or simply localized
in the same area. I generated several gene disruptions in the 74D-694
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background that alter the localization or morphology of either the mitochondria or
ER. The distance of Sup35NM-GFP aggregates from the cell periphery in
deletion mutants were assessed and compared to isogenic wildtype strains.
Num1p and Mdm36p are mitochondrial tethering proteins (Lackner et al., 2013).
Deletion of either gene releases mitochondria from the cellular cortex, however
Sup35NM-GFP localization is unchanged in the mutants (Fig. 7.2). Mmm1p and
Mdm12p link the mitochondria with the ER (Kornmann et al., 2009). Deletion of
either gene leads very condensed mitochondria in the center of the cell, yet also
does not alter Sup35 distribution from the cell periphery. Fis1p is a protein that
functions in mitochondrial fission (Zhou et al., 2014). Similar to the other
deletions impacting mitochondrial morphology, Sup35NM-GFP localization was
also unchanged in this mutant. Together, I conclude that changes in
mitochondria morphology and position do not impact the sequestration of
Sup35NM-GFP.
Ice2p and Cho2p are two proteins that support cortical ER integrity
(Lowen et al., 2007; Hermesh et al., 2014), and deletion of either results in less
robust cortical ER (Figure 7.2). Sup35NM-GFP is unaltered in either of these
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Figure 7.2: Disruptions to the Mitochondria or ER do not alter Sup35NMGFP aggregate localization. A and B. Sup35NM-GFP was induced in 74D-694
strains individually containing different genetic mutants disrupting mitochondria
and/or ER morphology/localization. Representative images of each are shown in
A. 3D-coordinate mapping was used to quantify distance to the periphery of
aggregates in each strain. No significant difference was found for any deletion
strain compared to the wildtype using T-test analysis.
mutants. Similar to changes to the mitochondria, mutations altering cortical ER
structure do not change the sequestration of Sup35NM-GFP.
Although changes to the morphology and localization of the mitochondria
and ER did not alter sequestration of Sup35NM-GFP, selective autophagy
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pathways exist for both organelles. As shown before in Chapter 6, enhancing
reticulophagy did not alter the formation of Sup35NM-GFP aggregates, while
mitophagy was inconclusive. To confirm that selective autophagy does not
impact the formation of aggregates, I disrupted genes that impaired mitophagy
(atg32Δ; Kanki et al., 2009) and reticulophagy (atg40Δ; Mochida et al., 2015).
Neither disruption altered Sup35NM-GFP positioning near the cell periphery
(Figure 7.2). Taken together, this suggests that Sup35NM-GFP aggregates are
localized near the periphery of the cell, but at an unknown site that is
independent of most organelles and is influenced by general autophagy.

7.3 Discussion
In this chapter I investigated the spatial localization of newly formed
Sup35NM-GFP aggregates with peripherally localized organelles. Despite
localization to the mitochondria and ER, disruption of either organelle did not
alter the peripheral localization of Sup35NM-GFP, suggesting that sequestration
is not dependent on either organelle. Although the localization of existing
Sup35NM-GFP aggregates has been proposed to be at distinct inclusions or the
surface of organelles, my work suggests that newly formed aggregates have
different behavior.
Using 3D microscopy and time-lapse recordings, I have found that the
localization of newly formed Sup35NM-GFP aggregates is not as clear as others
have described. In Chapter 6 I showed that Sup35NM-RFP aggregates do not
localize with the PAS, Q-Bodies, or IPOD as previously expected. In this chapter,
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I showed that newly formed aggregates, while they do appear to localize to the
surface of the mitochondria and ER, are not associated with either organelle as
heat induced aggregates were proposed to be (Zhou et al., 2014). Up to this
point, the only change found to alter the sequestration of Sup35NM-GFP
aggregates has been the disruption of the actin cytoskeleton (Chapter 4). Mathur
et al. (2009) also found that aggregates are peripherally localized initially, but
after an extended period of time suggest that aggregates are moved inward in
the cell to the vacuole. My data supports that aggregates are not initially localized
to the vacuole, and therefore the peripheral localization is not at IPOD.
Rather, initial localization of aggregates is to an unknown peripheral site, which I
term PPOD, Peripheral Protein Deposit. It is possible that PPOD represents a
new retention site for the initial management of protein aggregates near the
periphery of the cell, however it is also possible that this peripheral site is simply
an unoccupied space in the cell that aggregates can occupy. Further work will be
needed to identify what other factors exist as part of PPOD and whether this
peripheral sequestration is unique to Sup35NM-GFP or part of a general cellular
response to protein aggregate formation, to better explain the biological
relevance of the peripheral localization.
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Chapter 8: Newly Formed Sup35NM-GFP Aggregates Localize
with Hsp104p and Co-chaperones
8.1 Introduction
In the previous chapters I have shown that newly formed Sup35NM-GFP
aggregates do not localize with previously defined inclusion bodies (Chapter 6) or
to the surface of distinct organelles such as the mitochondria or ER (Chapter 7).
However, I have shown that both actin (Chapter 4) and Myo2p (Chapter 5) do
play a role in the management of these aggregates. While actin and Myo2p are
involved, it is unclear what other molecular factors play a role in the formation of
Sup35NM-GFP aggregates. The goal of this chapter is to explore the role of the
Hsp104p chaperone complex in protein aggregate formation as a possible
molecular factor involved in managing protein aggregate formation.
Using 2D snapshot imaging, Saibil et al. (2012) and Arslan et al. (2015)
each showed that de novo Sup35NM-GFP aggregates colocalize with Hsp104p,
Sis1p, and Ssa1p. Hsp104p is a AAA+-ATPase that binds to co-chaperones
Ssa1p and Sis1p. Together, this complex has been shown to extract proteins
from within an aggregate through a central pore using ATP hydrolysis. This
extraction causes the misfolded protein to unfold as it exits the chaperone
(Glover and Lindquist, 1998; Tessarz et al., 2008). Prion propagation is
dependent on Hsp104p as the chaperone complex severs aggregates into
smaller propagons that can be transmitted to daughter cells (Chernoff et al.,
1995; Moriyama et al., 2000; Cox et al., 2003; Shorter and Lindquist, 2004;
Kryndushkin et al., 2011).
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Based on the role of Hsp104p in prion propagation, one might expect that
Hsp104p would disassemble newly formed Sup35NM-GFP aggregates, and
therefore reduce aggregate appearance. Conversely, Hsp104p is required for
prion formation (Zhou et al., 2001). This requirement is likely due to the fact that
Hsp104p is necessary to maintain the [PIN+] prion, which enhances de novo
aggregate formation (Derkatch et al., 2001). However, it has also been
suggested that the co-localization of Hsp104p with Sup35NM-GFP aggregates
may be needed potentially as a scaffolding function to regulate interaction with
other cellular factors allowing for aggregate formation (Saibil et al., 2012). While
aggregate in these previous studies were de novo, formation had been induced
for well over 24 hours, therefore the involvement of Hsp104p with newly formed
aggregates has not been established.
Here, I investigate the localization between newly formed Sup35NM-RFP
aggregates, and Hsp104p-GFP during the two steps of formation. Using 3D
timelapse microscopy, I show the temporal localization of aggregates with
Hsp104p throughout step 1 and 2. I also confirm the requirement of Hsp104p in
the formation of Sup35NM-GFP aggregates by inducing formation in a genetic
strain without Hsp104p. This chapter helps define the temporal association of
Hsp104p with newly formed protein aggregates.
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8.2 Results
8.2.1 Sup35NM-RFP aggregates co-localize with Hsp104p and associated
chaperones
Sup35NM-RFP was overexpressed in strains containing an endogenously
tagged Hsp104-GFP. Using 3D-time-lapse microscopy, Hsp104-GFP was
normally observed as diffuse cytoplasmic fluorescence, with an occasional single
inclusion that was previously characterized to be an age associated deposit
(Sarrikangas et al. 2015). Upon the formation of Sup35NM-RFP, early foci
appeared to be co-localized with Hsp104p (Figure 8.1A). Throughout the timelapse, Hsp104-GFP remained associated with Sup35NM-RFP into step 2 when
the aggregates were sequestered at the cell periphery. PCC analysis of colocalization during step 1 and step 2 showed values that were similar to the
positive control (Sup35NM-GFP and Sup35NM-RFP, Figure 8.1B).
Next, I asked whether Sup35NM-RFP co-localized with Sis1-GFP and Ssa1GFP, the Hsp104p co chaperones. Focusing solely on sequestered aggregates
in step 2, both co-chaperones co-localized with Sup35NM-RFP. Our
observations were confirmed by PCC analysis, where PCC values between
Sup35NM-RFP and Sis1-GFP or Ssa1-GFP were similar to the positive control
(Figure 8.2). Taken together, these results suggest that Sup35NM-RFP
aggregates are associated with Hsp104p prior to sequestration, suggesting that
the chaperone complex may be involved in the cellular response mechanism to
newly formed protein aggregates outside of dissaggregase activity.
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8.2.2: Sup35NM-RFP Aggregates Cannot Form without Hsp104p
The formation of Sup35NM-GFP aggregates is dramatically enhanced in
the presence of the [PIN+] prion (Derkatch et al., 2001; Osherovich et al., 2001),
as well as in the presence of several other protein aggregates such as
polygluatmine aggregates associated with the Human Huntington’s disease. As
mentioned above, Sup35NM-GFP does not form aggregates in hsp104Δ strains
(Zhou et al., 2001), likely due to the loss of [PIN+]. However, it has never been
tested whether Sup35NM-GFP aggregates can be induced in the presence of
other aggregating proteins, such as polyglutamine aggregates associated with
Huntingtion’s, that do not require Hsp104p (Derkatch et al., 2004). Using an
hsp104Δ strain, I induced Sup35NM-RFP formation in the presence of a plasmid
that contains a galactose inducible expanded glutamine tract associated with
exon 1 of the Huntingtin protein, Gal-HttQ103-GFP (Q103-GFP). Q103-GFP
aggregates formed within several hours of galactose addition, which often
resembled large non-uniform dots or wide lines. Yet, even after 24 hours of both
Sup35NM-RFP and Q103-GFP expression, most of the cells continued to display
diffuse Sup35NM-RFP fluorescence. While there was an extremely small
population of cells that contained Sup35NM-RFP aggregates, these aggregates
did not look like typical Sup35NM-GFP as they matched the Q103-GFP
aggregate appearance almost perfectly, not appearing as the normal clean dot
punctate or thin, crisp ring/lines (Figure 8.3). Therefore the requirement for
Hsp104p in Sup35p aggregate formation is supported by the lack of Sup35NMRFP aggregate formation in these cells.
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Figure 8.1: Newly formed Sup35NM-RFP aggregates localize with Hsp104p.
A. BY4741 cells with endogenously expressed Hsp104-GFP were subjected to
Sup35NM-RFP induction that was imaged using 3D timelapse microscopy.
Representative images are shown of a de novo formed Sup35NM-RFP
aggregate during Step 1 (left image) and Step 2 (right image). B. PCC
assessment was performed for the control, and Hsp104-GFP and Sup35NM-RFP
at both the mobility/coalescence and sequestration phases.

Figure 8.2: Newly Formed Sup35NM-RFP Localizes with Sis1-GFP and
Ssa1-GFP. Left. Sup35NM-RFP was induced in 74D-694 cells with either
endogenously tagged Sis1-GFP or Ssa1-GFP. Right. PCC assessment of cells
represented of the left is shown.
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Figure 8.3: Sup35NM-RFP Does Not Form Typical Aggregates in Strains
Without Hsp104. Sup35NM-RFP was induced in hsp104Δ cells with Q103-GFP
expression. Cells were visualized after 24 hours of induction, and nearly all cells
contained diffused Sup35NM-RFP expression. Very few cells contained
Sup35NM-RFP aggregates as shown in the image.

8.3 Discussion
In this chapter I investigated the role of Hsp104p on the formation of
Sup35NM-RFP aggregates. From the detection of early foci, Sup35NM-RFP
aggregates colocalize with Hsp104-GFP, and remain co-localized throughout
mobility and sequestration steps. Sis1-GFP and Ssa1-GFP are also co-localized
with Sup35NM-RFP aggregates. My work also supports the requirement of
Hsp104p for the formation of Sup35NM-RFP aggregates. While it is known that
Hsp104p functions as a dissaggregase that severs protein aggregates, the role
that the chaperone plays in the formation of Sup35NM-GFP aggregates is still
unclear.
Both Saibil et al. (2012) and Arslan et al. (2015) have previously shown
that Sup35NMp aggregates colocalize with Hsp104p in [PIN+] cells at time points
after step 2, or aggregate sequestration to the periphery. Now, my data indicates
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that this co-localization occurs as soon as the early foci are detected. I postulated
that the association between Hsp104p and Sup35NM-GFP aggregates possibly
occurs prior to the detection of early foci, when the proteins are forming
oligomeric complexes. We attempted protein sedimentation experiments to
determine whether Hsp104p would co-sediment with Sup35NM-GFP as soon as
8 hours of induction. While Sup35NM-GFP (Lyke and Manogaran., 2017) and
endogenous Sup35p (Fig. 3.1) can sediment as soon as 8 hours of
overexpression, we found that Hsp104p sedimented without any Sup35NM-GFP
overexpression. The sedimentation without Sup35NM-GFP aggregation is most
likely due to Hsp104p’s association with Rnq1p because cells are [PIN+] causing
the Rnq1p to sediment with the heavy fractions.
Given the localization during step 1 of formation, it is possible that
Hsp104p has another functional role in the management of the aggregate
beyond mere severing. Heat stress induced protein aggregates, as detected
through Hsp104-GFP, have been shown to exhibit reduced mobility when the
actin cytoskeleton is disrupted with LatA (Liu et al., 2010) or decreased
asymmetric inheritance in Myo2 mutants (Bockler et al., 2017). Both studies
propose a role for Hsp104 in the management of these aggregates. These
results are consistent with my findings that Sup35NM-GFP mobility is also
reduced in both actin (Fig 4.3; Table 4.1) and Myo2p mutants (Fig. 5.2, Table
5.1). Based on these observations, it is possible that Hsp104p facilitates the
interaction between protein aggregates and the Myo2p-actin trafficking network.
Hill et al. (2016) suggested that the association between Hsp104p and Vac17p or
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Vps1p is needed for interaction between Myo2p and cargo such as the vacuole.
Deletion of Vps1p disrupted the ability of Hsp104p associated aggregates to
interact with Myo2p (Kumar et al., 2017). Therefore it is plausible that Hsp104p is
localized with Sup35NMp aggregates from the initial appearance as the
chaperone is providing the interaction with the trafficking mechanism in the cell to
properly manage the newly formed aggregate.
Taken together, the Hsp104p chaperone complex may serve multiple
functions with the formation of protein aggregates. Understanding what these
different functions may be will be important to understand how the cell responds
to and manages the formation of protein aggregates. It is also important to note
that Hsp104p associates with many protein aggregates, setting up a potential
system in which the initial cellular response is similar between multiple
aggregates. Further investigation of Hsp104p and the role it plays during protein
aggregate formation will be critical to define the cellular mechanisms involved.
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Chapter 9: Characterization of Stress Granule Formation
9.1 Introduction
As shown in Chapter 8, Sup35NM-GFP aggregates colocalize with
Hsp104-mCherry throughout the process of formation, suggesting that Hsp104p
may play a role in aggregate trafficking mechanisms. However, stress granules
are often visualized by an Hsp104-GFP marker. Stress granules are
membraneless organelles that form in response to cellular stress such as heat
and chemical treatment and are comprised of protein and RNA (Protter and
Parker, 2016). Contrary to Sup35NM-GFP that irreversibly aggregates, stress
granules are reversible. Upon heat or chemical stress, RNA and protein
assemble into aggregates yet disassemble upon removal of the stress (Protter
and Parker, 2016). The goal of this chapter is to investigate whether the
formation of stress granules is managed by similar cellular mechanisms as newly
formed Sup35NM-GFP aggregates.
The formation of stress granules is suggested to take place through a
multi-step process. Kroshwald et al. (2015) found that the proteins in stress
granules go through a liquid-liquid phase prior to coalescing into an aggregate
structure. Newly formed heat induced aggregates have been shown to be mobile
and coalesce shortly after appearing (Escusa-Toret et al, 2013). The step-wise
formation of stress granules is supported by work in mammalian systems that
propose three stages of assembly including nucleation, growth, and fusion
(Wheeler et al., 2016). In Chapter 3, I demonstrated that the formation of
Sup35NM-GFP similarly takes place through a two step process involving
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mobility (and coalescence), and sequestration. It is possible that the stress
granule undergo similar steps to what I have observed and quantitated with
Sup35NM-GFP aggregates.
There is evidence that actin plays a role in the management of stress
granules. Hsp104p marked stress granules colocalize with the actin cytoskeleton
(Liu et al, 2010). The number of Hsp104p associated stress granules increases
in stressed cells treated with the actin inhibitor LatA, suggesting that actin
influences the coalescence of aggregates (Specht et al., 2011). While it is
unclear whether the interaction between actin and stress granules is similar to
that of Sup35NM-GFP, it is possible that the behavior of stress granule formation
may be influenced by actin networks.
Here I investigate the formation of Hsp104-mCherry stress granules.
Through quantification of formation, stress granules and Sup35NM-GFP
aggregates appear to each follow a similar two step process of formation. The
formation of stress granules is also effected similarly when disruptions to the
actin cytoskeleton are used. This work suggests that Hsp104 associated stress
granules all undergo a two step formation process that is influenced by actin
networks.

9.2 Results
9.2.1 Stress Granules Follow the 2-Step (Mobility/Coalescence and
Sequestration) Process of Formation
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To investigate the behavior of stress granules, I induced aggregate
formation using sodium azide (NaN3) in widltype BY4741 cells. NaN3 treatment
has been shown to lead to the aggregation of several stress granule associated
proteins including Pab1p and Pbp1p (Buchan et al., 2011), as well as Hsp104p
(Cherkasov et al., 2013). Heat stress was not used to induce stress granule
formation as our actin mutants are temperature sensitive, therefore chemical
stress allows for investigation of stress granule formation under wildtype
conditions and in actin mutants. Using 3D-time-lapse microscopy, Hsp104mCherry foci appear within 15 minutes after sodium azide treatment. These initial
Hsp104-mCherry foci, which will be called ‘early foci’ are very mobile. The
average rate of movement is 0.49µm/min. The rate of movement fits into the
previously reported range of heat induced aggregates of 0.3-0.8µm/min by
Escusa-Toret et al. (2013). The slope of the movement is negative, which is
consistent with the slope of movement for Sup35NM-GFP aggregates in the
same genetic background (Figure 9.1, Table 9.1). Both Hsp104-mCherry and
Sup35NM-GFP have high mobility during the first 10 minutes of formation, and
each slow down to similar values by the third 10 minute interval. MAD values
between stress granules and Sup35NM-GFP are also similar, suggesting that
there the rate of movement is not constant but is constantly changing over time.
Cells induced for stress granules contained a median of 2 Hsp104mCherry foci per cell after 3-4 hours of stress. These values are higher than the
1 aggregate per cell observed for Sup35NM-GFP (Figure 9.2). However, it
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Figure 9.1: Hsp104-mCherry stress granules are mobile initially during
formation. A. Sup35NM-GFP or Hsp104-mCherry stress granules were induced
in wildtype BY4741 strain cells. 3D-timelapse microscopy was used to record
early foci formation, with representative images shown. A representative particle
trace for the white caret marked stress foci in the yellow outlined cell is shown. B.
The rate of movement is shown in the graph on the right, with a trend line with
slope representing change in rate over quantification. C. Stress granule formation
was induced in BY4741 wildtype expressing Hsp104-mCherry. 3D-timelapse
microscopy was used to record stress foci formation, with representative images
shown. The rate of movement is shown in the graph on the right for each of the
labeled foci, with a trend line with slope representing change in rate over
quantification.

Sup35NMGFP
Hsp104mCherry

Overall rate Rate
(μm/min)

Rate in first
10 minutes

Rate in third
10 minutes

Slope

MAD

0.66 +/- 0.5

1.2 +/- 0.52

0.47 +/- 0.38

-0.028 +/- 0.007

0.30 +/- 0.06

0.49 +/- 0.49*

0.84 +/0.66*

0.34 +/- 0.36
-0.019 +/- 0.006

0.25 +/- 0.06

Table 9.1: Mobility Comparison of Sup35NM-GFP and Hsp104-mCherry
Early Foci in Wildtype Cells. Statistical analysis was performed by MannWhitney test (* p < 0.01).
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Figure 9.2: Stress Granule Coalescence and Sequestration Compared to
Sup35NM-GFP. A. Hsp104-mCherry stress granules were induced in wildtype
BY4741 strain cells. 3D-timelapse microscopy was used to record early foci
formation, with representative images shown to demonstrate coalescence. Each
arrow indicates a separate early foci, with colors merging as foci merge,
eventually becoming a purple arrow when all three early foci have coalesced. B.
Coalescence was quantified for cells with either Sup35NM-GFP or Hsp104mCherry induced. T-test was used for comparison (* p < 0.01). C. Sequestration
was quantified for the same aggregates in B.

should be noted that coalescence still occurs for Hsp104-mCherry foci as
observed (Figure 9.2). The increase in aggregate number is more than likely due
to the large number of proteins and RNA that is incorporated into stress granules
whereas in Sup35NM-GFP induction aggregate formation is mostly due to the
transient expression of a single protein. Both aggregates also had similar
behavior in the second step of formation, sequestration. Stress granules were
localized near the cell periphery (0.79µm) similar to Sup35NM-GFP (0.88µm;
Figure 9.2). Taken together, these data suggest that the initial formation of
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Hsp104-mCherry associated stress granules exhibit a similar two step formation
behavior as Sup35NM-GFP aggregates.
9.2.2: Stress Granule Formation is Effected By Actin Mutation
Similar to Sup35NM-GFP, mobility of Hsp104-mCherry stress granules
was decreased in genetic strains with actin mutations. The overall average rate
of movement decreased in act1-122 and act1-120 strains to 0.24 and
0.28µm/min, respectively (Figure 9.3 and 9.4). During the first ten minutes of
formation, the average rate in wildtype was 0.84µm/min, compared to just
0.32µm/min and 0.33µm/min in act1-122 and act1-120 respectively. By the third
10 minute interval the average rate in wildtype was 0.34µm/min, while in act1122 and act1-120 the rate hardly changed, decreasing slightly to 0.21µm/min and
0.28µm/min respectively (Table 9.2). The small change in mobility over time for
both actin mutants was reflected by a slope that was almost zero (Figure 9.4).
These data are very similar to the slope of Sup35NM-GFP aggregates in act1122 and act1-120 (Table 4.2).

130

Figure 9.3: Mobility of stress induced Hsp104-mCherry foci in wildtype and
act1-122 strains. A. Stress granule formation was induced in BY4741 wildtype
and act1-122 cells expressing Hsp104-mCherry. 3D-timelapse microscopy was
used to record stress foci formation, with representative images shown. A
representative particle trace for the white caret marked stress foci in the yellow
outlined cell is shown. The rate of movement is shown in the graph on the right,
with a trend line with slope representing change in rate over quantification.
Slopes were significantly different by MAD analysis.
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Figure 9.4: Rate of movement quantification in multiple actin mutant
strains. Stress granule formation was induced in BY4741 wildtype, act1-122,
act1-120, and act1-101 cells expressing Hsp104-mCherry. 3D-timelapse
microscopy was used to record stress foci formation, with representative images
shown. Top: The Mobility of each individual foci is shown per three minute
increment. Middle: The Slope of mobility for each foci is shown every three
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minutes. Bottom: The percent of per minute events separated by the distance
moved by foci.

Wildtype
act1-122

Overall rate Rate
(μm/min)
0.49 +/- 0.49
0.24 +/- 0.17*
0.29 +/- 0.29*

act1-120
act1-101

0.64 +/- 0.69

Rate in first
10 minutes
0.84 +/- 0.66
0.32 +/0.21*
0.33 +/0.32*
1.11 +/- 0.87

Rate in third
10 minutes
0.34 +/- 0.36
0.21 +/- 0.16
0.28 +/- 0.28
0.39 +/- 0.36

Slope

MAD

-0.019 +/- 0.006
-0.005 +/0.004*
-0.005 +/0.005*
-0.028 +/- 0.015

0.25 +/- 0.06
0.09 +/- 0.05
0.14 +/- 0.12
0.40 +/- 0.16

Table 9.2: Quantification of Mobility for Hsp104-mCherry Stress Granules.
Statistical Analysis performed using Mann-Whitney Test (* p < 0.01).

Meanwhile, act1-101 increased mobility with a rate of movement during
the first 10 minutes of 1.11µm/min, but slowing to 0.39µm/min by the third 10
minute interval. (Figure 9.4, Table 9.2). The change in mobility is reflected by the
negative slope for the trendline, and high MAD values indicate that mobility was
highly inconsistent over time. Again, the mobility differences of Hsp104-mCherry
in the act1-101 compared to wildtype is similar to observations of Sup35NMGFP, suggesting that there are similar mechanisms of managing both Sup35NMGFP and stress granules.
The act1-122 and act1-120 strains also showed an increased number of
stress granules, and larger distributions in the distance from the cell periphery.
While wildtype cells had a median of 2 aggregates per cell, act1-122 and act1120 cells had a median of 3 aggregates per cell after 3-4 hours of stress (Figure
9.5). Some cells had as many as 8 aggregates per cell. These strains also
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exhibited a wider distribution of aggregate location from the cell periphery,
localizing on average 1.02 and 1.00µm from the cell periphery in act1-122 and
act1-120 strains (Figure 9.6). Once again, these actin mutants were in contrast to
act1-101, which did not impact coalescence or sequestration of stress granules.
Taken together, the similar quantification of mobility, coalescence, and
sequestration of Sup35NM-GFP and Hsp104-mCherry stress granules suggests
that the cellular response to newly formed protein aggregates may be a universal
response to aggregates associated with Hsp104p.

Figure 9.5: Coalescence of Hsp104-mCherry stress granules. Stress granule
formation was induced in BY4741 wildtype, act1-122 , act1-120, and act1-101
cells each expressing Hsp104-mCherry. The number of stress foci per cell was
quantified and the average is displayed in the graph. Representative images are
also shown for each strain. act1-122 and act1-120 strains were significantly
different from wildtype by T-test comparison (* p < 0.01).
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Figure 9.6: Sequestration of Hsp104-mCherry Stress Granules. Stress
granule formation was induced in BY4741 wildtype, act1-122 , act1-120, and
act1-101 cells each expressing Hsp104-mCherry. Stress foci localization was
quantified using coordinate mapping and is displayed in violin plot. act1-122 and
act1-120 strains were significantly different from wildtype by T-test comparison. (*
p <0.01)

9.3 Discussion
Here I have shown that the formation of Hsp104-mCherry stress granules
follows a similar two step process of formation as Sup35NM-GFP aggregates do.
For both types of aggregates, formation begins with highly mobile early foci that
are capable of coalescing together, and over time become static near the
periphery of the cell. The dynamics of formation are also impacted, or reduced,
when the actin cytoskeleton is disrupted. Together, this work suggests that both
Sup35NM-GFP aggregates and Hsp104-mCherry stress granules are initially
managed by similar mechanisms in the cell.
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Previous studies have suggested that the formation of stress granules is a
multistep process that involves the coalescence of early foci (Kroshwald et al.,
2015; Wheeler et al., 2016). My results support a multi-step formation process
that involves the mobility and coalescence of early foci. This behavior is also
impaired by mutations made to the actin cytoskeleton. While the involvement of
the actin cytoskeleton has been implicated previously (Liu et al., 2010; Specht et
al., 2011), quantification performed here gives strong evidence that actin does
impact the formation of stress granules. Although Zhou et al (2011) proposed
that the actin cytoskeleton had an indirect effect on the mobility of stress
granules, here my data suggests that actin may have a prominent role in not only
the mobility of stress granules, but also in coalescence and sequestration. Given
the similarity in behavior between stress granules and Sup35NM-GFP
aggregates, it could be possible that actin is responsible for providing the
network by which newly formed aggregates are trafficked.
It is unclear whether Hsp104p serves a multifunctional role in the
chaperones association with both Sup35NM-GFP aggregates and stress
granules. While it is established that Hsp104p is necessary for the reversible
nature of stress granules, the chaperone may also function to associate
aggregates with cellular response machinery. Recent work suggests that
Hsp104p plays a role in the remodeling of the actin network. Tessarz et al.
(2009) found that Hsp104p interacts directly with the machinery used to remodel
the actin cytoskeleton, and degradation of Hsp104p from the cell results in
perturbation of the actin network. It is possible that Hsp104p interacts with the
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actin network to link protein aggregates to a distinct site in the cell, that is
impaired in actin mutants. What role Hsp104p plays in the formation of protein
aggregates should be explored further to better understand the cellular
mechanisms used. While humans do not possess a homolog to Hsp104p, it is
possible that other factors in protein quality control are involved to manage
protein aggregate formation, and this work will provide the foundation to
understand what the other factors may be unlocking knowledge into the
progression of protein aggregate related diseases.
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Chapter 10: Characterization of TDP-43 Aggregate Formation
10.1 Introduction
In the previous chapters, I observed that the behavior of Sup35NM-GFP
and stress granules are similar, undergoing a 2-step formation process that
appears to be dependent upon actin networks. However, Hsp104p is required for
both Sup35NM-GFP aggregate formation and stress granule formation (Sanchez
and Lindquist, 1990; Cherkosov et al., 2013). To understand whether Hsp104p
plays an important role in this 2-step process, it is important to test protein
aggregates that form independently of Hsp104p. The goal of this chapter is to
observe the formation of TDP-43 protein aggregates, which form independent of
Hsp104p, and use quantification of TDP-43 aggregate formation to better
understand the role of Hsp104p in the management of newly formed protein
aggregates.
TDP-43 is the human TAR DNA binding protein linked to sporadic
amyotrophic lateral sclerosis (Arai et al, 2006; Newmann et al., 2006). While the
protein is not endogenous to yeast, a humanized yeast model was first used by
Johnson et al (2008) in an effort to better understand localization and
aggregation of the protein within an in vivo cellular system. These studies found
that expression of TDP-43 in yeast results in both cytoplasmic aggregates and
cytotoxicity (Johnson et al., 2008).
While both Sup35NM-GFP and TDP-43 both form cytoplasmic
aggregates, TDP-43 aggregates are different. TDP-43p does not form
aggregates that are amyloid in character, nor are they SDS-resistant (Johnson et
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al., 2008). The formation of visual aggregates also does not require Hsp104p, as
hsp104Δ strains are able to form TDP-43 aggregates that continue to exhibit
toxicity (Johnson et al., 2008). However, the formation of aggregates has never
been characterized, leaving the role or involvement of Hsp104p in managing
aggregate formation unclear. The behavior of newly formed TDP-43 aggregates
will provide insight into whether actin networks play a role in managing many
different types of newly formed aggregates, and determine the role of Hsp104p
on the initial cellular response to protein aggregate formation.
Here, I investigate the dynamics of TDP-43-YFP aggregate formation.
Results indicate that the formation of TDP-43 aggregates is a 2-step process,
similar to Sup35NM-GFP and stress granules. While somewhat muted, the
behavior of TDP-43 aggregates is changed in actin mutants and cells lacking
Hsp104p, suggesting a potential role for both the actin network and the molecular
chaperone in the initial management of aggregates. This work helps enhance our
understanding of the formation process of protein aggregates and the
requirements for cellular mechanisms to manage aggregation.

10.2 Results
10.2.1 TDP-43-YFP Aggregate Formation Follows the 2-Step Behavior
Previously Observed
A galactose inducible plasmid containing TDP-43-YFP was introduced into
the BY4741 genetic background. Strains grown in galactose form TDP-YFP
aggregates upon within 3 hours. 3D-time-lapse recordings indicated that newly
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formed TDP-43-YFP aggregates were highly mobile (Figure 10.1), with an
average overall rate of 0.98µm/min (Table 10.1). At first glance, the rate is higher
than the average for both Sup35NM-GFP and Hsp104-mCherry (0.66µm/min and
0.49µm/min respectively). When the rate was analyzed in 10-minute segments,
TDP-43 is remained mobile both in the first (1.08µm/min) and third 10-minute
interval (0.95µm/min; Table 10.1). In contrast, Sup35NM-GFP and stress
granules have considerably less mobility in the third 10-minutes. However, the
average slope of the trendlines was still negative, as evidence by the decreased
rate between the first ten minutes and third ten minute interval (Table 10.1). MAD
values (0.54) also indicate that the rate of movement varied largely from the
trendline, suggesting that mobility was not constant. Together, while TDP-43YFP aggregates display a faster rate of movement compared to Sup35NM-GFP
and stress granules, yet the aggregates continue to slows down over time
through formation, albeit on a longer timescale. The faster rate and smaller
decrease over time is could be due to the constant overexpression of TDP-43YFP resulting in a large amount of protein that the cell is constantly attempting to
incorporate into new aggregates. This constant expression is different from
Sup35NM-GFP, which is transiently expressed. It is also possible that the cell is
not as efficient in recognizing and/or sequestering an expressed heterologous
protein.
While the mobility of TDP-43-YFP aggregates deviated from Sup35NMGFP and Hsp104-mCherry, both coalescence and sequestration were nearly
identical. Cells had a median of 1 TDP-43-YFP aggregate, which was localized
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Figure 10.1: Mobility of TDP-43-YFP aggregates in wildtype and act1-122
strains. TDP43-YFP was induced in High [PIN+] BY4741 wildtype and µd [PIN+]
BY4741 act1-122 cells. Strains were imaged in 3D-timelapse with representative
images from a single timelapse shown. A particle trace representative of the
white caret marked aggregate in the blue outlined cell is shown. The rate of
movement is shown in the graph on the right, with a trend line with slope
representing change in rate over quantification.

Sup35NM-GFP
Hsp104mCherry
TDP-43-YFP

Overall
rate Rate
(μm/min)
0.66 +/- 0.5
0.49 +/0.49*
0.98 +/0.84*

Rate in first
10 minutes

Rate in third
10 minutes

Slope

MAD

1.2 +/- 0.52
0.84 +/0.66*

0.47 +/- 0.38

-0.028 +/- 0.007

0.30 +/- 0.06

0.34 +/- 0.36

-0.019 +/- 0.006

0.25 +/- 0.06

1.08 +/- 0.89

0.95 +/- 0.71*

-0.010 +/- 0.009*

0.54 +/- 0.21

Table 10.1: Mobility Comparison of Different Protein Aggregates. Statistical
analysis comparison to Sup35NM-GFP was performed by Mann-Whitney test (* p
< 0.)
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on average 0.75µm from the periphery (Figure 10.2). This similar behavior
suggests that the coalescence and sequestration of TDP-43-YFP aggregates in
wildtype conditions are very similar to Sup35NM-GFP and stress granules,
suggesting that similar mechanisms may be at play for the initial cellular
response to general aggregate formation.

10.2.2 Formation of TDP-43-YFP Aggregates in Actin Mutants
Since TDP-43-YFP a 2-step formation process, I investigated whether formation
would also be impaired by disruption to the actin cytoskeleton similar to
Sup35NM-GFP. Mobility was drastically reduced in act1-122 and act1-120
mutants (0.77 and 0.74µm/min respectively; Figure 10.1 and 10.3). Similar to
Sup35NM-GFP and stress granules, the mobility observed in act1-122 hardly
changed throughout recording, representing the constant, static positioning of the
aggregate. act1-120 however, exhibited a decrease in mobility that was larger in
magnitude than wildtype. The mobility in act1-101 strains was similar to wildtype
at 1.04µm/min overall, although the rate during the first 10 minutes interval was
much higher than mobility in wildtype cells (Table 10.2).
Coalescence and sequestration were also quantified for TDP-43-YFP
aggregates. As expected based on results with Sup35NM-GFP and Hsp104mCherry, act1-122 and act1-120 cells contained a median of 2 aggregates per
cell, with localization of 1.14µm and 0.92µm from the periphery for act1-122 and
act1-120 respectively (Figure 10.4 and 10.5). In contrast, the act1-101 strains
contained a median of 1 aggregate per cell localized 0.72µm from the cell
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Figure 10.2: Coalescence and Sequestration of Newly Formed Aggregates.
A. Sup35NM-GFP, Hsp104-mCherry, and TDP-43-YFP aggregate formation was
induced in BY4741 wildtype strain cells. The number of aggregates per cell was
quantified and is displayed. B. The same aggregates counted in A were
quantified for spatial localization to the cell periphery. Statistical analysis was
performed using T-test to Sup35NM-GFP.

Wildtype
act1-122
act1-120
act1-101

Overall rate
Rate (μm/min)
0.98 +/- 0.84
0.77 +/- 0.57*
0.74 +/- 0.49*
1.04 +/- 0.80

Rate in first
10 minutes
1.08 +/- 0.89
0.84 +/- 0.67
0.89 +/- 0.63
1.33 +/- 0.84

Rate in third
10 minutes
0.95 +/- 0.71
0.79 +/- 0.53
0.55 +/- 0.27*
0.87 +/- 0.70

Slope

MAD

-0.010 +/- 0.009
-0.004 +/- 0.010
-0.018 +/- 0.020
-0.020 +/- 0.010

0.54 +/- 0.21
0.41 +/- 0.08
0.37 +/- 0.12
0.55 +/- 0.18

Table 10.2: TDP-43-YFP Mobility Quantification in Wildtype and Actin
Mutant Strains. Statistical analysis comparison to Sup35NM-GFP was
performed by Mann-Whitney test (* p < 0.01).
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Figure 10.3: Mobility of TDP-43-YFP in actin mutant strains.TDP43-YFP was
induced in High [PIN+] BY4741 wildtype, act1-120, and act1-101, and µd [PIN+]
BY4741 act1-122 cells. Strains were imaged in 3D-timelapse and the rate of
movement for four individual cells was quantified for each. Top: Mobility for
individual foci is graphed per three minute increments of recordings. Middle: The
slope of the mobility of each individual foci is graphed per three minute
increments of recording. Bottom: The distance moved for each foci per minute
was recorded and binned by length, and is represented by the percent of events
per distance moved.
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Figure 10.4 Coalescence of TDP-43-YFP aggregates in wildtype and actin
mutants. TDP43-YFP was induced in High [PIN+] BY4741 wildtype, act1-120,
and act1-101, and µd [PIN+] BY4741 act1-122 cells. The number of protein
aggregates per cell was quantified and the average is displayed in the graph.
Representative images are also shown for each strain. T-test analysis showed
significant difference between the wildtype strain, and act1-122 and act1-120
strains (* p < 0.01
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Figure 10.5: Sequestration of TDP-43-YFP Aggregates in wildtype and actin
mutant strains. TDP43-YFP was induced in High [PIN+] BY4741 wildtype, act1120, and act1-101, and µd [PIN+] BY4741 act1-122 cells. Protein aggregate
localization was determined in each strain by coordinate mapping, and is
displayed in the violin plot. Wildtype was significantly different from act1-122 and
act1-120 strains by T-test analysis. (* p<0.01)

periphery (Figure 10.4 and 10.5), which was similar to wildtype. Together, the
change in aggregate formation suggests that both the formation of TDP-43-YFP
aggregates, as well as Sup35NM-GFP and stress granules, with an intact actin
cytoskeleton required for proper behavior.

10.2.3 TDP-43-YFP Aggregate Formation is Independent of [PIN+] in act1122 strains
The formation of Sup35NM-GFP aggregates is dependent on the
presence of [PIN+], but are not toxic. Cells containing TDP-43p aggregates are
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toxic regardless of the [PIN+] state (Johnson et al., 2008), however, toxicity
appears to be worse in [PIN+] strains (Park et al., 2017). Therefore, I wanted to
confirm that the behavior observe of TDP-43-YFP aggregates was not a product
of our cells containing [PIN+] and the possible interaction between them. I found
that in [pin-] strains, the number of TDP-43-YFP aggregates was consistent with
my previous wildtype results (Figure 10.6). Localization of aggregates to the cell
periphery was also unchanged between [PIN+] and [pin-] cells. I also observed
that act1-122 mutants lacking [pin-] still have an increased number of aggregates
and wider distribution of peripheral localization than wildtype [pin-] cells. Since
TDP-43-YFP aggregation appeared unchanged in [pin-] cells suggests that [PIN+]
does not play a role in the formation and aggregation of TDP-43.

Figure 10.6: The Presence of [PIN+] does not affect TDP43p aggregate
dynamics. A. TDP43-YFP was induced in [pin-] BY4741 wildtype and act1-122
strains. Representative images are shown. The average number of protein
aggregates per cell was quantified and is displayed. T-test analysis was used to
show significant difference between wildtype and act1-122 strains. B. Protein
aggregate localization was quantified using coordinate mapping. Wildtype and
act1-122 were significantly different by T-test analysis. (* p<0.01)
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10.2.4 Hsp104p Impacts Early Foci Formation of TDP-43-YFP
Although previous work has suggested that TDP-43 aggregates are
independent of Hsp104p, I wanted to test whether Hsp104p had a role in the
behavior of newly formed aggregates. First, I asked whether TDP-43 and
Hsp104p are co-localized. Cells containing TDP-43-YFP aggregates did not have
distinct Hsp104-mCherry foci supporting a lack of interaction (Figure 10.7). In
fact, most cells contained diffuse Hsp104-mCherry fluorescence suggestive that
the chaperone was not accumulating at any particular site in these cells.
Next, I tested whether TDP-43 aggregates exhibit the 2-step behavior
without Hsp104p, I turned to an hsp104Δ strain and quantified the dynamics of
aggregate formation. If Hsp104p was required for mobility, then loss of HSP104
would lead to decreased mobility of TDP-43 aggregates. The average rate of
movement in the deletion strain was 0.58 µm/min, which is much lower than the
average rate of movement in the wildtype strain (Figure 10.8). During the first 10
minutes of appearance the rate of movement in the hsp104Δ strain was
0.89µm/min and slowed to 0.30µm/min by the third 10 minute interval. The rate
of movement, slope in trend, and MAD value are all different for the hsp104Δ
strain compared to wildtype (Table 10.3). Since the mobility of TDP-43-YFP
aggregates is much different in the hsp104Δ strain, this difference suggests that
while Hsp104p may not be necessary for the formation of aggregates, the
chaperone does have an important role in the behavior of aggregates.
The coalescence of aggregates was also impaired in the hsp104Δ strain.
Cells contained a median of 2 aggregates per cell, double the number of
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Figure 10.7: TDP-43-YFP does not localize with Hsp104-mCherry. TDP-43YFP aggregates were induced in wildtype BY4741 cells expressing Hsp104mCherry. Cells were imaged and assess for colocalization between the two
proteins. PCC was not used for quantification as cells containing TDP-43-YFP
aggregates contained only diffuse Hsp104-mCherry and artificially show
colocalization.
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Figure 10.8: Quantification of TDP-43-YFP Formation in hsp104Δ strains. A.
TDP-43-YFP was induced in hsp104Δ. A representative image is shown. B.
Strains were imaged in 3D-timelapse and the rate of movement for four individual
cells was quantified for each. Graphs for each strain are shown with trend line. C
and D. TDP-43-YFP was induced in Wildtype and hsp104Δ strains. The number
of aggregates per cell was quantified and is shown above. The localization of
aggregates was also quantified by measuring the distance to the periphery for
each. Statistical analysis was performed using Students T-Test ( * p < 0.01).

Rate in first
10 minutes
1.08 +/- 0.89

Rate in third
10 minutes
0.95 +/- 0.71

Slope

MAD

Wildtype

Overall rate
Rate (μm/min)
0.98 +/- 0.84

-0.010 +/- 0.009

0.54 +/- 0.21

hsp104Δ

0.58 +/- 0.52*

0.90 +/- 0.71

0.30 +/- 0.23*

-0.029 +/- 0.013

0.37 +/- 0.06

Table 10.3: Quantification of Mobility of TDP-43-YFP aggregates in
hsp104Δ. Statistical analysis comparison to Sup35NM-GFP was performed by
Mann-Whitney test (* p < 0.01).
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aggregates observed in wildtype strains (Figure 10.8). Previous work that
showed TDP-43p still formed aggregates in hsp104Δ strains only qualitatively
compared the appearance of aggregates (Johnson et al., 2008), potentially
overlooking the effect Hsp104p has on aggregate formation. Interestingly, both
mobility and coalescence of TDP-43-YFP in hsp104Δ strain is similar to TDP-43
mobility and coalescence in act1-122 and act1-120 strains, suggesting that the
Hsp104p and actin may serve similar roles during the formation of protein
aggregates.
The distance to the periphery was also quantified in hsp104Δ strains.
TDP-43-YFP aggregates were localized 0.66µm from the cell periphery, similar to
aggregates in wildtype localized 0.75µm from the periphery (Figure 10.8). The
normal localization of aggregates suggests that Hsp104p does not play a role in
the second step of formation, however given that the deletion strain effects both
mobility and coalescence, Hsp104p may have a role in the first step of aggregate
formation.

10.3 Discussion
In this chapter I investigated the formation of TDP-43-YFP aggregates.
Although there were subtle differences in quantification between Sup35NM-GFP
and Hsp104-mCherry stress granules, TDP-43-YFP displayed a similar trend in
behavior. Aggregate formation started with high mobility that was lost over time
as aggregates coalesced, eventually localizing near the cell periphery. The first
step of formation is impaired by both mutations to actin or disruption of Hsp104p.
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However, only actin alters the sequestration of TDP-43-YFP aggregates.
Together this work suggests that both actin and Hsp104p are involved in the
initial response of protein aggregates, while peripheral localization may be the
result of an unknown mechanism that is also actin dependent.
The behavior of TDP-43-YFP aggregate formation has not been
characterized previously. While work before has investigated the presence of
aggregates and toxicity, the data here represents the first quantification of TDP43-YFP aggregate formation. As described, aggregates displayed characteristic
behavior for the initial appearance of protein aggregates based on my previous
work. Sup35NM-GFP, stress granules, and TDP-43-YFP aggregates each
initially appear as mobile early foci that are capable of coalescing together. After
a short period of time aggregates become static at the cell periphery. The actin
cytoskeleton appears to impact step 1 for all three aggregate types, but only step
2 for Sup35NM-GFP and stress granules. Together, this work suggests that the
initial formation of protein aggregates is managed by an actin dependent process
that may be part of a general response to aggregate formation.
The ability of TDP-43-YFP to aggregate was shown previously to be
independent of Hsp104p (Johnson et al., 2008), and my results support this claim
(Figure 10.6). However, my work also suggests that Hsp104p does play a role in
managing aggregate formation. Unlike previous studies, I quantified the
formation of TDP-43-YFP aggregates in cells with and without Hsp104p. Cells
lacking Hsp104p had altered dynamics of aggregate formation. The change in
formation suggests that while TDP-43-YFP forms aggregates without Hsp104p,
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the chaperone plays a role in the cellular response to newly formed TDP-43
aggregates. It is possible that Hsp104p facilitates interaction between protein
aggregates and the actin cytoskeleton as disruptions of either alter step one of
formation similarly. Hsp104p associated stress granules have been shown to
have localization changes in disruption strains of Vac17p or Vps1p (Hill et al.
2016; Kumar et al., 2017). Similarly, mutation to Myo2p to prevent the binding of
Vac17p has similar effects on Hsp104p aggregates (Hill et al., 2016; Bockler et
al., 2017). Both Vac17p and Vps1p interact with Myo2p to facilitate cargo
binding. Taken together, Hsp104p may facilitate interaction between protein
aggregates and a protein such as Vac17p or Vps1p, which allows interaction with
Myo2p for trafficking along the actin cytoskeleton.
Overall, this chapter has demonstrated that yet another type of protein
aggregate follows a similar 2-step process of formation that is impacted by the
actin cytoskeleton. Further work is needed to identify what other players are
involved in this mechanism and what role they play, such as Hsp104p, to fully
understand how the cell is responding to the formation of protein aggregates.
Knowing how the cell responds to the formation of protein aggregates may
provide clues as to why older cells struggle to manage aggregates and why the
formation of protein aggregates is often associated with disease.
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Chapter 11: Discussion
11.1: Summary
This dissertation further characterized the behavior and dynamics of newly
formed protein aggregates in yeast. Innovative quantifiable techniques to
measure the two-step process of aggregate formation were established (Chapter
3). To do this two different wildtype strains were quantified, both having similar
aggregate behavior although subtle differences were found in consequence of
aging disparities. Using the quantification of wildtype as a baseline, disruption of
the actin cytoskeleton was found to impair the dynamics of both step 1 and 2 of
formation (Chapter 4). Similarly, mutations to Myo2p disrupted step 1 of
aggregate formation (Chapter 5), but not step 2, suggesting that the Myo2p
motor protein is necessary for early foci dynamics but not peripheral
sequestration. Subsequent work shows that contrary to previous reports, newly
formed aggregates are not localized to protein inclusions (Chapter 7) or the
surface of distinct organelles (Chapter 8), but rather simply to the periphery of the
cell to an undefined location. Here, this final chapter discusses the implications of
the results described on the current state of the field, and provides potential
future experiments that will help further this knowledge.

11.2: Overall Mechanism
11.2.1 Actin-Myosin Mediated Step 1
Mutations to either actin (Chapter 4) or Myo2p (Chapter 5) decreased the
mobility and coalescence of newly formed Sup35NM-GFP aggregates observed
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using 3D time-lapse microscopy. Both Hsp104-mCherry stress granules (Chapter
9) and TDP-43-YFP aggregates (Chapter 10) had similar alterations to behavior
in mutant yeast strains. My work supports the role of actin and Myo2p on early
foci dynamics of stress granules that was previously proposed (Liu et al., 2010;
Specht et al., 2011, Zhou et al., 2011; Hill et al., 2016; Bockler et al., 2016).
While the effects of mutations to actin or Myo2p are consistent in my study and
with others, it remains unclear how exactly early foci behavior is impacted by
actin cytoskeleton trafficking mechanisms.
Recent work has explored the relationship between heat induced protein
aggregates and Myo2p, finding that a potential interaction between the aggregate
and Myo2p exists through an intermediate protein such as Vac17p or Vps1p (Hill
et al., 2016; Kumar et al., 2017). Mutations to Myo2p that prevent interaction with
Vac17p was found to alter the inheritance of heat induced protein aggregates
(Hill et al., 2016; Bockler et al., 2016), suggesting that there may be an
association of aggregates either to the vacuole or the intermediate protein
directly. Association to the vacuole is unlikely, as I did not observe localization
between aggregates and the vacuole (Figure 6.5), therefore it seems likely that
newly formed protein aggregates are capable of associating with an intermediate
protein to facilitate mobility and coalescence through a mechanism other than
organelle attachment.
Both Sup35NM-GFP and stress induced aggregates are highly associated
with the chaperone protein Hsp104p. It is possible that Hsp104p facilitates the
interaction between protein aggregate and intermediate protein to be trafficked
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along the actin-myosin network. This proposed mechanism involving Hsp104p to
facilitate interaction with the actin-myosin network is supported by observations
that the mobility and coalescence of TDP-43-YFP aggregates is impaired in the
absence of Hsp104p (Figure 10.7 and Table 10.2), which does not require
Hsp104p for formation suggesting that Hsp104p is important for step 1 of
aggregate formation regardless of necessity. Hsp104p may associate with newly
formed protein aggregates at or before their visualization, and facilitate
interaction with an unknown protein that links the protein aggregate complex to
Myo2p for trafficking along the actin cytoskeleton (Figure 11.1A). Further work
will be necessary to understand how Hsp104p is able to interact with Myo2p and
potentially facilitate the mobility of newly formed protein aggregates.

11.2.2: Actin Mediated Step 2
The second step in the formation of protein aggregates is peripheral
localization, or sequestration. Sharma et al (2017) described the static
localization of newly formed Sup35NM-GFP aggregates as being at the periphery
of the cell, but was not able to quantify this localization. My work suggests that
regardless of aggregate type, newly formed aggregates are indeed localized near
the periphery of the cell consistently. Previous work suggested that Sup35NMGFP aggregates localized to the protein deposit IPOD (Tyedmers et al., 2010),
however this localization did not seem likely as association of IPOD to the
vacuole would mean the inclusion would not always be consistently localized.
Consistent with this notion, I found that newly formed aggregates were not
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A

Protein Aggregate

Hsp104

Unknown Intermediate

Myo2
Actin

B
Actin Patch

Figure 11.1: Current Model of Step 1 and 2 of Protein Aggregate Formation.
A. Early foci are highly mobile in the cell, with the potential to coalesce into a
larger aggregate that can remain mobile for some time. The insert shows the
proposed association of the early foci with the actin-Myo2p complex, mediated
through Hsp104p interaction and an unidentified protein. B. In step 2 of
formation, aggregates are localized to the cell periphery, and this localization is
dependent on actin, and Hsp104p remains associated with the aggregate. It is
unclear however what the association between the aggregate, actin, and
Hsp104p are at this point.
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localized to any previously defined protein inclusion, including IPOD (Chapter 6),
and the consistent localization suggests that Sup35NM-GFP incorporation into
IPOD is unlikely initially. Although, it is possible that long after the initial formation
of aggregates they are moved to a specialized inclusion, such as IPOD. Mathur
et al (2009) described Sup35NM-GFP formation as being peripheral as I have,
however over time they found that aggregates are sequestered into the cell by
the vacuole, suggesting that the peripheral localization that I observe is only part
of the initial response.
Interestingly, despite the static localization, mutations to the actin network
that impacted step 1 also alter the peripheral localization of aggregates.
Disruption with pharmacological agents in cells with Sup35NM-GFP aggregates
resulted in a change of localization, suggesting that the actin cytoskeleton is
necessary for maintaining peripheral localization (Chapter 4). Mutations to Myo2p
did not alter aggregate localization (Chapter 5), suggesting that the motor protein
is only involved in step 1 of formation.
The mechanism by which the actin cytoskeleton impacts the localization of
newly formed protein aggregates is undetermined. It is possible that protein
aggregates are localized to unoccupied space in the cell, but mutations to actin
may cause changes to the localization of organelles and other cellular
components. These changes may be enough to alter where and if any
unoccupied space in the cell exists, therefore altering localization of the protein
aggregate.
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It is also possible that the localization of aggregates is determined more
directly to the actin cytoskeleton. Disruptions to cortical actin patch proteins
decreases the formation of Sup35NM-GFP aggregates, however are also
associated with an increase in toxicity with induction (Ganusova et al., 2006),
suggesting that there is a link between cortical actin and protein aggregates. It is
possible cortical actin is used to hold protein aggregates to a single site at the
periphery of the cell until protein quality control is able to manage the aggregates
through a different pathway. Heat induced aggregates have been proposed to be
tethered by actin to deposition sites given the requirement of actin for asymmetric
inheritance and localization (Song et al., 2014). Given our understanding of the
mechanism of step 1 of formation, protein aggregates may be trafficked along
actin networks to dense actin patches at the periphery of the cell, where
aggregates remain associated with the actin patch for static localization through
an unknown interaction (Figure 11.1B). Given that improper localization of
aggregates can lead to enhanced toxicity, furthering our understanding of the
mechanisms behind sequestration of protein aggregates is necessary.
Identification of where protein aggregates localize at the periphery of the cell may
help define how protein aggregates are managed.

11.2.3: Age-Related Decline in Managing Protein Aggregates
Many protein aggregate related diseases are prevalent in an aging
population, and this is reflected in studies of protein aggregate biology. Older
cells or those with genetic disruptions that mimic accelerated aging in yeast,
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contain more protein aggregates and loss of asymmetric inheritance of protein
aggregates during cell division (Erjavec et al., 2007; Speldewinde et al., 2017).
Similarly, I found that in the 74D-694 background cells that had gone through
many cell divisions had more protein aggregates than those who had rarely
divided, suggesting a role of age in managing protein aggregates (Chapter 3).
Although wildtype BY4741 did not display this effect, this genetic background
with mutations to the actin cytoskeleton did (Chapter 4). Given that the number of
protein aggregates in the cell appears to be mostly impacted by age, one might
infer that step 1 of aggregate formation is impaired by an age related effect. This
age effect could be related to the actin cytoskeleton, which when impaired results
in more aggregates per cell in older cells, and since the actin cytoskeleton is
necessary for proper coalescence. It is possible that finding a mechanism by
which to enhance the robustness of the actin cytoskeleton would counteract the
reduction of coalescence observed in older yeast strains, and could decrease
toxicity associated with protein aggregation. Determining whether the number of
protein aggregates influences the toxicity associated to aggregation will help
future understanding of the implications of age related effects.

11.3: Comparison of Different Aggregate Types
As described in Chapter 1, there are three main methods to induce protein
aggregation in yeast: overexpression, stress, and heterologous expression. In
this study I quantified the formation of a protein aggregate from each of the three
different methods of aggregation expression (Hsp104-mCherry stress granules,
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Sup35NM-GFP, and TDP-43-YFP). Since the expression for these aggregates is
different, the behavior of each is expected to be different. Hsp104-mCherry
stress granules form rapidly within minutes of the addition of chemical stress,
while Sup35NM-GFP aggregates take the longest of the three to form at 12-16
hours for visible early foci. TDP-43-YFP forms aggregates at an intermediate rate
compared to the other two, forming in just a couple of hours from initial
expression. Given these differences in the rate of formation, it was expected that
the behavior of the aggregates might be different. Stress granule formation is so
fast and incorporates a large portion of cytosolic components, that it may be
difficult for the cell to respond to and manage each of the early foci that appear,
whereas the slow formation rate of Sup35NM-GFP should be much easier for the
cell to act on. TDP-43-YFP is constantly overexpressed to ensure there is always
protein available in the cell to aggregate, but this overexpression combined with
the protein being non-endogenous to yeast may make it difficult to respond to or
even recognize. Despite these differences, all three aggregates generally had
similar formation behavior: mobile early foci that slowed over time, coalescence
of early foci, and peripheral localization.
Given a similar initial behavior in the cell, it seems likely that the same
cellular mechanism is responsible for recognizing and responding to aggregate
formation. I suspect that the chaperone Hsp104p is an important part of this initial
cellular response. Without Hsp104p, TDP-43-YFP aggregates have reduced
mobility and coalescence, suggesting a role for the chaperone in step 1 of
formation. However, neither Sup35NM-GFP or stress granule formation can be
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quantified in cells lacking Hsp104p due to requirements for formation. As
previously described, Hsp104p may facilitate interaction between protein
aggregate and the trafficking machinery in yeast.
Aggregate recognition may also be associated with sHSP’s. In fission
yeast, Hsp16p is necessary for aggregate fusion and asymmetric inheritance of
stress induced aggregates (Coelho et al., 2014). Similarly, in budding yeast
Hsp42p and Hsp26p have proposed roles in aggregate recognition and
localization (Specht et al., 2011; Malinovska et al., 2012). However, my data
suggests that Hsp42p is not involved with Sup35NM-GFP aggregate formation.
Rather, the Hsp104p co-chaperone Ssa1p is known to recruit Hsp104p to protein
aggregates (Winkler et al., 2012). It is possible that Ssa1p initially recognizes the
formation of protein aggregates, and subsequently recruits Hsp104p to facilitate
interaction with the trafficking mechanism for proper management of the
aggregate. Identifying how protein aggregates are initially recognized in the cell
may be difficult to assess as recognition may take place prior to visualization of
aggregates. Given the association of Hsp104p with Sup35NMp aggregates at the
initial appearance of aggregates, this suggests that the cellular response to
protein aggregate formation is prior to visualization. While biochemical methods
can be used to interpret aggregate association prior to visualization, current
techniques do not allow for a reliable approach to address this question or
understand the mechanism by which aggregates would be recognized by the
cell.
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11.4: Implications
As described previously, the quantitative techniques used to describe the
behavior of aggregate formation are novel. Previous studies have investigated
the formation of protein aggregates, but not to the extent that I have done here.
These techniques set the stage for future experiments and expanded use of 3D
time-lapse microscopy to explore the behavior of different processes in yeast.
This quantification will be extremely useful in understanding the mechanisms of
aggregate formation beyond what I have described here. However, it is feasible
that these same methods can be applied to other mechanisms of yeast cellular
biology. Processes such as autophagy or the inheritance of organelles can now
be quantified in real time for their behavior, and enhance our understanding of
these cellular mechanisms.
The two-step behavior of protein aggregate formation described here will
also be influential in creating more targeted experiments in the future to
understand protein aggregate associated disease. Similar to protein aggregates
in yeast, aggresomes in mammalian cells have been found to be trafficked by
dynein motor proteins along microtubule networks (Olzmann et al., 2008). While
the systems and components are different, the mechanisms of managing protein
aggregates appear to be very similar. Understanding protein aggregate formation
in a simple system like yeast may direct studies in higher organisms to
homologous cellular components, expediting our understanding. This in turn has
the potential to lead to new therapeutics that target prevention or early treatment
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of human diseases, rather than the current approaches that are focused on
dissolving existing aggregates.
Together, this dissertation identifies a novel approach to characterize the
formation of protein aggregates in yeast. This approach and subsequent study
has uncovered many details about the mechanisms managing protein
aggregates that were previously unknown, changing the dogma of the current
field. Further work using these techniques will strengthen our understanding of
protein aggregate formation, and potentially lead to the development of strategies
to treat or prevent protein aggregate associated diseases much more efficiently.
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